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Abstract 
Normal pressure hydrocephalus (NPH) is characterised by a build-up of cerebrospinal fluid 
(CSF) in the brain despite apparently normal CSF pressure at lumbar puncture. In addition to 
movement and urinary symptoms, patients commonly display cognitive decline and apathy. 
NPH is recognised as an important cause of cognitive decline as it is thought be reversible with 
surgical CSF diversion (e.g. shunt surgery). However, this remains controversial and the 
neuropsychology of NPH is relatively poorly understood. Further, despite being the most 
commonly reported neuropsychiatric symptom in NPH, the significance of the symptom of 
apathy has not yet been elucidated. This thesis aims to expand on the neuropsychological and 
neuropsychiatric research in NPH, with the main objectives being to investigate 
neuropsychological outcome, and the significance of the symptom of apathy in NPH. 
 In order to investigate neuropsychological outcome following shunt surgery in NPH, a 
systematic review and meta-analysis was conducted (Chapter 2). The findings from studies 
which used a battery of neuropsychological tests to assess cognitive outcome in NPH were 
combined. Meta-analyses were conducted on pre-operative and difference scores for the most 
commonly used neuropsychological tests. These were seven tests which spanned global 
cognitive function, learning and memory, executive function and psychomotor speed. Results 
for all tests were significant in the direction of improvement. However, the significance of the 
results for two measures of executive function were deemed not to be robust. This is discussed 
in line with previous research which suggests that executive function may be less likely to 
improve following shunt surgery than other neuropsychological domains. 
 Next, the thesis focuses on the symptom of apathy. Chapter 3 investigated whether 
apathy in NPH relates to cognitive outcome and to a measure of ventricular enlargement. A 
reduction in apathetic symptoms following treatment was associated with better performance 
in a measure of global cognitive function. Further, larger ventricles (which may indicate greater 
disease severity/ brain damage) was associated with more severe apathy. A structural MRI study 
was then conducted to expand on these findings and to define brain structural correlates of 
apathy in NPH (Chapter 4). Results from this study suggested a potential role of the caudate 
nuclei in apathetic symptoms in NPH. 
 Finally, consideration is given to the assessment of apathy in NPH. Since apathy is 
rarely investigated in patients with NPH it is unclear which assessment method is most 
appropriate for this patient group. Chapter 5 presents findings from a feasibility study of a novel 
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reward learning task to determine whether it might be useful as an objective measure of 
motivation and apathy in NPH. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
Declaration 
This dissertation is the result of my own work and includes nothing which is the outcome of 
work done in collaboration except as specified below, in the Acknowledgements, and in the 
text. It is not substantially the same as any that I have submitted, or, is being concurrently 
submitted for a degree or diploma or other qualification at the University of Cambridge or any 
other University or similar institution except as declared in the Preface and specified in the text. 
I further state that no substantial part of my dissertation has already been submitted, or, is being 
concurrently submitted for any such degree, diploma or other qualification at the University of 
Cambridge or any other University or similar institution except as declared in the Preface and 
specified in the text. It does not exceed the prescribed word limit for the relevant Degree 
Committee.  
 Chapter 2: I conducted the literature review and extracted the raw data. The statistical 
analyses were conducted with help from Dan Jackson.  
Chapters 3 and 4: The analyses in chapters 3 and 4 were conducted using previously 
collected data. The neuropsychological and imaging data were collected by previous 
PhD students Elise DeVito, Charlotte Housden, and Nicole Keong. I was responsible 
for the conception and design of the analyses, statistical and imaging analyses and 
interpretation of results. The bicaudate ratios for Chapter 3 were calculated by myself 
and Prof John D. Pickard since Prof Pickard has considerable expertise in calculating 
bicaudate ratios.  
Chapter 5: Charlotte Housden programmed the simple Salience Attribution Task and 
recruited and tested the older adult participant group. I recruited and tested the younger 
adult participant group, conducted the statistical analysis (for both groups), and 
interpreted the results. 
 
 
 
 
 
v 
 
Acknowledgements 
Firstly, I would like to thank all of the individuals who took part in the studies contained in this 
thesis as well as in other projects I was involved in over the past four years.  
I would like to thank my supervisors, Professor Barbara Sahakian and Professor John 
Pickard, for giving me the chance to do a PhD and for believing in me. I am privileged to have 
been mentored by two incredibly inspiring individuals but on top of that, both have been 
tremendously kind, encouraging, and supportive. I have learned so much from both of you and 
cannot thank you enough for the opportunities you have given me.  
I would also like to thank my undergraduate supervisor and good friend Professor 
Trevor Harley for first igniting my passion for research, for encouraging me to do a PhD, and 
for his continued support and advice. 
I have had the good fortune to meet so many wonderful people at Cambridge who have 
supported me and my PhD research in various ways. In particular, I would like to thank the 
following individuals: Dan Jackson for kindly giving up so much of his time to assist with the 
meta-analysis project and to teach me statistics; Elise DeVito, Charlotte Housden, Clare 
Killikelly, and Nicole Keong for their invaluable advice and mentorship; Roger Tait, Tom 
Mole, and Elijah Mak for their help during the structural imaging projects; Sharon Erzinclioglu, 
Liam Nestor, Valerie Voon, and Anne Manktelow for their help during projects not included in 
the thesis; Karen Ersche, Alonso Pena, and Marius Mada for interesting discussions and their 
enthusiasm for research; and Mr Matthew Garnett, Eva Nabbanja, Maria Harrington, Mita 
Brahmbhatt, Marek Czosnyka, Zofia Czosnyka, and other members of the Department of 
Clinical Neurosciences for their knowledge and guidance. I would also like to thank the staff 
and members of the Department of Psychiatry for providing a vibrant and supportive 
community. Lastly, special thanks to George Savulich for providing extensive support and 
advice throughout all aspects of this process, for being a friend as well as a mentor, and for the 
much needed trips to the pub! 
 Additionally, I am grateful for the encouragement I have received from my family, the 
Moir family, and my friends. I thank my mam and my dad for always encouraging me to 
succeed. I thank my friends, especially Kirsten Stark for her wisdom, and Rachel Ewenson who 
is always a huge source of moral support. And finally, I would like to thank Graeme Moir for 
providing all kinds of support, encouragement, patience, and understanding. I couldn’t have 
done it without you! 
vi 
 
Original Papers 
The following publications have arisen from work contained in this thesis (see Appendix D for 
full texts): 
 
Peterson, K. A., Savulich, G., Jackson, D., Killikelly, C., Pickard, J. D., & Sahakian, B. J. 
(2016). The effect of shunt surgery on neuropsychological performance in normal 
pressure hydrocephalus: a systematic review and meta-analysis. Journal of Neurology, 
263(8), 1669-1677. 
 
Peterson, K. A., Housden, C. R., Killikelly, C., DeVito, E. E., Keong, N. C., Savulich, G., 
Czosnyka, Z., Pickard, J. D., & Sahakian, B. J. (2016). Apathy, ventriculomegaly and 
neurocognitive improvement following shunt surgery in normal pressure 
hydrocephalus. British Journal of Neurosurgery, 30(1), 38-42. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vii 
 
Table of Contents 
Abstract ................................................................................................................................... ii 
Declaration............................................................................................................................. iv 
Acknowledgements ................................................................................................................ v 
Original Papers ...................................................................................................................... vi 
Table of Contents ................................................................................................................. vii 
List of Figures ...................................................................................................................... xiii 
List of Tables ........................................................................................................................ xv 
Abbreviations ..................................................................................................................... xvii 
Chapter 1 .................................................................................................................................... 1 
Introduction ............................................................................................................................ 1 
1.1. General introduction ................................................................................................................ 1 
1.2. Normal pressure hydrocephalus .............................................................................................. 4 
1.2.1. CSF flow ............................................................................................................................. 4 
1.2.2. Pathophysiology ................................................................................................................ 5 
1.2.3. Epidemiology ..................................................................................................................... 8 
1.2.4. Clinical features ................................................................................................................. 9 
1.2.5. Diagnosis ......................................................................................................................... 10 
1.2.6. Treatment ........................................................................................................................ 13 
1.2.7. Outcome .......................................................................................................................... 14 
1.3. The neuropsychology of normal pressure hydrocephalus ..................................................... 20 
1.3.1. Background...................................................................................................................... 20 
1.3.2. Neuropsychological impairment in NPH ......................................................................... 21 
1.3.3. Neuropsychological outcome following CSF diversion ................................................... 22 
1.4. Motivation and apathy in normal pressure hydrocephalus ................................................... 26 
1.4.1. Definitions and background ............................................................................................ 26 
1.4.2. The prevalence of apathy in NPH .................................................................................... 26 
viii 
 
1.4.3. Neural correlates of apathy in NPH................................................................................. 27 
1.4.4. Apathy scales ................................................................................................................... 29 
1.5. Aims of the thesis ................................................................................................................... 31 
Chapter 2 .................................................................................................................................. 32 
The effect of shunt surgery on neuropsychological performance in normal pressure 
hydrocephalus: a systematic review and meta-analysis ....................................................... 32 
2.1. Introduction............................................................................................................................ 32 
2.2. Methods ................................................................................................................................. 33 
2.2.1. Search strategy ................................................................................................................ 33 
2.2.2. Study selection ................................................................................................................ 34 
2.2.3. Primary outcome measures ............................................................................................ 34 
2.2.4. Neuropsychological tests ................................................................................................ 35 
2.2.5. Statistical analysis ............................................................................................................ 36 
2.3. Results .................................................................................................................................... 37 
2.3.1. Search results .................................................................................................................. 37 
2.3.2. Average pre-operative scores ......................................................................................... 38 
2.3.3. Average difference scores (pre- to post-shunt) .............................................................. 40 
2.3.4. Interpretation of difference scores ................................................................................. 40 
2.3.5. Moderator variables ........................................................................................................ 42 
2.3.6. Forest plots ...................................................................................................................... 42 
2.4. Discussion ............................................................................................................................... 46 
2.4.1. Predicting improvement ................................................................................................. 49 
2.4.2. Extent and duration of improvement ............................................................................. 50 
2.4.3. Limitations and methodological considerations ............................................................. 50 
2.5. Conclusions............................................................................................................................. 51 
Chapter 3 .................................................................................................................................. 52 
Apathy, ventriculomegaly and neurocognitive improvement following shunt surgery in 
normal pressure hydrocephalus ............................................................................................ 52 
ix 
 
3.1. Introduction............................................................................................................................ 52 
3.2. Methods ................................................................................................................................. 53 
3.2.1. Patients ............................................................................................................................ 53 
3.2.2. Imaging analysis .............................................................................................................. 54 
3.2.3. Neuropsychological assessment ..................................................................................... 54 
3.2.4. Statistical analysis ............................................................................................................ 56 
3.3. Results .................................................................................................................................... 57 
3.3.1. Demographic information ............................................................................................... 57 
3.3.2. Prevalence of apathy and depression ............................................................................. 57 
3.3.3. Correlation between neuropsychological test scores and apathy and depression ........ 60 
3.3.4. Pre-operative bicaudate ratio ......................................................................................... 61 
3.3.5. Neuropsychological outcome .......................................................................................... 61 
3.3.6. Correlation between change in neuropsychological test scores with change in apathy 
and depression .......................................................................................................................... 63 
3.4. Discussion ............................................................................................................................... 64 
3.4.1. Limitations ....................................................................................................................... 66 
3.5. Conclusions............................................................................................................................. 67 
Chapter 4 .................................................................................................................................. 68 
Brain structural correlates of cognitive dysfunction and neuropsychiatric symptoms in 
normal pressure hydrocephalus ............................................................................................ 68 
4.1. Introduction............................................................................................................................ 68 
4.1.1. Total brain volume in NPH .............................................................................................. 68 
4.1.2. Subcortical volumetric changes in NPH .......................................................................... 69 
4.2. Methods ................................................................................................................................. 71 
4.2.1. Ethical approval ............................................................................................................... 71 
4.2.2. Participants ...................................................................................................................... 71 
4.2.3. Neuropsychological assessment ..................................................................................... 71 
4.2.4. MR imaging protocol ....................................................................................................... 72 
x 
 
Part I: Global and regional volumetric analysis in normal pressure hydrocephalus: association 
with cognitive function and neuropsychiatric symptoms ..................................................... 73 
4.3. Methods ................................................................................................................................. 73 
4.3.1. Image analysis ................................................................................................................. 73 
4.3.2. Statistical analysis ............................................................................................................ 74 
4.4. Results .................................................................................................................................... 75 
4.4.1. Demographic information ............................................................................................... 75 
4.4.2. Ventricular volumes ........................................................................................................ 76 
4.4.3. Correlation of demographic data with volumetric data ................................................. 76 
4.4.4. Correlation of demographic data and ventricular volume with neuropsychological test 
scores in the NPH group ............................................................................................................ 78 
4.4.5. Baseline total brain volume, grey matter volume, and white matter volume ............... 78 
4.4.6. Subcortical volumetric comparisons between patients with NPH at pre-shunt and 
controls ...................................................................................................................................... 79 
4.4.7. Correlation between SDGM structure volumes and cognitive test scores at pre-shunt 80 
4.4.8. Subcortical volumetric comparisons between patients with NPH at post-shunt and 
controls ...................................................................................................................................... 81 
4.4.9. Correlation between SDGM structure volumes and cognitive test scores at post-shunt81 
4.4.10. Pre- and post-shunt volumetric comparisons ............................................................... 82 
4.4.11. Neuropsychological outcome ........................................................................................ 82 
4.4.12. Correlation of percent change in cognitive test scores with SDGM structure and 
ventricular volumes ................................................................................................................... 82 
4.5. Summary ................................................................................................................................ 83 
4.5.1. Pre-operative total brain volume .................................................................................... 83 
4.5.2. Subcortical deep grey matter structure volumes ........................................................... 84 
4.5.3. Rationale for Part II ......................................................................................................... 86 
Part II: Volume of the caudate nucleus in NPH: association with apathy and cognition ..... 88 
4.6. Introduction............................................................................................................................ 88 
4.7. Methods ................................................................................................................................. 88 
xi 
 
4.7.1. Image analysis ................................................................................................................. 88 
4.7.2. Statistical analysis ............................................................................................................ 89 
4.8. Results .................................................................................................................................... 90 
4.8.1. Demographic information ............................................................................................... 90 
4.8.2. Comparison of volumes obtained via automated and manual segmentation ............... 90 
4.8.3. Correlation between demographic data and neuropsychological test scores ............... 91 
4.8.4. Pre- and post-operative volumetric results .................................................................... 91 
4.8.5. Correlation with neuropsychological test scores and neuropsychiatric symptoms ....... 92 
4.8.6. Distribution of AES-S ratings at pre- and post-shunt ...................................................... 94 
4.9. Discussion ............................................................................................................................... 95 
4.9.1. Structural MR imaging of NPH ........................................................................................ 96 
4.9.2. Limitations ....................................................................................................................... 97 
4.10. Conclusions........................................................................................................................... 97 
Chapter 5 .................................................................................................................................. 98 
Investigating the efficacy of a novel rewarding learning task as an objective measure of 
motivation and apathy in patients with normal pressure hydrocephalus .............................. 98 
5.1. Introduction............................................................................................................................ 98 
5.1.1. The Salience Attribution Test (Roiser et al. 2009) ......................................................... 100 
5.2. Methods ............................................................................................................................... 104 
5.2.1. Participants .................................................................................................................... 104 
5.2.2. The simple Salience Attribution Test (sSAT) ................................................................. 104 
5.2.3. Statistical analysis .......................................................................................................... 106 
5.3. Results .................................................................................................................................. 106 
5.3.1. Younger adults .............................................................................................................. 106 
5.3.2. Older adults ................................................................................................................... 108 
5.4. Discussion ............................................................................................................................. 109 
5.4.1. Alternative measures .................................................................................................... 110 
5.5. Conclusions........................................................................................................................... 111 
xii 
 
Chapter 6 ................................................................................................................................ 112 
General discussion .............................................................................................................. 112 
6.1. Summary of the thesis.......................................................................................................... 112 
6.2. Main contributions of this research ..................................................................................... 113 
6.3. Interpretation and integration of findings ........................................................................... 116 
6.3.1. Neuropsychological outcome following treatment for NPH ......................................... 116 
6.3.2. The symptom of apathy in NPH .................................................................................... 118 
6.3.3. Structural correlates of cognitive dysfunction and apathy ........................................... 121 
6.4. Summary of the limitations of the investigations ................................................................ 122 
6.4.1. Classification of significant improvement following shunt ........................................... 122 
6.4.2. Practice effects .............................................................................................................. 123 
6.4.3. Heterogeneity of groups ............................................................................................... 123 
6.4.4. Assessment methods .................................................................................................... 123 
6.5. Directions for future work .................................................................................................... 124 
6.5.1. Post-shunt neuropsychological functioning .................................................................. 124 
6.5.2. Apathy ........................................................................................................................... 124 
6.5.3. Structural imaging in NPH ............................................................................................. 124 
6.6. Achievement of the aims of this thesis ................................................................................ 125 
References .......................................................................................................................... 127 
APPENDIX A. The Cambridge State Apathy Evaluation scale (self-rated) ........................ 157 
APPENDIX B. Meta-analyses results when assuming alternative correlations between 
average pre- and post-operative scores ............................................................................. 158 
APPENDIX C. The Geriatric Depression Scale (short form) .............................................. 160 
APPENDIX D. Published papers ........................................................................................ 161 
 
  
xiii 
 
List of Figures 
Figure 1.1: Ventriculomegaly in a patient with normal pressure hydrocephalus ....................... 4 
Figure 1.2: Measurement of Evans' index on CT scan (from N. C. Keong, Czosnyka, Czosnyka, 
& Pickard, 2011) ...................................................................................................................... 11 
Figure 2.1: PRISMA flow chart for review .............................................................................. 38 
Figure 2.2: Forest plot for difference in MMSE ....................................................................... 42 
Figure 2.3: Forest plot for difference in RAVLT total verbal recall ........................................ 43 
Figure 2.4: Forest plot for difference in RAVLT delayed verbal recall ................................... 43 
Figure 2.5: Forest plot for difference in backwards digit span score ....................................... 44 
Figure 2.6: Forest plot for difference in phonemic verbal fluency ........................................... 44 
Figure 2.7: Forest plot for difference in trail making test B (seconds to complete) ................. 45 
Figure 2.8: Forest plot for difference in trail making test A (seconds to complete) ................ 45 
Figure 3.1: Measurement of bicaudate ratio on MRI axial flair ............................................... 54 
Figure 3.2: Frequency and severity of apathetic and depressive symptoms at pre- and post-shunt
 .................................................................................................................................................. 58 
Figure 3.3: Scatterplots of the relationships between bicaudate ratio and apathy and depression 
at pre-shunt ............................................................................................................................... 62 
Figure 3.4: Scatterplot showing the relationship between change in MMSE and change in AES-
S ................................................................................................................................................ 64 
Figure 4.1: Representative FIRST segmentation of subcortical structures in a patient with 
normal pressure hydrocephalus (left) and a healthy control subject (right) ............................. 74 
Figure 4.2: Scatterplots showing relationships between age and brain volume (ml) in NPH .. 77 
Figure 4.3: Scatterplot showing the relationship between white matter volume (ml) and score 
on Hopkins Verbal Learning Test - Delayed ............................................................................ 79 
Figure 4.4: Segmented right caudate in (A) axial section, (B) sagittal section, and (C) coronal 
section in a representative NPH patient; (D) 3D rendering of caudate volume ....................... 89 
Figure 4.5: Scatterplot showing the relationship between caudate volume and phonemic fluency 
performance (pre-shunt) ........................................................................................................... 92 
xiv 
 
Figure 4.6: Scatterplot showing the relationship between caudate volume and semantic fluency 
performance (pre-shunt) ........................................................................................................... 93 
Figure 4.7: Scatterplot showing the relationship between caudate volume and apathy (post-
shunt) ........................................................................................................................................ 94 
Figure 4.8: Box-plot diagram showing AES-S ratings in patients with NPH at pre- and post-
shunt ......................................................................................................................................... 95 
Figure 5.1: The Salience Attribution Test (from Roiser et al. 2009)...................................... 101 
Figure 5.2: Screenshots from the simple Salience Attribution Test ....................................... 103 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xv 
 
List of Tables 
Table 1.1: Examples of assessment scales for grading of severity of NPH and outcome ........ 16 
Table 1.2: Factors predictive of good and bad surgical outcome (from Vanneste, 2000)........ 19 
Table 2.1: Characteristics of the studies included in meta-analyses ........................................ 39 
Table 2.2: Meta-analyses results .............................................................................................. 41 
Table 2.3: Meta-regressions of average difference of MMSE on moderator variables ........... 42 
Table 3.1: Normal pressure hydrocephalus patient demographics ........................................... 59 
Table 3.2: Bivariate correlations between AES-S and GDS-15 ratings with neuropsychological 
test scores at pre-shunt .............................................................................................................. 60 
Table 3.3: Bivariate correlations between AES-S and GDS-15 ratings with neuropsychological 
test scores at post-shunt ............................................................................................................ 61 
Table 3.4: Neuropsychological tests results at baseline and three to nine months post-
operatively ................................................................................................................................ 63 
Table 3.5: Correlations between change in neuropsychiatric symptoms and change in 
neuropsychology ....................................................................................................................... 64 
Table 4.1: Demographic information for the NPH group ........................................................ 76 
Table 4.2: Results of ANCOVAs for group differences in grey matter, white matter, and total 
brain volume ............................................................................................................................. 78 
Table 4.3: Results of ANCOVAs for group differences in pre-shunt SDGM structure volumes
 .................................................................................................................................................. 80 
Table 4.4: Results of ANCOVAs for group differences in post-shunt SDGM structure volumes
 .................................................................................................................................................. 81 
Table 4.5: Neuropsychological outcome following shunt surgery ........................................... 83 
Table 4.6: Caudate volumes obtained via automated segmentation and manual tracing ......... 90 
Table 4.7: Caudate volumes obtained via manual tracing for patients included or excluded from 
automated segmentation ........................................................................................................... 91 
Table 5.1: Younger adults' mean (SD) response times (ms) and VAS ratings for high, medium, 
and low reward probability cues in blocks 1 and 2 ................................................................ 107 
xvi 
 
Table 5.2: Older adults' mean (SD) response times (ms) and VAS ratings for high, medium, and 
low probability reward cues in blocks 1 and 2 ....................................................................... 108 
 
Table B-1: Results of meta-analyses when assuming an alternative correlation of 0.4 ......... 158 
Table B-2: Results of meta-analyses when assuming an alternative correlation of 0.8 ......... 159 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xvii 
 
Abbreviations 
 
AD  Alzheimer’s disease 
AES  Apathy Evaluation Scale 
AES-C  Clinician-rated Apathy Evaluation Scale 
AES-I  Informant-rated Apathy Evaluation Scale 
AES-S  Self-rated Apathy Evaluation Scale 
ANCOVA Analysis of covariance 
ANOVA Analysis of variance 
BCR  Bicaudate ratio 
CANTAB Cambridge neuropsychological test automated battery 
CBF  Cerebral blood flow 
CSF  Cerebrospinal fluid 
CSF-TT Cerebrospinal fluid tap test 
CT  Computed tomography 
ELD  Continuous external lumbar CSF drainage 
ETV  Endoscopic third ventriculostomy 
GDS-15 Geriatric Depression Scale short form 
GM  Grey matter 
HVLT  Hopkins Verbal Learning Test 
IA  The Apathy Inventory 
ICP  Intracranial pressure 
iNPH  Idiopathic normal pressure hydrocephalus 
LARS  The Lille Apathy Rating Scale 
LP  Lumboperitoneal 
MMSE Mini-Mental State Examination 
MRI  Magnetic resonance imaging 
NART  National Adult Reading Test 
NPH  Normal pressure hydrocephalus 
NPI   Neuropsychiatric Inventory 
RAVLT Rey Auditory Verbal Learning Test 
xviii 
 
RCT  Randomised controlled trial 
Rout  Resistance to CSF outflow 
RT  Response time 
SDGM  Subcortical deep grey matter 
sNPH  Secondary normal pressure hydrocephalus 
sSAT  The simple Salience Attribution Test 
TMT-A Trail making test A 
TMT-B Trail making test B 
VAS  Visual analogue scale 
VP  Ventriculoperitoneal 
WM  White matter 
 
1 
 
Chapter 1  
Introduction 
 
1.1. General introduction 
The term “normal pressure hydrocephalus” (NPH) was first introduced by Hakim and Adams 
in 1965 following their observation of the symptomatic triad of gait apraxia, cognitive decline, 
and urinary incontinence in the presence of ventricular enlargement and normal cerebrospinal 
fluid (CSF) pressure in adult patients. Importantly, neurosurgical treatment using the then 
recently developed ventriculoperitoneal or ventriculoatrial CSF shunt resulted in marked 
improvement in functioning in these patients (Hakim & Adams, 1965). Today, the diagnosis 
and management of patients with NPH remains a challenge to clinicians. The pathological 
processes underlying the disorder are not completely understood, the heterogeneity of the 
disorder complicates differential diagnosis, and outcome following treatment can be difficult to 
predict.  
 
The symptoms of NPH develop insidiously, usually over a period of years. There have been 
very few longitudinal studies, and therefore it is not known when the ventriculomegaly 
develops. NPH can occur secondary to head injury, brain haemorrhage, or infection (secondary 
NPH; sNPH). However, in many cases, NPH occurs without any obvious cause (idiopathic 
NPH; iNPH). While sNPH can occur at any age, iNPH typically affects older adults.  
NPH is recognised as an important cause of cognitive decline as it is thought to be 
reversible with surgical CSF diversion. While improvement following shunting is most 
commonly observed in gait, the cognitive symptoms are also thought to show improvement in 
a number of patients and therefore NPH has been described as a reversible dementia. However, 
this is somewhat controversial likely due to the fact that there are no standardised clinical 
guidelines for assessing cognitive function in this patient group meaning that assessment 
methods often vary between centres, complicating interpretation of cognitive outcome.  
In recent years, there has been greater emphasis on quantifying cognitive outcome 
following treatment for NPH through the use of detailed neuropsychological assessments 
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although this is still an emerging aspect of NPH research and the neuropsychology of NPH is 
currently relatively poorly understood. A better understanding of the neuropsychology of NPH 
may be useful for diagnosis, and prediction and quantification of outcome following shunt 
treatment. 
In addition to the cognitive symptoms, neuropsychiatric symptoms such as apathy (a 
loss of motivation, or impaired goal-directed behaviour) are frequently reported in NPH patients 
(Adams, Fisher, Hakim, Ojemann, & Sweet, 1965; Caltagirone, Gainotti, Masullo, & Villa, 
1982; De Mol, 1986; Kanemoto et al., 2016; Kito et al., 2009). However, apathy has received 
little attention in NPH research. Apathy has been shown to be associated with severity of 
cognitive and functional impairment in patients with dementia (Boyle et al., 2003; Starkstein, 
Jorge, Mizrahi, & Robinson, 2006b) and may relate to dysfunction in the frontal or subcortical 
regions of the brain (Kanemoto et al., 2016; Levy & Dubois, 2006). Further, the symptoms of 
apathy may be misdiagnosed as depression which is more commonly assessed in NPH patients. 
Distinguishing apathy from depression is particularly important when considering treatment 
options. Therefore, there is clearly a need to assess the significance of the symptom of apathy 
in NPH patients.  
 
This thesis provides: 
 a meta-analysis of neuropsychological outcome following shunt surgery to determine 
from the literature whether there is a consensus as to which aspects of 
neuropsychological functioning improve following shunt surgery, 
 an investigation of the significance of the symptom of apathy in NPH and, specifically, 
whether apathy in NPH is related to cognitive function and to a measure of ventricular 
enlargement, 
 a structural magnetic resonance imaging (MRI) study to investigate structural correlates 
of cognitive dysfunction and apathy in NPH, and 
 a feasibility study of a novel reward learning task to determine whether it might be 
useful as an objective measure of motivation and apathy for use with patients with 
dementia/ cognitive decline (including patients with NPH). 
 
Chapter 1 begins with an introduction to NPH and includes an overview of the 
pathophysiological mechanisms underlying the disorder, the clinical features, diagnostic 
criteria, treatment methods, and criteria for classifying outcome following treatment. The 
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neuropsychology of NPH is then discussed. First, the typical pattern of neuropsychological 
impairment in NPH is described; and secondly, a summary of the research examining the effect 
of shunt surgery on neuropsychological performance is provided. The rationale for 
investigating apathy in NPH is then developed further, with a focus on possible neural 
mechanisms underlying this symptom in NPH. Current tools for assessing apathy are then 
reviewed. Chapter 1 concludes with a summary of the aims of the thesis. 
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1.2. Normal pressure hydrocephalus 
Normal pressure hydrocephalus (NPH) is characterised by 
a build-up of cerebrospinal fluid (CSF) in the brain which 
causes enlargement of the cerebral ventricles over time 
(ventriculomegaly; Figure 1.1) despite a mean CSF 
opening pressure within the normal range (<18 cmH2O or 
13 mmHg; Hurley, Bradley, Latifi, & Taber, 1999). The 
ventricular enlargement is out of proportion to cortical 
atrophy. Impairments in gait and balance develop 
gradually, and may be accompanied by urinary 
incontinence and progressive cognitive decline. CSF 
diversion (e.g. with shunt surgery) results in clinical 
improvement for the majority of patients (Klinge, Hellström, Tans, & Wikkelsø, 2012; Malm, 
Kristensen, Stegmayr, Fagerlund, & Koskinen, 2000; Toma, Papadopoulos, Stapleton, Kitchen, 
& Watkins, 2013). However, for some patients, CSF diversion may only slow symptom 
progression rather than lead to improvements in functioning.  
This section provides an overview of NPH, beginning with a description of the possible 
pathophysiological mechanisms underlying the disorder. 
 
1.2.1. CSF flow 
A disturbance of CSF dynamics is a primary feature of NPH. CSF has several functions 
including protection of the brain and spinal cord through buoyancy, removal of toxins and 
byproducts of brain metabolism, circulation of nutrients, and facilitation of molecular 
communication (Del Bigio, 2014; Kosztowski, Filippidis, Rory Goodwin, Elder, & Rigamonti, 
2014). CSF is primarily produced in the choroid plexi within the cerebral ventricles. It is also 
produced via diffusion of the interstitial fluid from the parenchyma of the brain and spinal cord 
through the ependymal lining of the ventricles (Battal et al., 2011). CSF flows via net bulk flow 
through the ventricular system and enters the subarachnoid space from the fourth ventricle 
(Kosztowski et al., 2014). It is then reabsorbed via the arachnoid granulations and arachnoid 
villi and, at least in rodents, via lymphatic channels (Del Bigio, 2014). It has also been suggested 
that absorption occurs via the brain capillaries (Greitz, 2004; Weerakkody et al., 2011). 
 
Figure 1.1: Ventriculomegaly 
in a patient with normal 
pressure hydrocephalus 
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There is a pulsatile flow of CSF through the ventricles (Kosztowski et al., 2014). 
According to the Monro-Kellie hypothesis, a volume increase in one of the four main 
intracranial components (the brain, CSF, arterial and venous blood) causes a corresponding 
decrease in volume in the other components (once the fontanelle has closed in childhood). Thus, 
the total volume of intracranial compartments remains constant (Greitz, 2004; Greitz et al., 
1992). During systole, expansion of the intracranial arteries is balanced by CSF expulsion 
through the foramen magnum and expulsion of blood from the veins into the dural venous 
sinuses (Greitz, 2004). Arterial compliance (expansion) dampens the arterial pulse wave, 
allowing constant capillary flow via the “windkessel” mechanism (Greitz, 2004). The 
dampened pulse wave in the artery is transmitted to the brain capillaries, causing a slight 
systolic volume increase in the brain. This expansion of the brain occurs inwards, compressing 
the ventricles, and causing pulsatile outflow of CSF through the aqueduct and the remaining 
ventricular system (Bradley, 2015). Respiration-induced changes in venous pressure also 
facilitate CSF flow. 
An obstruction to CSF flow inside the ventricular system causes obstructive, or non-
communicating hydrocephalus, while an obstruction to CSF flow outside of the ventricular 
system causes communicating hydrocephalus (Greitz, 2004). Further, NPH with a known cause 
(such as subarachnoid haemorrhage, meningitis, trauma, or neurosurgery; secondary NPH) has 
been distinguished from idiopathic NPH in which there is no known cause (Del Bigio, 2014; 
Vanneste, 1994). While baseline ICP is normal in NPH, intermittent elevations of pressure (B-
waves) have been detected (Crockard, Hanlon, Duda, & Mullan, 1977; Pickard et al., 1980). 
Consequently, “adult hydrocephalus syndrome” or “adult symptomatic hydrocephalus” have 
been suggested to be more appropriate terms than “normal pressure hydrocephalus” (Vanneste, 
2000) but these terms have not found general favour. 
 
1.2.2. Pathophysiology 
Although the precise pathophysiological mechanisms underlying NPH are not completely 
understood, a number of theories have been proposed and it is likely that NPH is caused by 
several underlying pathologic processes (Krauss et al., 1996). An overview of the main 
theoretical explanations for the development of NPH are outlined below. 
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CSF hydrodynamic factors 
According to an early theory of hydrocephalus, the bulk flow theory (Dandy & Blackfan, 1914), 
a hydrostatic pressure gradient (from a slightly higher pressure at the production sites to a 
slightly lower pressure at absorption sites) drives the flow of CSF through the ventricular 
system from production to reabsorption at the arachnoid villi (Battal et al., 2011). The theory 
states that ICP is dependent on a balance between CSF production and absorption, and that an 
imbalance between the two (or specifically, impaired reabsorption of CSF at the arachnoid villi) 
causes hydrocephalus. However, the bulk flow theory has been shown to be incompatible with 
communicating NPH as an absorption deficit across the arachnoid villi would not cause 
ventricular enlargement. That is, there would not be a pressure gradient between the ventricles 
and the subarachnoid space meaning that it would be the subarachnoid space which would dilate 
(Greitz, 2004; Vanneste, 2000). 
More recent theories suggest that absorption of CSF occurs in the capillaries of the 
central nervous system (Greitz, 2004) and that, in addition to bulk flow of CSF from the 
ventricles to the subarachnoid space, intraventricular pulsations related to the cardiac cycle 
contribute to CSF flow (Battal et al., 2011; Qvarlander, Lundkvist, Koskinen, Malm, & Eklund, 
2013). Increased CSF pulse pressure has been suggested to contribute to the development of 
NPH (Di Rocco, Pettorossi, Caldarelli, Mancinelli, & Velardi, 1977; Greitz, 2004) and may be 
related to vascular pathophysiology (Bateman, 2004). Decreased arterial compliance leads to a 
breakdown of the windkessel mechanism and a subsequent increase in intracerebral capillary 
pulsations (Greitz, 2004). This has been suggested to result in a “water hammer” effect, causing 
ventricular enlargement through shear stresses without an accompanying increase in ICP 
(Bateman, 2000; Di Rocco et al., 1977; Greitz, 2004; Stivaros & Jackson, 2007; Vanneste, 
2000). 
A CSF absorption deficit can be examined by measuring resistance to CSF outflow 
(Rout). Rout provides an indication of the ease of CSF absorption that occurs over all CSF outflow 
pathways (Malm, Jacobsson, Birgander, & Eklund, 2011), and a higher Rout has been associated 
with hydrocephalus (Boon, Tans, Delwel, Egeler-Peerdeman, Hanlo, Wurzer, Avezaat, et al., 
1997). Rout is suggested to affect ICP, pulsatility, CSF absorption, and craniospinal compliance 
(Malm et al., 2011). However, while some studies have found a relationship between Rout and 
ICP (Børgesen & Gjerris, 1987), others have not (Eide, Fremming, & Sorteberg, 2003), and its 
predictive validity remains uncertain (Vanneste, 2000). 
 
7 
 
Cerebrovascular risk factors 
The prevalence of cerebrovascular risk factors, including hypertension, cardiac disease, 
diabetes mellitus, and white matter lesions, has been shown to be high among patients with 
NPH (Boon et al., 1999; Casmiro et al., 1989; Graff-Radford & Godersky, 1987; Jaraj et al., 
2016; Krauss et al., 1996), although the causal direction is unclear (Boon et al., 1999; Momjian 
et al., 2004). It has been suggested that periventricular white matter lesions may lead to reduced 
elasticity of the periventricular tissue, and subsequent ventricular enlargement (Bradley, 
Whittemore, Watanabe, et al., 1991; Earnest, Fahn, Karp, & Rowland, 1974; Koto, Rosenberg, 
Zingesser, Horoupian, & Katzman, 1977). However, it has also been postulated that NPH may, 
in fact, cause periventricular changes (Fisher, 1982; George, 1991). 
Cerebral blood flow (CBF) may play an important role in the symptomology of NPH. 
Pre-operative reductions in CBF have been observed in the periventricular white matter regions, 
the cerebral cortex, and deep grey matter regions (Momjian et al., 2004; Owler et al., 2004; 
Owler & Pickard, 2001; Ziegelitz et al., 2014, 2015b). Frontal regions may be preferentially 
affected (Owler & Pickard, 2001). Further, CBF has been linked to clinical symptoms (Ziegelitz 
et al., 2015b) and post-shunt outcome (Klinge et al., 2008; Murakami, Hirata, & Kuratsu, 2007; 
Ziegelitz et al., 2015a).  Reduced CBF may be caused by neuronal loss or hypometabolism 
(Bateman, 2008) or by “hydrocephalic compression and stretching of the periventricular 
arterioles and venules” (Vanneste, 1994). Vanneste (1994) suggested that reduced 
periventricular blood flow may result in axonal dysfunction without loss of cellular integrity, 
while prolonged periventricular ischaemia may cause myelin disintegration and irreversible 
axonal loss and that this may explain why some patients do not improve following treatment.  
 
Venous hypotheses 
Bateman (2008) proposed a venous hemodynamic theory of NPH which centres on a positive 
feedback loop. He suggested that reduced craniospinal compliance leads to elevated venous 
pressure, which in turn causes the cortical veins to stiffen, further reducing craniospinal 
compliance. The reduced craniospinal compliance would limit arterial expansion in the 
subarachnoid space, propagating pulse waves into the brain parenchyma and capillaries 
(Bateman, 2008). As a result, hyperdynamic pulsations directed centrally may lead to 
ventricular enlargement due to disruption of glial tissue in the subependymal white matter, and 
reduced elastic recoil of this region. 
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CSF metabolism 
It has been suggested that changes to the choroid plexus associated with hydrocephalus, or 
downregulation of CSF production in response to acute hydrocephalus could underlie observed 
reductions in CSF production (Silverberg, Mayo, Saul, Rubenstein, & McGuire, 2003). A 
resultant reduction in CSF turnover would lead to reduced clearance of neurotoxins such as β-
amyloid, tau-protein, and pro-inflammatory cytokines (Kondziella, Sonnewald, Tullberg, & 
Wikkelso, 2008; Silverberg et al., 2003). This theory could explain the high rates of 
Alzheimer’s disease pathology in the cortex of NPH patients (Kondziella et al., 2008). 
 
Overall, altered CSF dynamics leading to reduced cerebral perfusion and subsequent hypoxia 
and ischaemia appear to be important pathophysiological mechanisms in NPH. Reduced 
periventricular blood flow likely underlies the symptomology in NPH (Vanneste, 2000). 
Ageing may make the brain susceptible to intermittent spikes of B waves, and increased CSF 
outflow resistance, leading to progressive ventriculomegaly and the development of NPH 
(Albeck et al., 1998). Indeed, it has been suggested that age-related changes in CSF production 
and turnover (that is, the observed reduction in CSF production and the increased Rout that 
occurs during ageing) may underlie a common pathological pathway leading to the 
development of Alzheimer’s disease (AD) or NPH, with a predominant reduction in CSF 
production leading to AD and a predominant increase in Rout leading to NPH (Silverberg et al., 
2003).  
 
1.2.3. Epidemiology 
The reported incidence of NPH ranges from 1.8 to 5.5 cases per million per year (Brean & Eide, 
2008b; Krauss & Halve, 2004; Vanneste, Augustijn, Dirven, Tan, & Goedhart, 1992). The 
prevalence of NPH in individuals older than 65 years was reported to be 0.41% by Trenkwalder 
et al. (1995), and 2.9% (iNPH) by Hiraoka, Meguro, and Mori (2008). It is estimated that NPH 
accounts for around 5% of dementia cases (Beck, Benson, Scheibel, Spar, & Rubenstein, 1982; 
Clarfield, 1988; Vanneste, 2000). 
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1.2.4. Clinical features 
While sNPH can present at any age, iNPH usually occurs in later life (Hebb & Cusimano, 2001) 
and with insidious onset of symptoms. Gait disturbance has been shown to be the most frequent 
symptom in NPH (Hebb & Cusimano, 2001) and is usually the first presenting symptom 
(Vanneste, 2000). Small steps, reduced foot to floor clearance, wide base, and disequilibrium 
are the principle features of NPH gait (Boon, Tans, Delwel, Egeler-Peerdeman, Hanlo, Wurzer, 
& Hermans, 1997; Bugalho & Guimarães, 2007; Stolze et al., 2000). The hypokinetic features 
may be indicative of subcortical dysfunction (specifically, damage to the basal ganglia), while 
disequilibrium may reflect frontal dysfunction (Bugalho & Guimarães, 2007). 
While the cognitive impairment in NPH is often characterised as “dementia”, this may 
be misleading. The term suggests an advanced stage of cognitive decline which many NPH 
patients do not reach and some patients have no, or only mild, evidence of dementia (Boon, 
Tans, Delwel, Egeler-Peerdeman, Hanlo, Wurzer, & Hermans, 1997; Iddon et al., 1999). The 
pattern of cognitive decline is of the “subcortical” type (DeVito et al., 2005), with measurable 
deficits in memory, speed of information processing, and visuospatial abilities, as well as 
increased inertia and apathy. NPH has been further characterised as a “fronto-subcortical 
dementia” due to commonly observed executive dysfunction in patients (DeVito et al., 2005).  
In comparison with AD, the pattern of cognitive decline in NPH is characterised by 
greater severity of impairments in executive function, attention, and visuospatial abilities 
(Ogino et al., 2006; Saito et al., 2011), with an absence of cortical dysfunction (Vanneste, 1994) 
and comparable or less severe memory impairment (Iddon et al., 1999; Ogino et al., 2006; Saito 
et al., 2011). This pattern of cognitive decline has been suggested to reflect less severe medial 
temporal lobe damage but more prominent frontal or fronto-subcortical changes in NPH 
compared to AD (Ogino et al., 2006). It has been suggested that in cases where cognitive decline 
is the most prominent symptom, or when dementia is severe, AD may be the most likely 
diagnosis (Vanneste, 2000). 
Increased urinary urgency and frequency are common features of NPH, however urinary 
incontinence generally only occurs in the later stages of disease progression (Ahlberg, Norlén, 
Blomstrand, & Wikkelsö, 1988; Iddon et al., 1999). The prevalence of urinary symptoms is 
reported to be 45-90% (Damasceno, Carelli, Honorato, & Facure, 1997; Hebb & Cusimano, 
2001). While it has been suggested that frontal dysfunction may underlie bladder disturbance 
in NPH, urinary incontinence has been shown to be present in the absence of severe cognitive 
impairment (Ahlberg et al., 1988). Ahlberg et al (1988) concluded that it is more likely that 
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bladder symptoms in NPH are due to impaired function in regions of the brain associated with 
micturition, while severe cognitive decline associated with frontal damage may increase the 
risk of urinary incontinence in NPH.  
 
1.2.5. Diagnosis 
Diagnosis of NPH is based on clinical history, examination, and neuroimaging findings. The 
classic clinical triad of gait disturbance, cognitive decline, and urinary incontinence with 
ventriculomegaly on computed tomography (CT) is suggestive of NPH (Vanneste, 2000), 
although many patients do not present with the complete symptom triad. Supplementary tests 
may assist in diagnosis or prediction of outcome.  
 
Brain imaging 
Brain imaging (e.g. CT or MRI) is used to assess ventricular size and to rule out other conditions 
which may mimic NPH. On CT, NPH patients show ventriculomegaly which is 
disproportionate to cerebral atrophy. Ventricular enlargement is assessed using a measure of 
the ratio of ventricular size to cranial diameter, such as the Evans’ index (Evans, 1942). The 
Evans’ index is the ratio of the maximal width of the frontal horns to the maximal biparietal 
diameter (Figure 1.2). An Evans’ index of 0.30 or greater indicates ventriculomegaly (Relkin, 
Marmarou, Klinge, Bergsneider, & Black, 2005).  
It should be noted that, while a high Evans’ index is often required for diagnosis, it may 
be present in patients with other causes of dementia and the Evans’ index does not significantly 
correlate with clinical improvement (Hebb & Cusimano, 2001). Furthermore, for some patients 
with minimal ventricular enlargement, such techniques may be insensitive. 
MRI is more useful for evaluating NPH patients as it has greater sensitivity for 
alternative diagnoses and allows evaluation of comorbid conditions such as cerebrovascular 
disease (Hebb & Cusimano, 2001; Vanneste, 2000). Additionally, MRI allows the identification 
of CSF flow effects which may be related to clinical outcome (Bradley, Whittemore, Kortman, 
et al., 1991; Egeler-Peerdeman, Barkhof, Walchenbach, & Valk, 1998). 
Other imaging markers which have shown to be predictors of a positive outcome 
following shunting include a small callosal angle (Virhammar, Laurell, Cesarini, & Larsson, 
2014b), wide temporal horns (Virhammar, Laurell, Cesarini, & Larsson, 2014a), and the 
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features of so-called ‘disproportionately enlarged subarachnoid space hydrocephalus’, i.e. tight 
high-convexity and medial subarachnoid spaces and enlarged Sylvian fissures (Hashimoto, 
Ishikawa, Mori, & Kuwana, 2010; Virhammar et al., 2014a). 
 
 
Figure 1.2: Measurement of Evans' index on CT scan (from N. C. Keong, Czosnyka, 
Czosnyka, & Pickard, 2011) 
 
CSF removal 
Removal of around 40-50 ml CSF with lumbar puncture (CSF tap test [CSF-TT]) is presumed 
to mimic shunt placement and has shown to result in clinical improvement in patients with NPH 
(Wikkelsø, Andersson, Blomstrand, & Lindqvist, 1982). The CSF-TT has variable predictive 
prognostic accuracy, however both false-positive and false-negative rates are high (Damasceno 
et al., 1997; Malm et al., 1995). 
To reduce false-negatives, continuous external lumbar CSF drainage (ELD) has been 
used to drain around 100-200 ml CSF daily for around five days (Chen, Huang, Liu, & Chen, 
1994; Haan & Thomeer, 1988). ELD has shown to be a good predictor of post-shunt outcome 
(Marmarou, Bergsneider, Klinge, Relkin, & Black, 2005). 
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CSF dynamics 
Continuous intracranial pressure monitoring frequently shows intermittent rises in ICP (B-
waves), although the significance of these is unclear as they are also demonstrated in healthy 
individuals (Mautner-Huppert et al., 1989; Vanneste, 2000). However, frequent occurrence of 
B-waves (>50% of ICP recording time) has been associated with good outcome following 
treatment, while infrequent B-waves has shown to predict poor outcome (Pickard et al., 1980; 
Vanneste, 2000). 
Resistance to CSF outflow is measured using lumbar CSF infusion tests in which CSF 
pressure is monitored during lumbar or ventricular infusion of artificial CSF (Katzman & 
Hussey, 1970). The capacity to absorb the additional fluid is reduced in patients with NPH, 
meaning ICP during infusion is increased. A steady state pressure plateau is calculated, which 
is the level at which absorption balances infusion. From this, Rout can then be calculated (Boon, 
Tans, Delwel, Egeler-Peerdeman, Hanlo, Wurzer, Avezaat, et al., 1997). Rout values of 18 
mmHg/ml per minute or higher are associated with good clinical outcome, however the 
predictive validity of lower values is limited and negative predictive power is low (Boon, Tans, 
Delwel, Egeler-Peerdeman, Hanlo, Wurzer, Avezaat, et al., 1997; Czosnyka & Pickard, 2004; 
Vanneste, 2000). Brean and Eide have found that CSF pressure pulsatility (quantified during 
infusion) and pulsatile ICP (assessed during over-night monitoring) may be more useful for 
predicting outcome (Brean & Eide, 2008a; Eide & Brean, 2010). 
 
Neuropsychological assessment 
While many of the early studies tended to rely on functional grading scales only (such as those 
presented in Table 1.1) for assessing cognitive function, more recent studies have emphasised 
the need for detailed neuropsychological assessment of patients with NPH. Neuropsychological 
assessment allows for more detailed quantification of cognitive symptoms, as well as their 
progression or response to treatment. Generalised screening measures, such as the Mini-Mental 
State Examination (MMSE; Cockrell & Folstein, 1988), are often used to assess cognitive 
decline in patients with NPH. The advantage of such tools are that they are both easy to use and 
quick to administer. However, for high functioning patients, these tests are insensitive to decline 
in specific aspects of higher order cognitive functions which may be early symptoms of a 
neurological problem. Accordingly, it is recommended that a battery of neuropsychological 
tests be administered in addition to the more generalised screening measures (DeVito et al., 
2005; Iddon et al., 1999). Tests of psychomotor speed or executive function may detect subtle 
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or early cognitive decline (Hebb & Cusimano, 2001; Iddon et al., 1999). Additionally, 
neuropsychological testing can detect the subcortical profile of dementia which is characteristic 
of NPH (Vanneste, 2000). 
 
Further, evidence-based guidelines for the clinical diagnosis of idiopathic NPH were developed 
by Relkin and colleagues (2005) who recommend that iNPH be classified as ‘probable’, 
‘possible’, or ‘unlikely’ based on clinical, historical, brain imaging, physical, and physiological 
criteria. 
 
1.2.6. Treatment 
Currently, the only method of treatment for NPH is surgical CSF diversion, with shunt surgery 
being the most commonly used procedure. Shunt surgery involves the surgical insertion of a 
tube to redirect excess CSF from the brain to another part of the body where it can be reabsorbed 
into the blood. Both cerebral and lumbar shunts are used to treat NPH. Cerebral shunts divert 
excess CSF from a specified ventricle within the brain, whereas lumbar shunts divert from the 
lumbar subarachnoid space. Common types of shunts used are listed below: 
 
Cerebral shunts 
Ventriculoperitoneal (VP) shunt  
Ventriculoatrial shunt  
Ventriculovenous shunt 
 
Lumbar shunts 
Lumboperitoneal (LP) shunt  
Lumbar subcutaneous shunt  
 
To date, there have been no randomised controlled trials (RCTs) investigating the efficacy of 
shunt surgery versus no treatment (Esmonde & Cooke, 2002), and studies assessing the natural 
progression of NPH are limited. A recent study, however, attempted to investigate the natural 
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progression of symptoms of iNPH in a set of patients for whom shunt surgery had been delayed 
due to uncontrollable circumstances (Andrén, Wikkelsø, Tisell, & Hellström, 2013). Thirty-
three patients had a median waiting time of 13.2 months for shunt surgery. During this period, 
the group deteriorated 23% on the total iNPH scale score (see Table 1.1 for a description of the 
iNPH scale) and showed worsening in gait, balance, and cognitive abilities. The researchers 
also compared outcome following shunt surgery in this group (iNPHDelayed) to that of a second 
group of patients who had a normal waiting time for surgery (iNPHEarly; median waiting time = 
6 days). The iNPHDelayed group had a significantly poorer outcome at post-shunt compared to 
the iNPHEarly group, highlighting the importance of early treatment. Despite the lack of RCTs, 
improvement rates as high as 80-90% have been documented following shunt surgery (Andrén 
et al., 2013; Eide & Sorteberg, 2010; Klinge et al., 2012). The improvement rates, combined 
with the evidence for decline in unshunted patients (Andrén et al., 2013; Toma, Stapleton, 
Papadopoulos, Kitchen, & Watkins, 2011), support the use of shunt surgery as a treatment 
option for NPH. 
Possible complications associated with shunt surgery include subdural haemorrhage due 
to over-drainage, subdural effusion, or infection (Borgbjerg, Gjerris, Albeck, & Børgesen, 
1995; Hebb & Cusimano, 2001). Shunt revision surgeries may also be required in instances of 
shunt malfunction.  
An alternative treatment to shunt surgery is endoscopic third ventriculostomy (ETV) in 
which a perforation is made in the floor of the third ventricle using an endoscope. CSF is 
therefore diverted from the ventricle into the basal cisterns. Although ETV has been shown to 
be an effective treatment option for obstructive hydrocephalus (Dusick, McArthur, & 
Bergsneider, 2008; Feng et al., 2004), the reported success rate of ETV for iNPH compared to 
shunting is variable (Fleck, Baldauf, & Schroeder, 2014). It has been suggested that ETV may 
be an effective treatment for a subset of patients with iNPH. Specifically, shorter duration of 
symptoms, prevalence of gait disturbance, slight mental impairment, and younger age have 
been associated with favourable outcome following ETV (Gangemi, Maiuri, Buonamassa, 
Colella, & de Divitiis, 2004; Hailong et al., 2008). 
 
1.2.7. Outcome 
There is no standard for assessing outcome following treatment for NPH, and methodological 
differences across studies complicate interpretation of outcome (Klinge, Marmarou, 
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Bergsneider, Relkin, & Black, 2005). For example, there is no consensus regarding the post-
operative assessment period, or which assessment measures should be used. Various scales have 
been developed for assessing severity of NPH and/or outcome. Such scales typically grade 
functioning or activities of daily living (e.g. Stein & Langfitt, 1974), or rate the clinical 
symptoms of gait, incontinence, and dementia (e.g. Eide, 2006; Kiefer, Eymann, & Meier, 
2002). Further scales have incorporated neuropsychological tests into the assessment protocol 
(Boon, Tans, Delwel, Egeler-Peerdeman, Hanlo, Wurzer, & Hermans, 1997; Hellström, Klinge, 
Tans, & Wikkelsø, 2012a). Examples of the types of scales used are presented in Table 1.1. 
Varying rates of improvement following treatment have been documented, often depending on 
which assessment scale is used (Klinge et al., 2005).  
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Table 1.1: Examples of assessment scales for grading of severity of NPH and outcome 
Scale Assessment criteria 
Stein & Langfitt Scale 
(1974) 
Grade 0   
Grade 1 
  
Grade 2   
Grade 3  
 
Grade 4  
No neurological deficit, able to work 
Minimal deficit, able to function independently at 
home 
Some supervision required at home 
Custodial care required despite considerable 
independent function 
No practical capacity for independent function 
Black Scale (1980) Excellent  
Good  
Fair         
Transient  
Poor 
Dead 
Resumed pre-illness activity without deficit 
Resumed pre-illness activity with moderate deficit 
Improved, but no return to previous work 
Temporary major improvement 
No change or worse 
Deceased within 6 weeks of surgery or as a result 
of surgery 
Kiefer Index (2002) Mental State 
 
 
 
 
Gait disorders 
 
 
 
 
 
 
Incontinence 
 
 
 
 
 
Dizziness  
0 = No apparent deficit 
1 = Forgetful, impaired concentration 
4 = Apathy, or only partly oriented 
6 = Totally disoriented 
 
0 = Not or only in special tests handicapped 
2 = Wide legged but per se safe gait 
4 = Troublesome gait, only with crutches possible 
5 = Only a few steps with the aid of one person 
possible 
6 = Unable to walk 
 
0 = None 
1 = Urge-incontinence 
3 = Intermittent bladder incontinence 
4 = Permanent bladder incontinence 
6 = Bladder and bowel incontinence 
 
0 = None 
1 = Intermittent spontaneous dizziness 
2 = Permanent dizziness 
NPH Grading Scale, 
(Eide, 2006) 
Gait 
disturbance 
 
 
 
 
 
 
 
 
Urinary 
incontinence 
 
5 = Normal gait 
4 = Gait is abnormal, but walking is possible 
without support. Imbalance when turning with 
short steps. Widened base and occasional falling 
3 = A cane is needed. Independent walking is 
possible but is unstable or the patient falls 
2 = Support from another person is needed. 
Ambulation is possible with help 
1 = Patient is bedridden or not able to ambulate 
 
5 = No subjective or objective incontinence 
4 = Urinary urgency. Rare incontinence 
3 = Occasional urinary incontinence 
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Dementia 
2 = Continuous urinary incontinence 
1 = Both urinary and faecal incontinence 
 
5 = Normal 
4 = Memory problems exist that are reported by 
patient or family 
3 = Important memory problems with more or less 
severe behaviour disturbances 
2 = Severe dementia 
1 = Vegetative 
iNPH Grading Scale 
(Kubo et al., 2008) 
Cognitive 
impairment 
 
 
 
 
 
 
 
 
Gait 
disturbance 
 
 
 
 
 
Urinary 
disturbance 
0 = Normal 
1 = Complaints of amnesia or inattention but no 
objective memory and attentional impairment 
2 = Existence of amnesia or inattention but no 
disorientation of time and place 
3 = Existence of disorientation of time and place 
but conversation is possible 
4 = Disorientation for the situation or meaningful 
conversation impossible 
 
0 = Normal 
1 = Complaints of dizziness of drift and dysbasia 
but no objective gait disturbance 
2 = Unstable but independent gait 
3 = Walking with any support 
4 = Walking not possible 
 
0 = Normal 
1 = Pollakiuria or urinary urgency 
2 = Occasional urinary incontinence 
3 = Continuous urinary incontinence 
4 = Bladder function is almost or completely 
deficient 
iNPH Scale, (Hellström 
et al., 2012a) 
Gait 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Neuro-
psychology 
 
The gait domain is evaluated by measurement of 
the number of steps and seconds needed to walk 10 
m at free pace, and using the following ordinal 
rating of the gait: 
 
1 = Normal 
2 = Slight disturbance of tandem walk and turning 
3 = Wide-based gait with sway, without foot 
corrections 
4 = Tendency to fall, with foot corrections 
5 = Walking with cane 
6 = Bi-manual support needed 
7 = Aided 
8 = Wheelchair bound 
 
The neuropsychology domain includes four 
variables derived from three neuropsychological 
tests: 
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Balance 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Continence 
The Grooved pegboard 
The Rey Auditory Verbal Learning Test  
The Swedish Stroop Test 
 
The balance domain is represented by an ordinal 
rating scale based on observations of the patients’ 
efforts to stand up straight on one or both legs: 
 
1 = Able to stand independently for more than    30 
s on either lower extremity alone 
2 = Able to stand independently for <30 s on either 
lower extremity alone 
3 = Able to stand independently with the feet 
together (at the heels) for more than 30 s 
4 = Able to stand independently with the feet 
together for <30 s 
5 = Able to stand independently with the feet apart 
(one foot length) for more than 30 s 
6 = Able to stand independently with the feet apart 
for <30 s 
7 = Unable to stand without assistance 
 
1 = Normal 
2 = Urgency without incontinence 
3 = Infrequent incontinence without napkin 
4 = Frequent incontinence with napkin 
5 = Bladder incontinence 
6 = Bladder and bowel incontinence 
 
The iNPH scale features instructions for converting 
each rating scale score into an overall domain score 
 
In a review of diagnosis and outcome in idiopathic NPH, Hebb and Cusimano (2001) reported 
an overall improvement rate of 59% (range, 24-100%), and prolonged or significant 
improvement in 29% (range, 10-100%) of patients. However, assessment measures and criteria 
for improvement varied across studies. They also found high rates of complications. They 
reported a complication rate of 38%, with 22% of patients requiring additional surgery and 6% 
of patients experiencing permanent neurological deficit or death. Regarding the symptom triad 
in NPH, gait has been shown to be the most likely symptom to show improvement (Klinge et 
al., 2005; Malm, Kristensen, Stegmayr, Fagerlund, & Koskinen, 2000; Malm et al., 1995; 
Petersen, Mokri, & Laws  Jr., 1985; Weiner, Constantini, Cohen, & Wisoff, 1995), while 
dementia has been reported to be the least likely symptom to show improvement (Duinkerke, 
Williams, Rigamonti, & Hillis, 2004; Petersen et al., 1985; Raftopoulos et al., 1994). 
19 
 
Guidelines for the assessment of outcome following shunt surgery have been developed 
(Klinge et al., 2005). Klinge et al. recommend that assessment of outcome be conducted at 
three, six, and 12 months following shunt surgery in order to differentiate short- and long-term 
response to treatment. Additionally, they highlight the importance of using objective scales to 
grade improvement of symptoms, in addition to functional scales, with psychometric evaluation 
noted to offer utility for assessment of the cognitive domain. 
 
An important goal of NPH research is the identification of factors which predict good outcome 
following treatment. Vanneste (2000) outlined factors which have been associated with good 
and bad surgical outcome (Table 1.2). 
 
Table 1.2: Factors predictive of good and bad surgical outcome (from Vanneste, 2000) 
Factors predictive of good surgical outcome Factors predictive of bad surgical results 
 Gait disturbance preceding mental 
impairment 
 A short history of mental deterioration 
 Only slight or moderate mental 
impairment 
 A known cause of communicating or non-
communicating hydrocephalus 
 A pattern of hydrodynamic hydrocephalus 
and absence of substantial white matter 
lesions on MRI 
 Substantial clinical improvement after one 
or several lumbar CSF taps or after ELD 
 Occurrence of B-waves during 50% or 
more of the recording time during 
continuous ICP monitoring 
 Resistance to CSF outflow of 18 
mmHg/ml per minute or higher during 
continuous lumbar CSF infusion test 
 Predominance of severe dementia 
 Dementia as the first neurological sign 
 MRI showing marked cerebral atrophy, 
widespread white matter involvement, or 
both 
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1.3. The neuropsychology of normal pressure hydrocephalus 
1.3.1. Background 
Clinical neuropsychology is the applied science of brain-behaviour relationships, which 
includes the study of the effects of abnormal brain function on cognition and behaviour. 
Neuropsychological impairment is a common feature of neurological conditions, reducing 
patients’ quality of life and independence. Despite increasing interest in the area, there remains 
a lack of neuropsychological research in the field of NPH. Cognition in NPH is often assessed 
using grading scales (such as those presented in section 1.2.7.) and therefore, rely on clinician-
rated evaluation of symptoms. Screening measures, such as the MMSE (Cockrell & Folstein, 
1988), are also frequently administered to give a general indication of cognitive functioning or 
degree of dementia. The MMSE is a brief examination assessing orientation to time and space, 
attention, recall, language, and drawing. However, the MMSE is prone to ceiling effects, and it 
is insensitive to subtle neuropsychological changes in areas such as memory and executive 
function (Iddon et al., 1999). Recent investigations have emphasised the need for detailed 
neuropsychological evaluation when assessing patients with NPH (e.g. Behrens et al., 2014; de 
la Calzada et al., 2010; DeVito et al., 2005; Duinkerke et al., 2004; Gleichgerrcht et al., 2009; 
Hellström et al., 2008; Hellström, Klinge, Tans, & Wikkelsø, 2012b; Katzen et al., 2011; 
Solana, Sahuquillo, Junqué, Quintana, & Poca, 2012). In such studies, general cognitive 
assessment measures are supplemented with a battery of neuropsychological tests typically 
covering memory, executive function, attention, language, visuospatial abilities, psychomotor 
speed, as well as behavioural measures.  
Neuropsychological investigations have helped to establish a cognitive profile for NPH 
which could aid diagnosis, clinical management, rehabilitation, and interpretation of outcome 
following treatment (DeVito et al., 2005), as well as providing an insight into the effect of shunt 
treatment on neuropsychological performance. Furthermore, neuropsychological testing may 
be more sensitive to early cognitive decline in patients with NPH than global screening 
measures (Iddon et al., 1999; Relkin & Katzen, 2014). However, currently there is no consensus 
about which neuropsychological tests are most appropriate for use in NPH research. 
In this section, findings from neuropsychological investigations of NPH are reviewed. 
First, the pattern of neuropsychological impairment associated with NPH is presented, followed 
by a review of neuropsychological outcome following treatment. 
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1.3.2. Neuropsychological impairment in NPH  
Studies investigating the neuropsychology of NPH have shown that patients typically present 
with impairments in a range of cognitive domains including in executive function, memory, 
psychomotor speed, and visuospatial abilities (DeVito et al., 2005; Duinkerke et al., 2004; 
Gleichgerrcht et al., 2009; Iddon et al., 1999; Katzen et al., 2011; Mataró et al., 2003; Saito et 
al., 2011; Solana, Sahuquillo, Junqué, Quintana, & Poca, 2012a). NPH has been described as a 
‘subcortical dementia’ (DeVito et al., 2005; Solana et al., 2012a; Vanneste & van Acker, 1990), 
meaning the pattern of cognitive decline is consistent with dysfunction of the subcortical 
structures. However, frontal functions (such as executive functions) may also be compromised 
as a result of damage to subcortical structures and/or fronto-subcortical connectivity and so 
NPH has been further classified as a ‘fronto-subcortical dementia’ (DeVito et al., 2005; 
Hellström et al., 2008; Iddon et al., 1999; Thomas et al., 2005). 
Impairment in tasks of executive function is a common feature of NPH (Iddon et al., 
1999; Solana et al., 2012a). Executive functions are higher order cognitive functions, such as 
decision making, planning, and problem-solving, which are associated with frontal lobe 
function. Patients with NPH have shown more severe executive dysfunction than patients with 
AD (Ogino et al., 2006; Saito et al., 2011). Ogino and colleagues (2006) postulated that the 
cognitive impairment in NPH may be due to damage to frontal regions, or to secondary frontal 
dysfunction resulting from reduced white matter cerebral blood flow in subcortical regions of 
the brain which connect with the frontal cortex.  
The memory deficit in NPH primarily presents as impaired immediate and delayed 
recall but intact or only mildly impaired recognition (Duinkerke et al., 2004; Hellström et al., 
2008; Vanneste, 2000; Walchenbach, Geiger, Thomeer, & Vanneste, 2002). Again, it has been 
suggested that the pattern of memory impairment is suggestive of frontal pathology (Iddon et 
al., 1999). Iddon and colleagues (1999) examined cognitive performance in a group of high 
functioning NPH patients (preshunt MMSE score = 24 or above; n = 6) using tests from the 
Cambridge neuropsychological test automated battery (CANTAB; Robbins et al., 1994). 
Patients were impaired on the CANTAB spatial recognition task, a measure of spatial 
recognition memory sensitive to frontal lobe damage, compared to healthy controls; however, 
they were unimpaired on the pattern recognition task, a measure of visual recognition memory 
which has shown to be sensitive to temporal lobe damage (Iddon et al., 1999). These findings 
give further support to the suggestion that frontal lobe pathology and/ or fronto-subcortical 
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changes underlie the cognitive decline in NPH (DeVito et al., 2005; Iddon et al., 1999; Ogino 
et al., 2006; Saito et al., 2011). 
Pathological changes of the corpus callosum have also been reported in NPH and linked 
to neuropsychological performance (Mataró et al., 2007). Stretching, uniform and focal 
thinning, and upward elevation of the corpus callosum have been reported (Hofmann et al., 
1995; Jinkins, 1991; Mataró et al., 2007; Röricht, Meyer, Woiciechowsky, & Lehmann, 1998). 
Mataró et al. (2007) found that smaller corpus callosum size was related to poorer 
neuropsychological performance. Specifically, the genu of the corpus callosum was related to 
psychomotor speed, while the rostral body and the splenium were associated with performance 
in tests of frontal function. The researchers concluded that atrophy in areas of the corpus 
callosum which contain projections from frontal cortical areas were most related to 
neuropsychological impairment. 
Patients with NPH have shown greater severity of impairment in visuospatial and 
visuoconstructional abilities than controls and patients with AD (Saito et al., 2011). Relkin and 
Katzen (2014) note impairment in performing clock drawing which, they suggest, indicates 
both visuospatial disturbances (related to dysfunction of posterior brain regions) and frontal 
dysfunction (i.e. disrupted planning, and self-monitoring). Indeed, reduced rCBF has been 
observed in the parietal regions in patients with NPH and may explain the observed impairments 
in visuospatial abilities (Relkin & Katzen, 2014; Saito et al., 2011). 
Impaired motor skills is one of the most consistent findings in patients with NPH. 
Patients display impairments in tests of psychomotor speed, manual dexterity, and manual 
coordination (Hellström et al., 2012b; Saito et al., 2011; Solana et al., 2012b). Dysfunction of 
the basal ganglia, or white matter projections to supplementary motor and frontal areas likely 
underlies impaired motor skills in NPH (Relkin & Katzen, 2014). 
 
1.3.3. Neuropsychological outcome following CSF diversion 
Reports of cognitive improvement following treatment for NPH led to its classification as a 
reversible dementia (DeVito et al., 2005; Thomsen, Børgesen, Bruhn, & Gjerris, 1986). 
Cognitive improvement has been observed following CSF diversion with both lumbar puncture 
and shunt surgery (Duinkerke et al., 2004; Foss, Eide, & Finset, 2007; Gleichgerrcht et al., 
2009; Hellström et al., 2008, 2012b; Iddon et al., 1999; Raftopoulos et al., 1994; Solana et al., 
2012a; Stambrook et al., 1988; Thomas et al., 2005; Wikkelsø et al., 1982). However, 
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classification of NPH as a reversible form of dementia remains controversial (Duinkerke et al., 
2004; Raftopoulos et al., 1994; Vanneste, 1994). While CSF drainage is generally considered 
to relieve problems with gait and incontinence, cognitive impairment is reported to be the least 
likely symptom to improve (Duinkerke et al., 2004; Petersen et al., 1985; Raftopoulos et al., 
1994). Reports of post-operative cognitive improvement vary, with as few as 0 to as many as 
80% of patients demonstrating some form of significant cognitive improvement (Duinkerke et 
al., 2004; Hellström et al., 2008; Poca et al., 2005; Raftopoulos et al., 1994; Thomas et al., 
2005). However, as there are no standardised guidelines for assessing cognitive outcome in 
NPH, cognitive assessment measures vary between centres (Toma et al., 2013) and many 
studies have used general screening measures which may not be sensitive to subtle changes in 
cognition. Studies that have focused on neuropsychological test performance generally show a 
beneficial effect of shunt surgery on cognitive function, however the pattern of 
neuropsychological change varies widely between studies. The findings to date are reviewed 
below. 
A number of studies have found the greatest improvement following shunt surgery to 
be on tests of memory. Duinkerke et al. (2004) investigated cognitive change following shunt 
surgery in 10 patients with iNPH, selected on the basis of positive response in any symptom to 
ELD. Post-operative assessments took place between six and 12 months post-shunt (mean = 8.2 
months). They defined improvement as a score increase of at least 1 standard deviation 
compared with the baseline score, or improvement by at least 20 percentile points in timed 
motor tests. The greatest improvement was observed in tests of memory with 80% of patients 
showing significant improvement in verbal memory and retention, and 50% in delayed verbal 
recall. About 50% of patients improved on tests of psychomotor speed and 50-60% improved 
in tests of executive function. Only 13% of patients improved in the Controlled Oral Word 
Association Test, a test of word fluency.  
 Thomas et al. (2005) investigated cognitive change between three and nine months post 
shunt surgery (mean = 3.9 months) in 42 patients with iNPH. They found significant 
improvement in tests of verbal memory, delayed verbal recall, and psychomotor speed. 
However, there was no significant improvement on the Stroop Colour-Word test, a measure of 
executive function, or on the Rey-Osterrieth Complex Figure test, a measure of 
visuoconstructional skills. They concluded that executive function may not improve due to 
irreversible fronto-striatal dysfunction. Similarly, Solana et al. (2012) observed improvement 
six months following shunt surgery in tests of psychomotor speed and verbal memory. 
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However, the proportions of patients who significantly improved in tests of executive function 
was low. 
Iddon et al. (1999) analysed cognitive outcome in a group of 11 patients with iNPH, 
split according to pre-operative MMSE score. Group 1 consisted of five patients who scored in 
the dementing range of the MMSE (a score below 24) at baseline. Group 2 were six patients 
who scored in the non-dementing range of the MMSE. Follow-up assessments were conducted 
at six months post-shunt. Group 1 showed significant improvement in the MMSE, with all 
patients scoring within the normal range at post-shunt. There was no significant difference in 
MMSE score for Group 2 at post-shunt. Group 2, however, completed a number of additional 
tests of executive function. Results showed no significant improvement in any of the tests of 
executive function. The researchers concluded that frontal executive impairment in NPH is not 
reversible.  
 
While the above studies find greatest evidence for improvement in tests of memory and 
psychomotor speed with little evidence for improvement in executive functions, other studies 
have observed a different pattern of neuropsychological change. Hellström et al. (2008) 
investigated cognitive outcome in 47 iNPH patients 3 months after shunt surgery. The battery 
of tests used covered reaction time, psychomotor speed, verbal learning and memory, executive 
function, and working memory. Statistically significant improvement was observed for all tests 
from baseline to follow-up except in two tests of short-term or working memory and a simple 
reaction time task. Greatest improvement was observed in the Stroop test, a measure of 
executive function and attention (82-91% of patients), and in the Grooved Pegboard test, 
measuring dexterity (86-90% of patients). In a later study, Hellström et al. (2012b) again 
demonstrated significant improvement in the Grooved Pegboard test and the Stroop test as well 
as in the Rey Auditory Verbal Learning Test (RAVLT), which measures verbal learning and 
memory. They concluded that these tests (particularly the Grooved Pegboard and the Stroop 
tests) are highly sensitive to treatment effects in NPH, and therefore the researchers 
recommended these tests for evaluation of cognitive change following shunt surgery. 
Saito and colleagues (2011) investigated cognitive outcome one year after shunt surgery 
in 32 patients with iNPH. They assessed memory, attention, language, executive function, 
psychomotor speed, and visuoperceptual and visuospatial skills. Significant group 
improvement from baseline to follow-up was found for a measure of psychomotor speed and a 
measure of executive function (the Frontal Assessment Battery, a bedside screening measure to 
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assess frontal lobe functions; Dubois, Slachevsky, Litvan, & Pillon, 2000). However, no other 
tests showed significant improvement. Gleichgerrcht et al. (2009) specifically sought to 
investigate changes in executive function following shunt surgery. They assessed language, 
attention, and executive function in a group of 10 patients with NPH who showed a positive 
response to ELD. Follow-up assessments were conducted between six and eight months 
following shunt surgery. There were significant group improvements in three out of the four 
tests of executive function. One of the three measures of language function also showed 
significant improvement. Performance on two tests of attention was not significantly improved. 
Lastly, Savolainen and colleagues (Savolainen, Hurskainen, Paljärvi, Alafuzoff, & 
Vapalahti, 2002) investigated cognitive outcome in patients with iNPH between three and 12 
months post-shunt. Twenty patients completed follow-up assessments after shunt surgery. The 
neuropsychological test battery covered learning and memory, visuoconstructional skills, 
verbal ability, attention and executive function. There were no significant differences in 
performance in any of the tests at outcome. 
 
Interpretation of cognitive outcome in NPH is complicated by methodological differences 
across studies to date. There is a lack of consensus for defining improvement (Hellström et al., 
2008; Solana et al., 2012b), patient selection criteria differ across the studies, and varying 
outcome intervals were used which can affect the results (Solana et al., 2012b). Furthermore, a 
number of the studies had small sample sizes. Overall, the results to date appear to support the 
notion that cognitive function is improved following shunt surgery. However, a clear pattern of 
neuropsychological change is yet to be elucidated. Determining a pattern of improvement may 
be useful for differential diagnosis. It may also provide insight into the neural mechanisms 
underlying the symptoms of NPH, and whether or not impairments in functioning are reversible. 
 Chapter 2 investigates the pattern of neuropsychological outcome in patients with NPH 
by using meta-analytic techniques, thus overcoming the sample size issue, with the aim being 
to establish a clearer profile of post-shunt neuropsychological change. Chapter 2 also 
investigates whether moderator variables (age, sex, or time between shunt and reassessment) 
predict cognitive outcome. Since it is unclear whether ceiling effects might underlie the absence 
of significant improvement in some neuropsychological tests, Chapter 2 also attempts to 
investigate this issue. 
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1.4. Motivation and apathy in normal pressure hydrocephalus 
1.4.1. Definitions and background 
Neuropsychiatric (behavioural or affective) symptoms, such as apathy or depression, are 
common in patients with dementia. These symptoms can lead to impairment in activities of 
daily living, cognitive decline, poorer quality of life, and greater caregiver burden (Lyketsos et 
al., 2002). Apathy in particular is associated with cognitive and functional impairment in 
patients with dementia (Boyle et al., 2003; Landes, Sperry, & Strauss, 2005; Starkstein et al., 
2006b), including in patients with iNPH (Kito et al., 2009), and in cognitively normal older 
individuals (Onyike et al., 2007); as well as increased caregiver burden (Kaufer et al., 1998). 
Therefore, apathy is an important symptom for investigation in NPH. 
Marin (1990) defined apathy as an absence or lack of motivation that is not attributable 
to cognitive impairment, emotional distress, or diminished level of consciousness. Apathy can 
be further defined as a reduction in the behavioural (lack of effort, dependency on others to 
structure activity), cognitive (lack of interest, lack of concern about one’s personal problems), 
and emotional (attenuated emotional responses to events) aspects of goal-directed behaviour 
(Marin, Biedrzycki, & Firinciogullari, 1991; Starkstein, Petracca, Chemerinski, & Kremer, 
2001). 
This section begins with a discussion on the prevalence of apathetic symptoms in NPH. 
Possible neural bases for apathy in NPH are then presented followed by an overview of the 
most commonly used apathy assessment measures.  
 
1.4.2. The prevalence of apathy in NPH 
Patients with NPH are frequently reported to display apathetic symptoms. Early investigations 
of NPH cited inertia, lack of spontaneity or initiative, and “apathy to the point of akinetic 
mutism” as the most notable behavioural symptoms in patients (Adams et al., 1965; Caltagirone 
et al., 1982; De Mol, 1986). However, despite this, few studies have objectively measured 
apathetic symptoms in patients with NPH and so the prevalence and severity of this symptom 
is not well established. Only two studies have provided information about the prevalence of 
apathy in NPH (Kanemoto et al., 2016; Kito et al., 2009). Kanemoto et al. and Kito et al. 
investigated neuropsychiatric symptoms in patients with iNPH using the Neuropsychiatric 
Inventory (NPI; see section 0 for a description). Apathy was found to be the most frequent 
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neuropsychiatric symptom in both studies (present in 70% of 64 patients in the study by Kito 
et al. and present in 86% of 22 patients in the study by Kanemoto et al.). Kito et al. further 
provided information about the severity of neuropsychiatric symptoms in their patients. Degree 
of apathy was found not to be severe despite the high prevalence.  
Symptoms of depression are more commonly assessed in patients with NPH. Apathy 
may be misdiagnosed as depression due overlapping symptoms (such as diminished interest, 
psychomotor slowing, fatigue/hypersomnia, and lack of insight), however, research suggests 
that apathy is distinct from depression (Landes, Sperry, Strauss, & Geldmacher, 2001). 
Symptoms which distinguish apathy from depression include blunted emotional response, 
indifference, low social engagement, poor persistence and diminished initiation, while 
symptoms of dysphoria, suicidal ideation, self-criticism, guilt, pessimism, and hopelessness are 
indicative of depression (Landes et al., 2001). It is important to distinguish apathy from 
depression as the two syndromes respond to different treatments. For example, apathy has been 
shown to respond to administration of the psychostimulant drug methylphenidate. (Herrmann 
et al., 2008; Keenan, Mavaddat, Iddon, Pickard, & Sahakian, 2005; Padala et al., 2010; 
Rosenberg et al., 2013). 
Israelsson, Allard, Eklund, and Malm (2016) investigated the prevalence of depression 
in a group of 165 iNPH patients. Depressive symptoms were present in 56% of patients pre-
operatively and 46% of patients following shunt treatment. However, apathy was not assessed 
in this study. In contrast, Kito et al. (2009) and Kanemoto et al. (2016) reported much lower 
prevalence rates for depression (14% and 36%, respectively). Therefore, apathy could be 
misattributed to depression when assessing depression alone in patients with NPH. It is 
important for future studies to assess both apathetic and depressive symptoms, separately, in 
patients with NPH in order to delineate the two. 
Chapter 3 investigates the prevalence of apathy and depression in patients with NPH at 
pre- and post-shunt. 
 
1.4.3. Neural correlates of apathy in NPH 
Due to lack of research, the neural underpinnings of apathy in NPH have not been elucidated. 
However, it has been suggested that frontal or subcortical pathology may underlie this 
symptom. 
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 Kito and colleagues (2009) found evidence for an association between apathy and 
cognitive impairment, measured using the iNPH Grading Scale (Kubo et al., 2008; see Table 
1.1 for a description) in patients with iNPH. The researchers suggested that apathy in NPH may 
be caused by damage to subcortical areas which project to the frontal lobes. More recently, 
Kanemoto and colleagues (2016) assessed change in neuropsychiatric symptoms three months 
following LP shunt surgery. A reduction in apathy post-shunt was associated with improved 
performance in the Frontal Assessment Battery, a measure of frontal lobe functioning, thus 
providing support to the notion that frontal lobe pathology may underlie apathy in NPH. 
Further evidence for fronto-subcortical pathology underlying apathy in NPH has come 
from imaging studies (DeVito, Salmond, Owler, Sahakian, & Pickard, 2007; Kanemoto et al., 
2015). DeVito et al. (2007) observed reduced caudate volumes in 11 patients with iNPH 
compared to healthy controls. Although volumes were not correlated with clinical measures, 
they hypothesised that the reduced caudate volumes may be important for the clinical symptoms 
of cognitive impairment and apathy. Recently, however, evidence has been found for an 
association between improvement in apathy following shunt surgery with improved rCBF in 
the anterior cingulate cortices and the right caudate nucleus (Kanemoto et al., 2015). Kanemoto 
et al. concluded that damage to the caudate could lead to frontal dysfunction and subsequent 
apathetic symptoms.  
The caudate nucleus forms part of the striatum, together with the putamen and nucleus 
accumbens. The striatum in turn is one component of the basal ganglia, a collection of structures 
which play important roles in movement, cognition, learning, and motivation or goal-directed 
behaviour (Belin, Jonkman, Dickinson, Robbins, & Everitt, 2009; Middleton & Strick, 2000; 
Redgrave et al., 2010; Robbins & Everitt, 1996; Schultz, 1999). The striatum is linked to the 
frontal cortex via parallel frontal-subcortical circuits, lesions to which can cause executive 
dysfunction, personality changes, and impaired motivation or apathy (Mega & Cohenour, 1997; 
Tekin & Cummings, 2002). Further, focal lesions of the basal ganglia can cause apathy (Levy 
& Czernecki, 2006; Tekin & Cummings, 2002), including lesions located in the caudate nucleus 
(Bhatia & Marsden, 1994; Caplan et al., 1990; Mendez, Adams, & Lewandowski, 1989; Trillet, 
Croisile, Tourniaire, & Schott, 1990; Wang, 1991). 
Overall, the findings from the above studies combined with evidence for reduced rCBF 
in periventricular and frontal regions in NPH (Momjian et al., 2004; Owler et al., 2004; Owler 
& Pickard, 2001; Ziegelitz et al., 2014, 2015b) suggest that fronto-subcortical changes in NPH 
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may give rise to apathy. Therefore, apathy and cognitive dysfunction in NPH may have 
common pathophysiological underpinnings.  
Chapters 3 and 4 investigate neural correlates of apathy (and cognitive impairment) in 
patients with NPH. Chapter 3 investigates whether degree of ventricular enlargement is related 
to apathy and depression. Chapter 4 extends the findings from Chapter 3 by conducting a 
structural MRI study to investigate whether patients’ symptoms are related to volumetric 
changes of the whole brain or of the subcortical structures. 
 
1.4.4. Apathy scales 
Apathy is typically measured using self- (patient), informant-, or clinician-rated scales. The 
most commonly used apathy scales are The Apathy Evaluation Scale, The Lille Apathy Rating 
Scale, and The Neuropsychiatric Inventory. Below is a brief description of each: 
 
The Apathy Evaluation Scale (AES; Marin, Biedrzycki, & Firinciogullari, 1991) 
Clinician-, informant-, and self-rated versions of the AES are available (AES-C, AES-I, and 
AES-S, respectively). The AES is an 18-item scale. There are three types of items, tapping 
behavioural, cognitive, or emotional aspects of goal-directed behaviour. Responses to items are 
recorded using a 4-point Likert-type scale with the categories: Not at All Characteristic; Slightly 
Characteristic; Somewhat Characteristic; and Very Characteristic. Higher scores indicate more 
severe levels of apathy. 
 
The Lille Apathy Rating Scale (LARS; Sockeel et al., 2006) 
The Lille Apathy Rating Scale consists of 33 items, covering nine domains of apathy: reduced 
everyday productivity, lack of interest, lack of initiative, lack of novelty seeking/ motivation, 
emotional blunting, lack of concern, poor social life, and extinction of self-awareness. The 
LARS utilises a structured interview format between the clinician and the patient. There is also 
a caregiver-based version (Dujardin, Sockeel, Delliaux, Destée, & Defebvre, 2008).  
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The Neuropsychiatric Inventory (NPI; Cummings et al., 1994) 
The Neuropsychiatric Inventory is an informant-based questionnaire which assesses a range of 
neuropsychiatric symptoms. The NPI assesses ten behavioural symptoms: delusions, 
hallucinations, agitation, depression, anxiety, elation, apathy, disinhibition, irritability, and 
aberrant motor behaviour. The questionnaire contains screening questions for each behaviour. 
For example, the screening questions for assessing the presence of apathy are as follows: Has 
the patient lost interest in the world around him/ her? Has he/ she lost interest in doing things 
or a lack of motivation for starting new activities? Is he/ she more difficult to engage in 
conversation or in doing chores? Is the patient apathetic or indifferent? If, based on the 
response to the screening questions, a behaviour is indicated to be present, a number of 
additional questions are asked followed by determination of the frequency and severity of that 
behaviour. For each behavioural domain there are four scores: frequency, severity, total 
(frequency x severity), and caregiver distress. Further, a total NPI score can be calculated by 
combining the scores for the individual domains. 
 
In addition, a number of apathy scales have been developed by modifying the above scales. The 
State Apathy Evaluation scale conceived by researchers at the University of Cambridge 
(Blackwell, Paterson, Barker, Robbins, & Sahakian, 2008) is a slightly modified version of the 
Apathy Evaluation Scale. It contains the same 18-item scale used in the AES but with slightly 
altered wording which allows the assessment of state rather than trait apathy (see Appendix A). 
It is scored in the same way as the AES. Starkstein et al. (Starkstein et al., 1992) developed The 
Apathy Scale, also based on the AES. Rather than using a self-rated format as in the AES, The 
Apathy Scale features a number of questions which should be read to the patient by the 
examiner and patients are provided with four possible answers as in the AES. The Apathy 
Inventory (IA; Robert et al., 2002) assesses three domains of apathy: emotional blunting, lack 
of initiative, and lack of interest. The IA (including administration and scoring) is based on the 
Neuropsychiatric Inventory and includes both patient- and caregiver-based versions. 
 In the studies contained in this thesis, apathy was measured using the Cambridge State 
Apathy Evaluation scale (Blackwell et al., 2008) in order to more accurately measure state-
related changes in apathy between pre- and post-shunt assessment visits. The abbreviations 
AES, AES-C, AES-I, and AES-S are used in relation to the State Apathy Evaluation scale in 
the same way as for the Apathy Evaluation Scale, as described in Section 0. 
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 Chapter 5 develops the rationale for developing an objective measure of apathy since 
apathy is currently measured using rating scales which are inherently subjective. Although 
every measure is taken to ensure the information obtained from self-rated scales is as accurate 
as possible at the CSF disorders clinic at Addenbrooke’s Hospital, an objective measure would 
clearly be hugely beneficial, particularly for use with patients with cognitive decline. In Chapter 
5, the feasibility of a novel reward learning task as an objective measure of motivation or apathy 
is evaluated. 
 
1.5. Aims of the thesis 
This thesis aimed to expand on the neuropsychological and neuropsychiatric research in NPH. 
Chapter 2 presents results from a meta-analysis of neuropsychological outcome following shunt 
surgery. The objective of this chapter was to combine the results from investigations of 
neuropsychological outcome in patients with NPH in order to try to determine which aspects of 
neuropsychological functioning improve following shunt surgery. Additionally, this study 
investigated whether moderator variables (age, sex, and time between shunt and reassessment) 
affected outcome on the MMSE. Chapter 3 investigated the significance of the symptom of 
apathy in NPH. Specifically, Chapter 3 investigated the prevalence of apathy in patients with 
NPH, and whether apathy in NPH is related to (i) ventricular enlargement; (ii) cognitive 
function; and (ii) cognitive outcome. Chapter 4 used structural imaging techniques, including 
automated measurement of total brain and subcortical segmentation; as well as manual tracing 
to investigate structural correlates of cognitive dysfunction and apathy in NPH. Chapter 5 
presents results from a feasibility study of a novel reward learning task to determine whether it 
could be used as an objective measure of motivation and apathy for use in patients with 
dementia (including patients with NPH). Chapter 6, the General Discussion, summarises the 
findings of the thesis within the context of the wider literature.  
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Chapter 2  
The effect of shunt surgery on neuropsychological performance in 
normal pressure hydrocephalus: a systematic review and meta-
analysis 
 
2.1. Introduction 
The classic triad of symptoms in normal pressure hydrocephalus (NPH) are gait disturbance, 
urinary incontinence, and progressive dementia/ cognitive decline (Hakim & Adams, 1965). 
Dementia-related symptoms are characterised by deficits in memory, visuospatial abilities, 
psychomotor speed and executive function (DeVito et al., 2005; Duinkerke et al., 2004; 
Gleichgerrcht et al., 2009; Iddon et al., 1999; Katzen et al., 2011; Mataró et al., 2003; Saito et 
al., 2011; Solana et al., 2012a). The effect of shunt treatment on cognitive performance in 
patients with NPH is controversial. While cerebrospinal fluid (CSF) drainage is generally 
considered to relieve problems with gait and incontinence, cognitive impairment is reported to 
be the least likely symptom to improve (Duinkerke et al., 2004). Rates of cognitive 
improvement range from 0 to 80% of patients in a given series (Duinkerke et al., 2004; 
Hellström et al., 2008; Poca et al., 2005; Raftopoulos et al., 1994; Thomas et al., 2005). 
However, methodological limitations have been identified which could explain the variability 
observed between studies. These include unclear patient selection criteria, inconsistent follow 
up intervals and use of subjective measures of improvement (Klinge et al., 2005). Additionally, 
due to the lack of standardised clinical guidelines for assessing cognitive function in this patient 
group, assessment methods often vary between centres with functional grading scales, clinical 
rating scales, and neuropsychological testing being employed (Klinge et al., 2005). Studies that 
have focused on neuropsychological test performance generally show a beneficial effect of 
shunt surgery on cognitive function. However, again, the pattern of post-operative 
neuropsychological improvement varies widely between studies (e.g. Duinkerke et al., 2004; 
Gleichgerrcht et al., 2009; Hellström et al., 2008; Solana et al., 2012).  
Investigations into the neuropsychology of NPH are plagued by the same limitations 
identified above, but further, many such studies have small sample sizes. This is the case for a 
number of reasons: NPH is a rare disorder (see section 1.2.3) and likely underdiagnosed due to 
the difficulty of diagnosis and the fact that the symptoms develop insidiously; most of the 
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patients with NPH are elderly and may have contraindications for shunt surgery; and in many 
cases, a high proportion of patients are lost to follow-up.  
Understanding the neuropsychology of NPH may be useful for differential diagnosis as 
well as interpretation of outcome following treatment (Solana et al., 2012b). The present study 
combined data from the most frequently used neuropsychological tests in an attempt to 
determine the effect of shunt surgery on neuropsychological performance in patients with NPH. 
Studies using neuropsychological tests to assess cognition before and after shunt surgery were 
included. Meta-analyses were conducted on the pre- to post-operative difference scores for each 
test. In case there was a lack of improvement in any of the cognitive domains which might have 
been due to a ceiling effect (i.e. patients were not significantly impaired in the test at baseline 
and so a significant improvement would not be expected to occur), meta-analyses were also 
conducted on the average pre-operative score for each test. Finally, exploratory analyses 
investigated the effects of moderator variables (age, sex, and time between shunt and 
reassessment) on cognitive outcome. This could be useful for predicting outcome following 
treatment. 
 
2.2. Methods 
2.2.1. Search strategy 
A systematic search of the electronic databases PubMed and Web of Science was conducted in 
October 2015 using the key words: ‘NPH’, ‘normal pressure hydrocephalus’, ‘cognition’, 
‘shunt outcome’, ‘neuropsychological outcome’ and ‘neuropsychological assessment’ 
(separately and in combination) for studies published before October 2015. Due to the limited 
pool of papers recovered, Google Scholar was included in the search strategy. Reference lists 
of relevant studies were searched manually. The present review did not have a registered 
protocol but followed the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) statement (Liberati et al., 2009). 
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2.2.2. Study selection 
Selection of studies 
Titles and abstracts of articles were scanned independently by two researchers (Katie Peterson 
and Clare Killikelly) to identify articles to retrieve in full. Disagreement was dealt with by 
discussion including a third person (George Savulich).  
 
Inclusion criteria 
Inclusion criteria were: (1) prospective investigations of cognitive outcome following shunt 
surgery; (2) patients were adults with a diagnosis of NPH; (3) within-subjects design; and (4) 
report of pre- and post-operative neuropsychological test scores. 
 
Exclusion criteria 
Exclusion criteria were: (1) case studies; (2) studies which did not use neuropsychological tests; 
(3) used neuropsychological tests which were not analysed based on insufficient data; (4) 
reported composite scores. One study (Poca et al., 2005) was excluded due to patient overlap 
with Poca et al. (2004). Three other papers were excluded due to likely patient overlap with 
other papers that involve larger patient numbers and were included in the review and the 
analyses that follow. These are detailed below: 
 de la Calzada et al. (2010) due to likely overlap with Poca et al. (2004) 
 Poca et al. (2001) due to likely overlap with Poca et al. (2004) 
 Wada et al. (2013) due to likely overlap with Yamamoto et al. (2013) 
 
2.2.3. Primary outcome measures 
Meta-analyses were conducted on pre-operative and “difference” scores for seven 
neuropsychological tests: the Mini-Mental State Examination (MMSE); the Rey Auditory 
Verbal Learning Test (RAVLT) total verbal recall and delayed verbal recall subtests; backwards 
digit span; phonemic verbal fluency; trail making test A (TMT-A); and trail making test B 
(TMT-B). Section 2.2.4 contains a description of each test. These tests were selected as each 
had at least five studies providing supporting data. Follow-up intervals ranged from three to 12 
months post-shunt (Table 2.1). One study reported outcome data from more than one post-
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operative assessment (Hellström et al., 2012b). In this case, data from the earliest follow-up 
assessment (3 months) were included.  
 
2.2.4. Neuropsychological tests 
The Mini-Mental State Examination (MMSE; Cockrell & Folstein, 1988) 
The MMSE is a widely used bedside measure for mental status evaluation. It is useful in 
detecting dementia and for assessing severity of dementia. The MMSE includes tests of 
memory, attention, personal orientation, reading, writing, and visuospatial ability. The 
maximum score is 30, and a score below the cut off of 24 is considered to indicate the presence 
of dementia. 
 
The Rey Auditory Verbal Learning Test (RAVLT; Schmidt, 1996) 
The RAVLT assesses verbal learning and memory. A list of 15 unrelated words are read aloud 
to the participant by the examiner. The participant is asked to recall as many of the words as 
they can. This is repeated five times. Thus the total verbal recall score is the total number of 
words correctly recalled over five trials (maximum score = 75). After a delay of 30 minutes, 
participants are again asked to recall as many of the words as possible from the list. The number 
of words recalled is the delayed verbal recall score (maximum score = 15). 
 
Backwards digit span (Wechsler, 1945) 
The backwards digit span test assesses working memory. In this task, participants must repeat 
strings of digits backwards. The score is the number of digits in the longest completed series. 
 
Phonemic verbal fluency (Benton & Hamsher, 1989) 
The phonemic verbal fluency task assesses executive function. Patients are asked to generate 
as many words as they can beginning with the letters ‘F’, ‘A’, then ‘S’ (or culturally adapted 
variations of these) with a time limit of 60 seconds per letter. The score represents the total 
number of words generated for the three letters combined.  
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Trail making test A (TMT-A; Reitan, 1958) 
The TMT-A assesses visual search scanning and psychomotor speed. The task involves 
connecting an array of 25 encircled numbers displayed on a sheet of paper. Participants must 
connect the numbers in sequential order without lifting the pen or pencil. The score is 
represented as the number of seconds taken to complete the task. 
 
Trail making test B (TMT-B; Reitan, 1958) 
The TMT-B is similar to the TMT-A, but the circles contain either a number (1-13) or a letter 
(A-L). Participants are instructed to connect the circles in sequential order but this time 
alternating between letters and numbers. Therefore, the TMT-B incorporates an executive 
component. As with the TMT-A, it is scored in seconds to complete. 
  
2.2.5. Statistical analysis 
Analyses were performed using Stata v13. Random-effects meta-analyses were performed 
using the average difference between pre-operative and post-operative scores (difference 
scores) as outcome data and the standard method of DerSimonian and Laird (DerSimonian & 
Laird, 1986). Average difference scores were provided by some studies, while for others these 
were calculated from average pre-operative and post-operative scores. In all meta-analyses, a 
positive difference indicates that the average post-operative score is more than the pre-operative 
score. Hence in some meta-analyses positive estimates indicate patient improvement and in 
others positive estimates indicate deterioration. However, pooled estimates from all seven meta-
analyses lie in the direction where post-operative scores are better than the corresponding pre-
operative score. 
To include all studies providing relevant outcome data, medians were used as means 
where these were reported. Where interquartile ranges or ranges were reported instead of 
standard deviations, these were converted to standard deviations by assuming that their bounds 
correspond to appropriate quantiles from a normal distribution. 
The within-study variances of the average differences were calculated using the reported 
standard deviations and the numbers of patients. For studies that did not give average difference 
scores directly, we calculated variances of the average pre-operative and post-operative scores 
in the same way and allowed for a correlation between these two scores when calculating 
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within-study variances of their difference; this is important because scores from the same 
patients will generally be positively correlated. We assumed a moderate correlation of 0.6 
between the average pre-operative and post-operative scores. Our conclusions were robust 
when assuming alternative correlations of 0.4 and 0.8 (results shown in Appendix B). 
Due to the small numbers of patients comprising the studies, the approximations that 
underlie the random-effects model are not especially precise. This is evident when, for example, 
studies’ statements about the statistical significance of their difference scores are not necessarily 
reflected in the forest plots. Therefore, whether the results are robust is carefully assessed 
below. 
Random-effects meta-analyses were also performed using average pre-operative scores 
to investigate whether instances of lack of improvement were due to ceiling effects. Finally, 
three random-effects meta-regression models were fitted using the average difference in MMSE 
as outcome data to assess the evidence that three covariates may be useful predictors of 
cognitive change. 
No statistical method was used to assess publication bias. Whilst recognising this as an 
important issue for meta-analyses, not all studies contribute outcome data to all meta-analyses. 
Hence the sample sizes are inadequate to assess this issue formally. Furthermore, it is plausible 
to assume an absence of publication bias in the present systematic review. This is because 
publication bias is usually thought to occur because studies indicating a treatment effect are 
more likely to be published but the studies included here do not compare treatment groups in 
this way. 
 
2.3. Results 
2.3.1. Search results 
Seventy-one studies were identified following a systematic literature search. Forty-eight were 
excluded (Figure 2.1) and twenty-three met criteria for inclusion in meta-analyses (Table 2.1). 
A subset of these studies provide outcome data for each neuropsychological test. Nineteen 
studies provide outcome data for the MMSE; seven studies provide outcome data for RAVLT 
total and delayed recall subtests; six studies provide outcome data for backwards digit span; 
eight studies provide outcome data for phonemic verbal fluency; 13 studies provide outcome 
data for TMT-A; and nine studies provide outcome data for TMT-B (Table 2.2; section 2.3.6). 
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Figure 2.1: PRISMA flow chart for review 
 
 
2.3.2. Average pre-operative scores 
The estimated average pre-operative score for each test was as follows: MMSE = 23.10 points 
(95% CI 22.13 to 24.08); RAVLT total verbal recall = 22.73 words (95% CI 19.86 to 25.61); 
RAVLT delayed verbal recall = 1.90 words (95% CI 1.22 to 2.57); backwards digit span = 2.92 
digits (95% CI 2.38 to 3.46); phonemic verbal fluency = 19.67 words (95% CI 13.60 to 25.74); 
TMT-B = 293.03 seconds (95% CI 221.09 to 364.97); and TMT-A = 132.48 seconds (95% CI 
108.48 to 156.49) (Table 2.2). 
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Table 2.1: Characteristics of the studies included in meta-analyses 
Study Patient n  Patient Selection 
Age of patients 
Mean (SD) years 
Follow-up Interval % males 
Andrén et al. (2013) 69* Patients with idiopathic NPH 70 (48-84) a 3 months 54 
Duinkerke et al. (2004) 
 
10 
 
Patients with idiopathic NPH who showed improvement in at 
least one clinical symptom with temporary lumbar drainage 
70.9 (10.26) 6-12 months 40 
Foss et al. (2007)  27 Patients with idiopathic NPH 72 (46-81)a 6-9 months 29.6 
Gleichgerrcht et al. (2009) 
 
10 Patients with NPH who showed clinical response to continuous 
CSF drainage 
69.4 (9.3) 6-8 months 
 
70 
Hellström et al. (2008) 47 Patients with idiopathic NPH 73 (24-84) a 3 months 47 
Hellström et al. (2012b) 142 Patients with idiopathic NPH 72.5 (30-87) a 3 months 51 
Hiraoka et al. (2015) 11 Patients with idiopathic NPH 77.9 (4.1) 3 months 40 
Iddon et al. (1999) 11 Patients with idiopathic NPH 69.64 (6.14) 6 months 72.7 
Katzen et al. (2011) 12 Patients with idiopathic NPH 74.92 (7.72) 6 months 33.3 
Kazui et al. (2015) 49* Patients with idiopathic NPH 76.4 (4.4) 3 months 41 
Lundin et al. (2013) 35 Patients with idiopathic NPH 73 (49-81)b 3 months 45.7 
Mataró et al. (2003) 8 Patients with idiopathic NPH 73.4 (6.8) 6 months 50 
Mataró et al. (2007) 18 Patients with idiopathic NPH 74.56 (7.06) 6 months 50 
Moriya et al. (2015) 32 Patients with idiopathic NPH 73.7 (6.8) 12 months 71.9 
Peterson et al. (2016) 22 Patients with NPH 68.3 (10.8) 3-9 months 63.6 
Poca et al. (2004) 43 Patients with idiopathic NPH 71.1 (6.9) 6 months 69.8 
Saito et al. (2011) 
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Patients with idiopathic NPH who showed ≥ 1 point reduction 
on the total iNPH Grading Scale following shunt surgery 
75.7 (4.5) 12 months 
 
50 
Savolainen et al. (2002) 51 Patients with idiopathic NPH 67.5 3-12 months 52.9 
Solana et al. (2012) 185 Patients with idiopathic NPH 73.96 (6.3) 6 months 60 
Stambrook et al. (1988) 14 Patients with NPH 66.0 (14.16) Mean = 23.73 weeks 64.3 
Thomas et al. (2005) 42 Patients with idiopathic NPH 73 (10) 3-9 months  45.2 
Virhammar et al. (2014b) 173 Patients with idiopathic NPH 74 (54-88)a 12 months 53 
Yamamoto et al. (2013) 16 Patients with idiopathic NPH 75.8 (4.9) 3 months 50 
Note: aMedian (range); bMean (range); *treatment-as-normal group; CSF, cerebrospinal fluid; NPH, normal pressure hydrocephalus.
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2.3.3. Average difference scores (pre- to post-shunt) 
There was a statistically significant effect of shunt surgery on cognition (MMSE: pooled 
average difference = 2.20 points, 95% CI 1.45 to 2.95, p < 0.001; I2 = 81.9%, Figure 2.2), 
memory (RAVLT total verbal recall: pooled average difference = 5.64 words, 95% CI 3.86 to 
7.43; p < 0.001, I2 = 57.2%, Figure 2.3; delayed verbal recall: pooled average difference = 1.43 
words, 0.55 to 2.31; p = 0.001, I2 = 89.3%, Figure 2.4), executive function (backwards digit 
span: pooled average difference = 0.36 digits, 0.04 to 0.67; p = 0.03, I2 = 87.0%, Figure 2.5; 
phonemic verbal fluency: pooled average difference = 2.73 words, 95% CI 0.84 to 4.63, p = 
0.005, I2 = 33.6%, Figure 2.6; TMT-B: pooled average difference = -43.46 seconds, 95 % CI -
83.23 to -3.70, p = 0.03, I2 = 77.7%, Figure 2.7), and psychomotor speed (TMT-A: pooled 
average difference = -25.90 seconds, 95% CI -36.11 to -15.69; p < 0.001, I2 = 36.1%; Figure 
2.8). 
 
2.3.4. Interpretation of difference scores 
All analyses show statistically significant estimated average differences in the direction of 
improvement following shunt surgery in the presence of moderate to high heterogeneity (Table 
2.2). There is strong evidence for five of these average differences: MMSE (p < 0.001), RAVLT 
total verbal recall (p < 0.001), RAVLT delayed verbal recall (p = 0.001), phonemic verbal 
fluency (p = 0.005) and TMT-A (p < 0.001). The remaining tests (backwards digit span, and 
TMT-B) show weaker significance levels (p = 0.03; 0.03; respectively). Given the problems 
associated with repeated testing, and because of the approximations made by the statistical 
methods used, we suggest that the statistical significance of these two tests be treated with 
caution and we do not view them as robust.  The I2 statistics range from 33-90%, indicating 
considerable between-study heterogeneity in all outcomes and meaning that the studies estimate 
substantially different effects. This means that any single study is susceptible to producing 
results that differ from the estimated average differences. The pooled estimates must therefore 
be interpreted as population average differences, and not study specific differences, in 
accordance with the random effects model for meta-analysis.   
Visual analysis of the forest plots supports the above interpretations. For all forest plots, 
average scores across studies are in very good directional agreement with the estimated average 
difference scores, but this is less clear for backwards digit span and TMT-B.  
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Table 2.2: Meta-analyses results 
Note: MMSE, Mini-mental state examination; RAVLT, Rey Auditory Verbal Learning Test; TMT, trail making test; *estimates of the underlying mean pre-shunt and the 
underlying mean difference scores, terminology used in line with Higgins, Thompson, and Spiegelhalter (2009) who note that the inference from a random-effects meta-
analysis is an “estimate of the underlying mean effect μ”. Here, we substitute “effect” with “pre-shunt score” and “difference score” to more accurately represent the data.
Cognitive 
Domain 
Test 
n of 
Studies 
Estimated 
average  
pre-shunt 
score*  
95% CI 
Estimated 
average 
difference*  
95% CI  p 
Cochran’s Q  
(d.f.; p) 
I2 
Estimated 
between-
study 
variance 
Global 
function 
MMSE 19 23.10 points 22.13, 24.08 2.20 points 1.45, 2.95 < 0.001 
99.62  
(18; < 0.001) 
81.9% 1.99 
Learning and 
memory 
RAVLT total 7 22.73 words 19.86, 25.61 5.64 words 3.86, 7.43 < 0.001 
14.02 
(6; 0.03) 
57.2% 2.68 
 
RAVLT 
delayed 
7 1.90 words 1.22, 2.57 1.43 words 0.55, 2.31 0.001 
56.33 
(6; < 0.001) 
89.3% 1.11 
Executive 
function 
Backwards 
digit span 
6 2.92 digits 2.38, 3.46 0.36 digits 0.04, 0.67 0.03 
38.61 
(5; < 0.001) 
87.0% 0.12 
 
Phonemic 
verbal 
fluency 
8 19.67 words 13.60, 25.74 2.73 words 0.84, 4.63 0.005 
10.55 
(7; 0.16) 
33.6% 2.32 
 TMT-B 9 293.03 sec 221.09, 364.97 -43.46 sec -83.23, -3.70 0.03 
35.89 
(8; < 0.001) 
77.7% 2494.80 
Psychomotor 
speed 
TMT-A 13 132.48 sec 108.48, 156.49 -25.90 sec -36.11, -15.69 < 0.001 
18.78 
(12; 0.09) 
36.1% 104.03 
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2.3.5. Moderator variables 
All nineteen studies included in the analysis of moderator variables provided information about 
average age, time-to-retest and % males. Random effects meta-regressions using average 
difference in MMSE as outcome data were all non-significant (Table 2.3). This study did not 
find evidence that average age, time-to-retest or sex predict improvement on the MMSE. 
 
Table 2.3: Meta-regressions of average difference of MMSE on moderator variables 
Covariate Estimate Standard Error P value 95% CI 
Time-to-retest 
(months) 
0.01 0.13 0.96 -0.24, 0.25 
Av. age (years) -0.15 0.15 0.29 -0.44, 0.13 
% male 0.05 0.03 0.09 -0.01, 0.11 
 
2.3.6. Forest plots 
 
Figure 2.2: Forest plot for difference in MMSE 
The pooled outcome was determined using a random-effects model. Average 
differences are shown with 95 per cent confidence intervals. 
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Figure 2.3: Forest plot for difference in RAVLT total verbal recall 
The pooled outcome was determined using a random-effects model. Average 
differences are shown with 95 per cent confidence intervals. 
 
 
Figure 2.4: Forest plot for difference in RAVLT delayed verbal recall 
The pooled outcome was determined using a random-effects model. Average 
differences are shown with 95 per cent confidence intervals. 
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Figure 2.5: Forest plot for difference in backwards digit span score 
The pooled outcome was determined using a random-effects model. Average 
differences are shown with 95 per cent confidence intervals. 
 
Figure 2.6: Forest plot for difference in phonemic verbal fluency 
The pooled outcome was determined using a random-effects model. Average 
differences are shown with 95 per cent confidence intervals. 
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Figure 2.7: Forest plot for difference in trail making test B (seconds to complete) 
The pooled outcome was determined using a random-effects model. Average differences are 
shown with 95 per cent confidence intervals. 
 
Figure 2.8: Forest plot for difference in trail making test A (seconds to complete) 
The pooled outcome was determined using a random-effects model. Average differences are 
shown with 95 per cent confidence intervals. 
46 
 
2.4. Discussion 
The aim of the current review was to determine the effect of shunt surgery on 
neuropsychological test performance in patients with NPH. Twenty-three studies (containing 
information for 1059 patients) were eligible for inclusion within one or more meta-analyses. 
Meta-analyses were conducted on average pre-operative and average “difference” scores for 
seven neuropsychological tests. Statistically significant estimated average difference scores 
were observed for all tests in the direction of improvement following shunt surgery. However, 
detailed examination of the results suggested robust evidence for improved MMSE, RAVLT 
total verbal recall, RAVLT delayed verbal recall, phonemic verbal fluency and TMT-A only. 
Meta-regressions revealed no significant effects of age, time-to-retest or sex on average MMSE 
difference score. 
 
Memory 
Post-shunt improvement in memory is frequently reported in patients with NPH. Significant 
improvement has been found for visual recall (Kahlon, Sundbärg, & Rehncrona, 2002; Larsson, 
Wikkelsø, Bilting, & Stephensen, 1991), spatial memory (Iddon et al., 1999), and in various 
subtests of the Wechsler Memory Scale (Chaudhry et al., 2007; Duinkerke et al., 2004; Solana 
et al., 2012a; Thomas et al., 2005). However, the Rey Auditory Verbal Learning test appears to 
be highly sensitive to cognitive improvement in NPH. The present study found robust evidence 
for improvement in the total and delayed verbal recall subtests and significant improvement has 
also been documented in RAVLT retention score (Chaudhry et al., 2007; Duinkerke et al., 
2004). 
 
Executive function 
It is unclear from the literature whether executive function improves following shunt surgery. 
Indeed, only one of three tests of executive function showed robust evidence for improvement 
(phonemic verbal fluency) in the above meta-analyses. The remaining two (backwards digit 
span and TMT-B) had weaker significance levels, and supporting studies did not indicate 
agreement in the direction of improvement. Meta-analyses were performed using average pre-
operative scores to investigate whether instances of lack of improvement were due to ceiling 
effects. The estimated average pre-operative score for backwards digit span was 2.92 digits. 
Median score in this test by 159 healthy controls in a study by Hellstrom et al. (2008) was 4 
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digits. Estimated average pre-operative score for TMT-B was 293.03 seconds. Normative data 
provided by Tombaugh (2004) suggests individuals aged 70 to 74 complete this test in 109.95 
seconds (less time indicates better performance). Estimated average pre-operative scores for 
both tests indicated that, on average, patients were impaired in these tests compared to age-
matched normative data. This suggests that ceiling effects cannot explain the lack of robust 
evidence for improvement in these tests following shunt. Nevertheless, robust evidence for 
improvement was observed for phonemic verbal fluency. However, phonemic verbal fluency 
is simplistic compared to executive tests with strategic or problem solving aspects. Therefore, 
improvement in this test likely reflects improved attentional capacity rather than higher level 
executive function.  
Overall, given the tests that could be included in the analyses, the results of the present 
study do not provide strong evidence for improvement in executive function following shunt 
surgery, tentatively supporting the hypothesis that executive impairment in NPH may reflect 
irreversible damage to fronto-subcortical connectivity.  
 
Psychomotor speed 
There was good evidence for improvement in psychomotor speed, as measured by the TMT-A. 
Due to lack of data, other tests of psychomotor speed could not be included, although 
improvements have also been documented in the Grooved pegboard test (Hellström et al., 
2012b), the Purdue pegboard test (Mataró et al., 2003), and the Line-tracing test (Thomas et al., 
2005). 
 
Global cognitive functioning 
The present study found robust evidence for improved performance on the MMSE. This test is 
commonly used to assess cognitive function in NPH, although results vary with some studies 
finding significant improvements (Mataró et al., 2007; Thomas et al., 2005; Yamamoto et al., 
2013), and others finding no change (Gleichgerrcht et al., 2009; Poca et al., 2004, 2005; Saito 
et al., 2011). A ceiling effect may explain why some studies find no change on the MMSE. 
High functioning patients can perform well on this test while specific cognitive deficits may be 
missed unless detailed neuropsychological testing is conducted (Relkin & Katzen, 2014). 
Indeed, in their study, Iddon et al. (1999) split patients according to their pre-operative MMSE 
scores. Patients who scored in the dementing range of the MMSE at baseline (<24 points) 
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improved to the normal range post-operatively. However, no significant difference was 
observed between baseline and outcome scores for patients who did not score in the dementing 
range at baseline. Therefore, it is important that cognitive assessments include a battery of 
neuropsychological tests in addition to the MMSE. 
 
Practice effects 
Studies with test-retest control groups provide evidence that improvements following shunt 
surgery are due to treatment effects rather than practice effects. Katzen and colleagues (2011) 
found greater improvement in measures of mental tracking speed and sustained attention in 
shunted idiopathic NPH patients than in healthy controls who had undergone repeated testing. 
Saito and colleagues (2011) found evidence for improvements in executive function following 
shunt which were not ascribable to practice effects. Furthermore, Solana and colleagues (2010) 
investigated the effect of testing-retesting in patients with NPH using a battery of 
neuropsychological tests administered over four consecutive days. No learning effect was 
observed for any of the tests and it was concluded that improvements following shunt reflect a 
true treatment effect. 
 
In summary, the results suggest that, on average, shunt surgery has a beneficial effect on 
neuropsychological functioning, including in the domains of verbal learning and memory, 
psychomotor speed, and global cognitive functioning. This could be beneficial to patients in a 
range of ways related to their daily functioning. However, the present study did not find strong 
evidence for improvements in executive function. Executive functions include abilities such as 
planning and decision-making, abilities which are important for the successful completion of 
day-to-day activities.  
 As outlined in section 1.3.3, a number of studies have hypothesised that executive 
dysfunction in NPH may be irreversible. However, some studies did find improvements on tests 
of executive function. For example, Hellström and colleagues (2008, 2012b) found high rates 
of improvement using the Swedish version of the Stroop test (Hellström & Scharin, 2001). The 
Stroop test measures naming speed, response selection, and inhibition and consists of different 
subtasks i.e. naming the colours of various shapes; or naming the printed colour of incongruent 
colour words (e.g. the word “blue” printed in red). Therefore, the task provides different types 
of outcome data. The Stroop test could not be included in the present study due to an insufficient 
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number of supporting studies providing data for the various components of the test, and 
therefore, this data is missing from the analyses of executive function.  
 While the variability in outcome reported across studies may be due to test selection, 
evidence remains which suggests that this is not the sole explanation. For example, some studies 
report signiﬁcant improvement in performance on the backwards digit span test following shunt 
(Gleichgerrcht et al., 2009; Hellström et al., 2008; Mataró et al., 2007; Solana et al., 2012a), 
whilst others report no change (de la Calzada et al., 2010; Mataró et al., 2003; Poca et al., 2004, 
2005). Similarly, improvements in the Stroop test have been observed in some studies 
(Duinkerke et al., 2004; Hellström et al., 2008, 2012b), but not in others (Mataró et al., 2003, 
2007; Savolainen et al., 2002; Thomas et al., 2005). While one study suggested that a ceiling 
effect could explain the absence of improved executive function following shunt (Chaudhry et 
al., 2007), other studies have found that performance in tests of executive function is 
disproportionately impaired in NPH patients at baseline (Iddon et al., 1999; Saito et al., 2011).  
Therefore, the results to date suggest that outcome in the domain of executive function 
is variable in patients with NPH. This may indicate that, of the neuropsychological domains in 
which patients show impairments, executive function is the least likely to respond to shunting, 
perhaps only showing improvements in a subgroup of shunted patients. However, further 
investigation using more sensitive tests of executive function is needed to clarify the issues 
highlighted above. 
 
2.4.1. Predicting improvement 
Since shunt surgery is an invasive procedure and patients are often elderly, it is important to 
identify factors which predict positive outcome following treatment. Previously, Chang, 
Agarwal, Williams, Rigamonti, and Hillis (2006) found evidence for associations between age 
and sex with cognitive outcome following shunt. Specifically, they found that younger age 
predicted good outcome on tests of memory, and that women were more likely than men to 
exhibit improvements on non-memory tests. 
In order to investigate predictors of positive cognitive outcome in the present study, age, 
sex, and time between shunt and reassessment were included as moderator variables in three 
random-effects meta-regression models to assess the evidence that they may be useful 
predictors of cognitive outcome. Results suggested no significant effects of age, sex, or time 
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between shunt and reassessment on outcome in the MMSE. However, this was an exploratory 
analysis and effects may be observed using other measures of cognitive or functional outcome. 
 
2.4.2. Extent and duration of improvement 
Although cognitive improvement has been observed in patients with NPH following shunt 
surgery, patients remain impaired in neuropsychological tests compared to age-matched 
controls. Shunted patients have shown to perform significantly poorer than healthy controls in 
tests of psychomotor speed, memory and executive function at both three and 12 months post-
shunt (Hellström et al., 2008, 2012b). The present study investigated outcome between three 
and 12 months post-shunt, however, from the available data, outcome at longer durations could 
not be assessed. To determine the extent of cognitive recovery, longer-term monitoring of 
patients is required using multiple post-operative assessments as improvements have been 
documented as late five years post-shunt (Kahlon, Sjunnesson, & Rehncrona, 2007). Tracking 
post-shunt neuropsychological change is important for a number of reasons, such as providing 
information about subtle changes to functioning, and informing treatment options.  
 
2.4.3. Limitations and methodological considerations 
The present study did not attempt to formally assess the risk of bias because of small sample 
sizes and the difficult nature of determining what constitutes study quality in this area. 
Methodological differences across studies complicate interpretation of results. Variability 
within tests used meant that the analyses were limited to seven neuropsychological tests when 
others may show improvement following shunt surgery. Furthermore, higher level executive 
functions could not be assessed with the restricted set of tests used to date. Additionally, time 
between shunt and reassessment varied with three, six and 12 month delays being used. 
Consistency here is pertinent as different patterns of improvement may be seen at different 
intervals. Improvement may be observed more readily at shorter intervals due to immediate 
effect of the shunt, whereas initial improvement may be missed at longer intervals due to effects 
of comorbid disorders or increasing age (Solana et al., 2012b). 
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2.5. Conclusions 
The present study found evidence for improved performance in global cognitive function, 
verbal learning and memory, and psychomotor speed following shunt surgery. However, the 
results did not provide strong evidence for improvement in tests of executive function based on 
the available data. In order to clarify these findings, there is a need to assess high-level executive 
functions in patients with NPH before and after shunt surgery. Additionally, longer-term 
monitoring of patients is required to determine the extent to which cognitive functions may 
improve. The Mini-Mental State Examination, the Rey Auditory Verbal Learning Test, 
phonemic verbal fluency and trail making test A may be useful for assessment of cognitive 
outcome following treatment for NPH. 
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Chapter 3  
Apathy, ventriculomegaly and neurocognitive improvement 
following shunt surgery in normal pressure hydrocephalus 
 
3.1. Introduction 
Chapter 2 provided evidence for improved neuropsychological performance following shunt 
surgery in patients with NPH, particularly in global cognitive functioning, learning and 
memory, and psychomotor speed. Problematically however, apathy is often observed in NPH 
patients (DeVito et al., 2007; Keenan et al., 2005), yet the significance of this symptom for 
cognitive function and outcome has not been elucidated.  
Only two studies have objectively assessed apathetic symptoms in patients with NPH 
(Kanemoto et al., 2016; Kito et al., 2009). Kanemoto et al. and Kito et al. investigated the 
prevalence of neuropsychiatric symptoms in patients with idiopathic NPH (iNPH) using the 
Neuropsychiatric Inventory (NPI; Cummings et al., 1994). Kanemoto et al. reported a 
prevalence of 86% in a group of 22 patients with iNPH and Kito et al. reported a prevalence of 
70.3% in a group of 64 patients with iNPH. In both cases, apathy was found to be the most 
frequent neuropsychiatric symptom. Further, Kito et al. found an association between increased 
apathy with more severe cognitive impairment as measured by the iNPH Grading Scale 
(iNPHGS; see Table 1.1 for a description; Kubo et al., 2008). Meanwhile, Kanemoto et al. 
found that a reduction in apathy severity following lumboperitoneal shunt surgery was 
associated with improved performance in the Frontal Assessment Battery, a measure of frontal 
lobe functioning. These findings suggest that the symptom of apathy in NPH may be a 
significant obstacle for cognitive function and outcome. 
Due to the lack of research into this symptom, the neural underpinnings of apathy in 
NPH have not been established. Kanemoto et al. (2016) hypothesised that frontal lobe 
pathology may underlie apathy in NPH, whereas Kito et al. hypothesised that apathy could arise 
due to impaired oxygen metabolism or cerebral perfusion in areas of the brain that form parts 
of the fronto-subcortical circuits. 
A subcortical pathological basis for apathy was further hypothesised by DeVito et al., 
(2007) following their observation of diminished caudate volume in patients with NPH. The 
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caudate nucleus, a subcortical structure and part of the fronto-subcortical dopaminergic system, 
plays a role in reward processing and motivation (Haruno et al., 2004). Importantly, dysfunction 
of subcortical structures has been associated with apathy (Bhatia & Marsden, 1994; Caplan et 
al., 1990; David et al., 2008; Levy & Dubois, 2006; Mendez et al., 1989). Therefore, caudate 
atrophy and impairments of associated striatal circuitry may underlie the symptom of apathy in 
NPH.  
It is not yet established whether caudate atrophy relates to degree of ventriculomegaly 
in NPH, however ventriculomegaly measured using the bicaudate ratio (BCR) has been shown 
to be associated with caudate atrophy in patients with Huntington’s disease (Aylward, 
Schwartz, Machlin, & Pearlson, 1991). The BCR is the width of the lateral ventricles at the 
level of the body of the caudate nuclei as a percentage of the width of brain across the same 
line (Figure 3.1). The BCR is a useful measure as it is easily obtainable without complex 
computerised techniques. The present study investigated whether BCR is related to apathy 
severity in patients with NPH. In addition, cognition and apathy were assessed before and after 
shunt surgery to explore the relationship between apathy and cognitive function and outcome, 
and to provide a clearer profile of the mechanisms driving post-shunt recovery. Apathy was 
assessed in the present study using the Cambridge State Apathy Evaluation scale (Blackwell et 
al., 2008; Appendix A), a modified version of the self-rated Apathy Evaluation Scale (AES-S; 
Marin et al., 1991), which was adapted specifically to measure state-related changes in apathy 
and is therefore more suitable for repeated assessment. Prevalence of apathy was also 
investigated using this measure. The prevalence of depression was assessed for comparison. 
 
3.2. Methods 
3.2.1. Patients 
Participants were patients who were given a diagnosis of possible or probable NPH at the CSF 
disorders clinic, Addenbrooke’s Hospital. As part of an ongoing audit, a clinically 
representative sample of 22 patients with NPH were referred by a neurosurgeon (JDP) to be 
included in the present study. All were assessed using a brief neuropsychological test battery 
as part of their normal clinical pathway prior to shunt surgery and three to nine months post-
shunt surgery (M = 4.17 months). Neuropsychological test data were collected at the CSF 
disorders clinic, Addenbrooke’s Hospital. 
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Figure 3.1: Measurement of bicaudate ratio on MRI axial flair 
An illustration of BCR before (a.) and following (b.) shunt surgery. BCR is 
calculated as the width of the lateral ventricles at the level of the body of the 
caudate nuclei as a percentage of the width of brain across the same line. In this 
example, BCR = 0.32 at pre-shunt scan and reduces to 0.31 at 3 month post-
shunt scan. 
 
3.2.2. Imaging analysis 
All patients were scanned using magnetic resonance imaging (MRI) or computed tomography 
(CT) prior to shunt surgery as part of the standard diagnostic procedure. MRI scans were used 
by a neurosurgeon to calculate BCRs. Where these were unavailable, CT scans were used (n = 
5). Figure 3.1 provides an illustration of BCR measurement in a patient with NPH before and 
following shunt surgery. 
 
3.2.3. Neuropsychological assessment 
Patients completed the Mini-Mental State Examination (MMSE), the Hopkins Verbal Learning 
Test (HVLT), the Controlled Oral Word Association Test (COWAT), the Cambridge State 
Apathy Evaluation scale (self-rated; AES-S), and the short form of the Geriatric Depression 
Scale (GDS-15) pre- and post-operatively. IQ was assessed using the National Adult Reading 
Test (NART). The tests are described in detail below. To minimise practice effects, alternate 
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versions of the phonemic and semantic fluency categories and the HVLT word list were used 
during the follow-up assessment. 
 
The Mini-Mental State Examination (MMSE; Cockrell & Folstein, 1988) 
The MMSE is a widely used bedside measure of mental status evaluation. It includes tests of 
memory, attention, personal orientation, reading, writing, and visuospatial ability. The 
maximum score is 30, and scores of 23 and below are in the dementia range. 
 
The Hopkins Verbal Learning Test (HVLT; Brandt, 1991) 
The HVLT assesses verbal learning and memory and has been shown to be sensitive to 
hydrocephalus (Iddon, Morgan, Loveday, Sahakian, & Pickard, 2004). The experimenter reads 
aloud 12 nouns, four words from one of three semantic categories (e.g. animals, human 
dwellings, and precious stones). The patient is then asked to repeat back as many of the words 
as they can immediately after hearing the list. This gives an immediate recall score out of a 
maximum of 12. This procedure is then repeated a further two times to assess learning. The 
learning score is the total number of words recalled after trials 1, 2, and 3 with a maximum of 
36. After a delay of 25-30 minutes the patient is asked to recall as many of the words from the 
list as they can giving a delayed recall score out of 12. 
 
The Controlled Oral Word Association Test (COWAT; Benton & Hamsher, 1989) 
Phonemic and semantic fluency tests from the COWAT were administered. Phonemic verbal 
fluency is assessed using the FAS version of the task. Patients are asked to generate as many 
words as they can beginning with the letters ‘F’, ‘A’, then ‘S’ with a time limit of 60 seconds 
per letter. The score represents total number of words generated for the three letters combined. 
For the semantic fluency task patients are asked to generate as many words as they can from a 
given category (e.g. animals) in 60 seconds. The score represents the number of words 
generated. 
 
The Cambridge State Apathy Evaluation scale (Blackwell et al., 2008) 
Apathy was assessed using the self-rated State Apathy Evaluation scale which is a modified 
version of the self-rated Apathy Evaluation Scale (AES-S; Marin et al., 1991). This scale was 
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chosen as it allows assessment of state-related changes in apathy between assessments. Scores 
range from 0 to 54. A score of 19-21 is defined as mild apathetic symptoms. A score of 22 or 
higher is defined as moderate apathetic symptoms. See Appendix A for items and instructions. 
 
The Geriatric Depression Scale 15 (GDS-15; Sheikh & Yesavage, 1986) 
Depression was assessed using the GDS-15 since depression has been shown to affect cognitive 
performance (Robbins, Elliott, & Sahakian, 1996). The GDS-15 is suitable for use in this 
population since it deemphasises the somatic symptoms associated with depression, therefore 
avoiding misattributing signs of physical disability or normal aging to depression (Sheikh & 
Yesavage, 1986). The GDS-15 is a self-rated scale consisting of 15 yes/ no questions. A score 
of 6 or higher is suggestive of depression (Herrmann et al., 1996). A score of 12 or higher was 
defined as severe depression (Israelsson et al., 2016). See Appendix C for items and 
instructions. 
 
The National Adult Reading Test (NART; Nelson, 1982) 
The NART is a measure of pre-morbid verbal IQ, testing proper pronunciation of irregular 
English words. Since pronunciation of words has been shown to be relatively unaffected by 
neurodegenerative diseases and normal aging, NART scores should be representative of the 
patient’s IQ prior to the onset of NPH (Crawford, Deary, Starr, & Whalley, 2001). 
 
3.2.4. Statistical analysis 
Differences in the prevalence of apathetic and depressive symptoms between pre- and post-
shunt assessments were evaluated in a within-subjects manner. That is, the same patients were 
assessed at both pre- and post-shunt. Therefore, McNemar’s test was used to evaluate 
differences in prevalence. Scores in the AES-S and GDS-15 were correlated with cognitive test 
scores at pre- and post-shunt. Pre-operative BCRs were correlated with patients’ pre-operative 
AES-S score, and GDS-15 score for comparison. BCR was also correlated with pre-operative 
MMSE score, IQ and age. Bivariate correlations were conducted using Spearman’s rho. Mean 
pre- and post-operative neuropsychological test scores were compared using paired samples t-
tests. One outlier was identified and removed from the phonemic fluency analysis as the pre-
operative score was >2.5 SDs above the mean. Scores in the AES-S, GDS-15, HVLT delayed, 
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and MMSE violated assumptions of normality. Wilcoxon signed-rank tests were therefore used 
to compare scores in these tests. To investigate the relationship between change in apathy (AES-
S) with change in neuropsychological test scores pre-operative scores were subtracted from 
post-operative scores to obtain a “change” (difference) score for each test. Correlations were 
then conducted using Spearman’s rho. Correlations between change in depression (GDS-15) 
and change in neuropsychological test scores were conducted for comparison.  
 
3.3. Results 
3.3.1. Demographic information 
Fourteen patients were male and eight were female. Mean (SD) age in years was 68.3 (10.80). 
Mean IQ and years of education was 109.4 (11.38) and 12.1 (2.49), respectively. Mean baseline 
MMSE was 25 (3.52). Mean pre-operative BCR was 0.29 (0.03) (significant ventriculomegaly 
= BCR ≥ 0.25). Individual patient details are shown in Table 3.1.  
 
3.3.2. Prevalence of apathy and depression 
One patient did not complete the AES-S at either pre- or post-shunt. Three additional patients 
did not complete the AES-S at pre-shunt. Therefore, 18 patients completed the AES-S at pre-
shunt, and 21 patients completed the AES-S at post-shunt. One patient did not complete the 
GDS-15 at either pre- or post-shunt. An additional one patient did not complete the GDS-15 at 
post-shunt. Therefore, 21 patients completed the GDS-15 at pre-shunt, and 20 completed the 
GDS-15 at post-shunt.  
 Frequency and severity of apathetic and depressive symptoms at pre- and post-shunt are 
shown in Figure 3.2. Cut-off points for the AES-S and GDS-15 for determining severity of 
symptoms are detailed in sections 0 and 0, respectively. Eight patients scored within the 
apathetic range of the AES-S at pre-shunt (44.44%). Specifically, four patients scored within 
the mild apathetic symptoms range (22.22%) and four patients scored within the moderate 
apathetic symptoms range (22.22%). At post-shunt, three patients scored within the apathetic 
range of the AES-S (14.29%; all scoring in the moderate apathetic symptoms range). 
 The GDS-15 scores for eleven patients at pre-shunt were suggestive of depression 
(52.38%). Within those patients, three scored within the severe depressive symptoms range 
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(14.29%). At post-shunt, the GDS-15 scores for five patients were suggestive of depression 
(25%). Three out of those five patients scored within the severe depressive symptoms range 
(15%).  
 Frequency of apathetic and depressive symptoms did not change significantly from pre- 
to post-shunt (AES-S, p = 0.092; GDS-15, p = 0.302). 
At pre-shunt the percentage of patients who scored within the apathetic range of the 
AES-S without also scoring in the depressive range of the GDS-15 was 11.76% (2/17), while 
the percentage of patients scoring in the depressive range of the GDS-15 without also scoring 
within the apathetic range of the AES-S was also 11.76% (2/17). 29.41% (5/17) of patients 
scored both within the apathetic range of the AES-S and within the depressive range of the 
GDS-15, at pre-shunt. 
 At post-shunt, one patient (5.26%) scored within the apathetic range of the AES-S but 
did not score in the depressive range of the GDS-15, and two patients (10.53%) scored in the 
depressive range of the GDS-15 without scoring in the apathetic range of the AES-S. Two 
patients (10.53%) scored both in the apathetic range of the AES-S and the depressive range of 
the GDS-15. 
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Figure 3.2: Frequency and severity of apathetic and depressive symptoms at pre- and 
post-shunt 
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Table 3.1: Normal pressure hydrocephalus patient demographics 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: a = pre-operative bicaudate ratio (greater BCR = greater degree of ventriculomegaly; significant ventriculomegaly = BCR ≥ 0.25), b = patient in a wheelchair, 
c = taken from CT scans, n/a = information not available. 
Patient 
No 
Age Sex IQ Years 
Edu 
Time to 
retest 
(months) 
Aetiology Gait 
Disturb 
Incontinence MMSE 
Pre 
MMSE 
Post 
Pre BCRa 
1 61 M 120 12 3 Idiopathic + + 23 26 0.33 
2 49 M 112 n/a 4 Secondary to IV ventricular 
outlet obstruction 
+ - 26 26 0.23 c 
3 56 M 117 11 3 Secondary to Pineal tumour 
and radiotherapy 
+ - 28 28 0.30 
4 73 M 98 11 3 Idiopathic + + 18 24 0.27 
5 74 F 100 n/a 9 Idiopathic + - 28 25 0.31 c 
6 60 M 116 12 3 Idiopathic + - 28 28 0.30 
7 65 M 92 10 8 Aqueduct stenosis + - n/a 29 0.37 
8 83 M 116 11 5 Idiopathic + n/a 28 23 0.29 
9 79 F 100 11 5 Idiopathic - - 18 21 0.29 
10 74 M 87 10 2 Query aqueduct stenosis + n/a 18 24 0.28 
11 76 M 103 11 5 Idiopathic + + 23 21 0.29 
12 52 M 109 11 3 Aqueduct stenosis + - 27 29 0.29 
13 62 F 100 11 2 Secondary to Chiari 
malformation, Aqueduct 
stenosis 
+ - 29 25 0.27 
14 82 F 115 9 3 Idiopathic + + 26 27 0.26 c 
15 56 F 111 16 3 Idiopathic + n/a 21 24 0.30 c 
16 77 M 115 9 3 Idiopathic + n/a 27 28 0.30 
17 79 F 124 12 8 Idiopathic ++ b n/a 26 27 0.33 
18 75 M 125 14 3 Idiopathic + - 27 30 0.28 
19 81 M 120 14 3 Idiopathic + - 27 28 0.26 c 
20 52 F 109 18 8 Aqueduct stenosis + - 24 27 0.29 
21 66 M 92 12 5 Idiopathic + + 26 27 0.24 
22 71 F 126 17 4 Idiopathic + - 27 26 0.26 
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3.3.3. Correlation between neuropsychological test scores and apathy and depression 
Table 3.2 shows results of correlations between scores in AES-S and GDS-15 with 
neuropsychological test scores at pre-shunt. Scores in AES-S and GDS-15 were significantly 
positively correlated (greater levels of apathy were associated with greater levels of depression). 
AES-S score was significantly negatively correlated with phonemic and semantic fluency 
scores. GDS-15 score was significantly negatively correlated with IQ, phonemic fluency score, 
and scores in the immediate and total subtests of the HVLT. For all significant negative 
correlations, greater levels of apathy or depression were associated with poorer performance in 
the corresponding cognitive tests (as well as lower IQ). There were no other significant 
correlations. 
 Table 3.3 shows results of correlations between scores in AES-S and GDS-15 with 
neuropsychological test scores at post-shunt. Again, scores in AES-S and GDS-15 were 
significantly positively correlated (greater levels of apathy were associated with greater levels 
of depression). AES-S score was significantly negatively correlated with phonemic fluency, 
HVLT immediate, HVLT total, HVLT delayed, and MMSE score. GDS-15 score was 
significantly negatively correlated with phonemic fluency score, only. As with at pre-shunt, for 
all significant negative correlations, greater levels of apathy or depression were associated with 
poorer performance in the corresponding cognitive tests. 
 
Table 3.2: Bivariate correlations between AES-S and GDS-15 ratings with 
neuropsychological test scores at pre-shunt 
Scale Age IQ GDS-15 Phonemic 
fluency 
Semantic 
fluency 
HVLT 
immediate 
HVLT 
total 
HVLT 
delayed 
MMSE 
AES-S  0.19 -0.29 0.66** -0.47* -0.51* -0.34 -0.46 -0.30 -0.40 
GDS-15 -0.03 -0.45* -- -0.51* -0.33 -0.56** -0.71** -0.31 -0.37 
Note: Results represent Spearman’s rho values. *p < 0.05, **p < 0.01. 
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Table 3.3: Bivariate correlations between AES-S and GDS-15 ratings with 
neuropsychological test scores at post-shunt 
Scale Age IQ GDS-15 Phonemic 
fluency 
Semantic 
fluency 
HVLT 
immediate 
HVLT 
total 
HVLT 
delayed 
MMSE 
AES-S  0.10 -0.03 0.49* -0.53* -0.38 -0.51* -0.57** -0.54* -0.55** 
GDS-15 0.21 -0.27 -- -0.48* -0.33 -0.27 -0.27 -0.22 -0.28 
Note: Results represent Spearman’s rho values. *p < 0.05, **p < 0.01. 
 
3.3.4. Pre-operative bicaudate ratio 
Significant positive correlations were observed between pre-operative BCR and pre-operative 
AES-S score, rs = 0.51, p = 0.03, and between pre-operative BCR and pre-operative GDS-15 
score, rs = 0.52, p = 0.02, (Figure 3.3). These significant correlations indicate that greater pre-
operative BCR (greater degree of ventriculomegaly) was associated with greater levels of 
apathy and depression. Pre-operative BCR was not significantly correlated with MMSE score 
(p = 0.76) or with age (p = 0.74). Although there was no significant correlation between BCR 
and age, partial correlations were conducted for both analyses controlling for age. Both AES-S 
score and GDS-15 score remained significantly positively correlated with pre BCR when 
controlling for effects of age. 
 
3.3.5. Neuropsychological outcome 
There were significant within-group differences between pre-operative and post-operative 
scores in phonemic fluency, semantic fluency, and HVLT delayed, all in the direction of 
improvement following shunt surgery (Table 3.4). No other significant group differences were 
observed. A Wilcoxon signed-ranks test demonstrated a non-significant trend for decreased 
apathy (AES-S) post-operatively, Z = -1.87, p = 0.06. A post-hoc power calculation was 
conducted using G*Power 3 to determine an estimate of the sample size required to achieve a 
significant difference in AES-S score from pre- to post-shunt. With alpha set at 0.05 and power 
set at 0.80, approximately 34 participants would be needed to achieve a medium effect size (d 
= 0.45).  
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Figure 3.3: Scatterplots of the relationships between bicaudate 
ratio and apathy and depression at pre-shunt 
Greater BCR = greater degree of ventriculomegaly; a higher AES-S rating (A.) 
suggests more severe levels of apathy; a higher GDS-15 rating (B.) suggests 
more severe levels of depression. 
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Table 3.4: Neuropsychological tests results at baseline and three to nine months post-
operatively 
Note: *p < 0.05; **p < 0.01; a nonparametric test, b mean ± SD, c direction of change (+ = improvement, - = decline). 
 
3.3.6. Correlation between change in neuropsychological test scores with change in apathy 
and depression 
Table 3.5 shows results of correlations between AES-S and GDS-15 change scores with change 
scores in the remaining neuropsychological tests. A significant positive correlation was 
observed between AES-S change and GDS-15 change, as AES-S score decreases so does GDS-
15 score (both improve). Additionally, there was a significant negative correlation between 
AES-S change and MMSE change. The nature of this relationship can be seen in Figure 3.4. As 
AES-S score decreases, MMSE score increases. That is, a reduction in apathy is associated with 
increased functional level as measured by the MMSE. No significant correlation was observed 
between GDS-15 and MMSE change. 
 
 
 
 
 
Neuropsychological Test 
 Pre-operative Post-operative    
 
N 
 
Median (IQR) 
 
Median (IQR) 
 
t / Z 
 
df 
 
p 
change c 
+/- 
Apathy Evaluation Scalea 18 17.50 (10.5) 10.00 (9.5) -1.87  0.06 + 
Geriatric Depression Scalea 21 6.00 (6) 2.00 (4.5) -1.29  0.20 + 
Phonemic Fluency* 21 27.90 ± 10.97b 34.14 ± 16.43b -2.38 20 0.03 + 
Semantic Fluency** 22 12.32 ± 5.79b 15.82 ± 7.02b -3.06 21 0.006 + 
HVLT Immediate 22 4.95 ± 1.86b 5.05 ± 2.14b -0.20 21 0.85 + 
HVLT Learning 22 17.27 ± 5.42b 18.91 ± 6.82b -1.26 21 0.22 + 
HVLT Delayeda* 22 1.00 (3) 3.00 (7) -2.14  0.03 + 
MMSEa 22 26.00 (4) 26.50 (3.75) -1.72  0.09 + 
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Table 3.5: Correlations between change in neuropsychiatric symptoms and change in 
neuropsychology  
Variables Age IQ Time 
to 
Retest 
BCR AES-S 
change 
GDS-15 
change 
Phonemic 
fluency 
change 
Semantic 
fluency 
change 
HVLT 
immediate 
change 
HVLT 
total 
change 
HVLT 
delayed 
change 
MMSE 
change 
AES-S 
change 
0.05 0.21 0.28 -0.36 -- 0.51* -0.38 -0.43 -0.24 -0.27 0.09 -0.70** 
GDS-15 
change 
0.27 0.10 0.25 -0.08 0.51* -- -0.16 -0.30 0.03 -0.18 -0.05 -0.41 
Note: Results represent Spearman’s rho values. *p < 0.05, **p < 0.01. “Change” scores were calculated by subtracting pre- scores from 
post-shunt scores. 
 
 
 
Figure 3.4: Scatterplot showing the relationship between 
change in MMSE and change in AES-S 
A positive MMSE difference score indicates improvement in global 
cognitive functioning from pre- to post-shunt, while a negative AES-S 
difference score indicates a reduction in apathy severity from pre- to post-
shunt. 
 
3.4. Discussion 
The present study investigated whether bicaudate ratio (degree of ventriculomegaly) relates to 
degree of apathy in patients with NPH, and whether there is a relationship between cognitive 
outcome and change in apathy severity following shunt treatment. The prevalence of apathetic 
and depressive symptoms was also investigated. BCR was significantly positively correlated 
with levels of apathy and depression at baseline. Additionally, there were significant group 
improvements from baseline to follow-up in tests of phonemic and semantic fluency, and 
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delayed verbal recall. Prevalence of apathy and depression was not significantly different at 
post-shunt compared to pre-shunt, although there was a non-significant trend for improved 
group apathy scores following shunt surgery. Importantly, a reduction in apathy was associated 
with improved performance in a measure of global cognitive function. No relationship was 
observed between changes in global cognitive function performance with changes in depressive 
symptoms.  
These findings highlight the importance of assessing apathy in patients with NPH. 
Apathy is associated with striatal dopaminergic pathology (David et al., 2008). Since pre-
operative BCR was positively associated with degree of apathy the symptom of apathy may 
indicate greater subcortical brain atrophy, possibly leading to impaired functioning of fronto-
striatal dopaminergic pathways in patients with NPH. Indeed, caudate atrophy has been 
observed in NPH patients (DeVito et al., 2007). BCR has previously been shown to be 
associated with caudate atrophy in patients with Huntington’s disease (Aylward et al., 1991) 
although this has not been confirmed in patients with NPH. However, the relationship between 
caudate volume and apathy in NPH should be investigated further.  
Additionally, the present findings suggest that alleviation of the symptom of apathy 
following shunt surgery is linked to improved functional level as measured by the MMSE. This 
effect may be modulated by dopaminergic activity (Keenan et al., 2005; Nakayama et al., 2007). 
For example, Keenan and colleagues (2005) found that administration of the psychostimulant 
drug methylphenidate was associated with reduced apathetic symptoms and increased 
performance in a Spatial Recognition task in a patient with NPH. Methylphenidate inhibits 
dopamine reuptake in the brain by blocking dopamine transporters (del Campo et al., 2013; 
Volkow et al., 1998), meaning the increase in dopamine level in the brain following 
methylphenidate administration may account for the observed reduction in apathy (Keenan et 
al., 2005). Therefore, a reduction in apathy severity following shunt may indicate improved 
functioning in areas of the brain which are associated with dopaminergic activity.  
BCR was also positively correlated with degree of depression in the patient sample and 
as level of apathy reduced (improved) post-operatively so did level of depression. Additionally, 
levels of apathy and depression were significantly positively correlated at both pre- and post-
shunt. Distorted reward processing, an aspect of depression (Roiser, Elliott, & Sahakian, 2012), 
likely overlaps with symptoms of apathy and therefore delineating these two symptoms is 
challenging. However, no association was observed between change in depression level and 
change in MMSE score (unlike with change in apathy severity). This suggests that apathy and 
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depression are differentially involved in the symptomology of NPH, and that alleviation of the 
symptom of apathy may be particularly important for cognitive outcome. Future studies should 
aim to disentangle depression and apathy in patients with NPH. 
 The prevalence of apathetic symptoms in the present study was 44% at baseline, and 
14% at post-shunt. This difference in frequency of apathetic symptoms was not statistically 
significant (using McNemar’s test), likely due to the small sample size given that only 18 of the 
22 patients completed the AES-S at both pre- and post-shunt. However, such a reduction in the 
frequency of apathetic symptoms does suggest that there is a beneficial effect of shunt surgery 
on apathetic symptoms in patients with NPH. The prevalence of apathetic symptoms was only 
reported twice before, with both studies using the Neuropsychiatric Inventory to assess apathy 
(Kanemoto et al., 2016; Kito et al., 2009). Kanemoto et al. reported a prevalence of 86% at 
baseline and 73% three months following shunt surgery in 22 patients and Kito et al. reported 
a prevalence of 70.3% at baseline in 64 patients. The prevalence of apathy was lower in the 
present study and likely reflects the use of different assessment measures. The prevalence of 
depressive symptoms in the present study was 52% at baseline, and 25% at post-shunt. This is 
similar to levels reported by Israelsson et al. (2016) (pre-shunt 56%; post-shunt 46%) also using 
the GDS-15, but greater than those reported by Kito et al. (pre-shunt 14%) and Kanemoto et al. 
(pre-shunt 36%; post-shunt 5%), both using the NPI. Therefore, the differences are again likely 
due to variations in assessment measures used.  
 
3.4.1. Limitations 
The present study did not include a measure of disease duration. Disease duration is often 
difficult to determine in patients with NPH due to the gradual nature of cognitive and functional 
decline, however it may relate to the magnitude of brain structural changes as well as to levels 
of apathy and depression. Future studies should attempt to examine whether disease duration 
relates to BCR and/ or neuropsychiatric symptoms in patients with NPH. In addition, common 
to investigations of NPH, the sample size is small meaning that results should be interpreted 
with caution. 
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3.5. Conclusions 
BCR is an easily obtainable measure of degree of ventriculomegaly in patients with NPH and 
may tentatively provide information about volume of subcortical regions (although this should 
be clarified in future studies). Greater BCR (greater degree of ventriculomegaly) was associated 
with more severe levels of apathy and depression at pre-shunt. It was speculated that apathy in 
NPH may be related to atrophy or dysfunction of the subcortical or fronto-subcortical regions 
(e.g. the caudate). The relationship between caudate volume and apathy in NPH should be 
examined further. Additionally, the findings suggest a potential role of apathy in patients’ post-
shunt functional outcome, as improved performance on the MMSE was associated with a 
reduction in severity of apathetic symptoms.  
Overall, the present study highlights the importance of assessing apathy in patients with 
NPH (a symptom which currently is not commonly assessed). Neither the prevalence of apathy, 
nor the effect of shunt surgery on severity of apathetic symptoms in patients with NPH are well 
established. Future research into the significance of apathy in NPH may provide important 
findings relevant for aiding differential diagnosis, as well as for informing treatment options. 
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Chapter 4  
Brain structural correlates of cognitive dysfunction and 
neuropsychiatric symptoms in normal pressure hydrocephalus 
 
4.1. Introduction 
The pathological bases for the cognitive and behavioural symptoms in normal pressure 
hydrocephalus (NPH) have not been elucidated. However, the symptoms may indicate 
dysfunction of subcortical regions. Chapter 3 reported associations between pre-operative 
bicaudate ratio (BCR) with levels of apathy and depression in patients with NPH. Specifically, 
greater BCR (greater ventriculomegaly) was associated with more severe levels of self-rated 
apathy and depression at pre-shunt. It was hypothesised that BCR may be related to subcortical 
atrophy or dysfunction of fronto-subcortical regions in NPH, and that this may underlie the 
symptom of apathy. Indeed, caudate atrophy has previously been observed in NPH patients 
(DeVito et al., 2007). To test this further, a structural magnetic resonance imaging (MRI) study 
was conducted to investigate global and regional volumetric changes in NPH and their 
association with apathy and cognitive dysfunction. 
 Global and regional brain volumetric changes in NPH have not been extensively 
investigated using quantitative MRI techniques. A well as ventriculomegaly, brain volume in 
patients with NPH may be related to disease severity, brain damage/ dysfunction, or atrophy. 
Previous research of volumetric changes in NPH are outlined below. 
 
4.1.1. Total brain volume in NPH 
It has not been established whether brain volume in NPH relates to clinical symptoms. One 
study investigated whether pre-operative intracranial compartment volumes (specifically, total 
intracranial volume, ventricular volume, brain volume, and pericerebral CSF volume) are 
related to post-shunt outcome (Palm et al., 2006). No statistically significant pre-operative 
volumetric differences were found between patients who improved following shunt and those 
who did not. Therefore, the researchers concluded that volumetric assessment had no utility for 
identifying shunt responders. However, relationships between volumes and clinical measures 
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at pre-shunt were not reported. Another study (Singer et al., 2012) reported increased global 
brain volume following diagnostic CSF removal (via lumbar puncture or external lumbar 
drainage) which they suggested may be clinically meaningful. However, they did not examine 
whether volumetric changes were related to clinical scores or clinical outcome. The present 
study extracted pre-operative total brain volume, total grey matter volume, and total white 
matter volume in a group of patients with NPH in order to examine whether volumes were 
related to cognitive function. Additionally, this study investigated whether total brain volume 
was reduced in patients with NPH compared to controls. 
 
4.1.2. Subcortical volumetric changes in NPH 
Periventricular regions are frequently implicated in studies of NPH and subcortical pathology 
has been suggested to contribute to the symptomology (Del Bigio, 1993; Momjian et al., 2004). 
The pattern of cognitive decline is consistent with dysfunction of subcortical structures and may 
indicate disruption to the subfrontal white matter, limbic connections, or connections between 
the frontal lobe and the subcortical deep grey matter (SDGM) structures (N. C. H. Keong et al., 
2016). Indeed, impaired rCBF has been found in the periventricular white matter and in the 
basal ganglia (Owler et al., 2004; Ziegelitz et al., 2014). 
 The presence of apathy (impaired goal-directed behaviour) in NPH is consistent with 
fronto-subcortical pathology. Apathy can result from lesions affecting fronto-subcortical 
circuitry (Mega & Cohenour, 1997; Tekin & Cummings, 2002), or from focal lesions of the 
basal ganglia (Levy & Czernecki, 2006; Tekin & Cummings, 2002), including lesions located 
in the caudate nucleus (Bhatia & Marsden, 1994). Diminished caudate volume in NPH patients 
was observed by DeVito et al. (2007) and hypothesised to contribute to the clinical symptoms 
of cognitive impairment and apathy. Chapter 3 found evidence for an association between 
greater bicaudate ratio (greater ventriculomegaly) with increased levels of apathy and 
depression in NPH patients. Additionally, evidence for associations between apathy and rCBF 
in the anterior cingulate cortices and the right caudate nucleus has been reported (Kanemoto et 
al., 2015). 
Subcortical volumes in NPH have not been extensively investigated using quantitative 
MRI techniques. The periventricular regions may be distorted due to enlargement of the 
ventricles. Atrophy may also occur over time due to ischaemia and subsequent cell death 
(Momjian et al., 2004; Vanneste, 1994). The few studies that have examined morphologic 
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changes to subcortical structures in NPH focused only on individual structures or did not relate 
volumetric data to clinical information (DeVito et al., 2007; Golomb et al., 1994; Savolainen et 
al., 2000). DeVito et al. observed reduced caudate volumes in NPH patients, however clinical 
information was not included in the study. Golomb et al. extracted hippocampal volumes in 
patients with NPH and correlated these with MMSE scores. They observed a significant 
reduction in hippocampal volume in the NPH patients compared to controls. Further, there was 
a significant positive correlation between hippocampal size and MMSE score in the NPH group. 
It was concluded that hippocampal atrophy may contribute to cognitive decline in some patients 
with NPH. Savolainen et al. also observed reduced hippocampal volume in NPH patients 
compared to healthy controls, but only on the left side. However, both Golomb et al. and 
Savolainen et al. extracted hippocampal volumes only. Therefore, total brain volume or 
volumes of other subcortical regions may also have been reduced and related to clinical or 
cognitive measures. 
The present study investigated subcortical volumetric change in NPH in a larger range 
of SDGM structures, compared to previous investigations, using both automated (FSL FIRST; 
www.fmrib.ox.ac.uk/fsl) and manual (ITK-SNAP; www.itksnap.org) segmentation techniques. 
Initially, subcortical volumes were estimated using automated segmentation techniques, 
however, in some of the patients there was displacement of the caudate nuclei due to 
ventriculomegaly. Therefore, manual tracing of the caudate was conducted to supplement 
automated caudate segmentation. This study aimed to investigate (i) volumetric differences in 
SDGM structures compared to healthy controls at pre- and post-shunt; (ii) pre- to post-shunt 
change in SDGM structure volumes; and (iii) whether SDGM structure volumes are related to 
cognitive function/ outcome or neuropsychiatric symptoms.  
 
This study is in two parts. Part I utilised automated segmentation techniques to extract pre-
operative total brain volume, grey matter volume, white matter volume, and pre- and post-shunt 
SDGM structure volumes for patients with NPH. Volumes were also extracted for a control 
group at a single time point. Associations with cognitive dysfunction and neuropsychiatric 
symptoms were then investigated. Part II more closely examines the relationship between 
caudate volume and apathy by supplementing the automated subcortical segmentation with 
manually segmented caudate volumes.  
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4.2. Methods 
4.2.1. Ethical approval 
Ethical approval for this study, as part of a larger research project entitled ‘Functional, Vascular 
and Structural Correlates of Reversible Dementia in Normal Pressure Hydrocephalus (NPH)’, 
was obtained from the Cambridgeshire 2 Local Research Ethics Committee (LREC No: 
06/Q0108/330).  
 
4.2.2. Participants 
Patients 
Patient participants were patients who were given a diagnosis of possible or probable NPH at 
the CSF disorders clinic, Addenbrooke’s Hospital. Patients with NPH were referred to be 
included in the study by a neurosurgeon (JDP). Sixteen of these patients were included in the 
analyses that follow, based on having been assessed and scanned both before and following 
shunt surgery (mean = 6 months post-shunt). There is an overlap of five patients in Chapter 3 
and Chapter 4. One patient was subsequently excluded from the following analyses as they had 
comorbid Alzheimer’s disease. One additional patient was excluded due to a complicated 
clinical course. 
 
Controls 
Healthy controls were recruited to take part in the project entitled ‘Functional, Vascular and 
Structural Correlates of Reversible Dementia in Normal Pressure Hydrocephalus’ via friends 
and family of patients recruited into the same study (to ensure that both groups are within 
similar age brackets), and via advertisement in the local area. Eight healthy controls were 
recruited into the study and were scanned at one time-point. 
 
4.2.3. Neuropsychological assessment 
Patients completed the Mini-Mental State Examination (MMSE), the Hopkins Verbal Learning 
Test (HVLT), the Controlled Oral Word Association Test (COWAT), the Cambridge State 
Apathy Evaluation scale (self-rated; AES-S), and the short form of the Geriatric Depression 
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Scale (GDS-15) pre- and post-operatively. IQ was assessed using the National Adult Reading 
Test (NART). To minimise practice effects, alternate versions of the phonemic and semantic 
fluency categories and the HVLT word list were used during the follow-up assessment. The 
tests are described in detail in section 3.2.3. 
 
4.2.4. MR imaging protocol 
MR Imaging was performed on a 3T Siemens Tim Trio using a 12 channel head matrix radio 
frequency receive coil. The MR imaging protocol included a PDT2, FLAIR, MPRAGE and 
DTI. The FLAIR (Fluid Attenuated inversion recovery) and PDT2 (Proton Density-T2 
weighted) fast spin echo pulse sequence was acquired with FOV 224mmx168mm, 5mm slice 
separation, giving a voxel size 0.7x0.7x5mm. The PDT2 had TR/TE1/TE2, 
4600ms/12ms/104ms and the FLAIR TR/TE of 7840/95ms with an inversion time T1=2500 
ms. The T1 weighted structural sequence (MPRAGE) was acquired with TR/TE of 
2300/2.98ms, with a resolution of 1x1x1mm. The DTI data set was acquired by using a spin 
echo diffusion-weighted echo planar imaging sequence with the following parameters: TR/TE, 
8300ms/98ms, matrix dimensions 96x96, FOV 192x192, slice thickness 2mm giving a voxel 
size of 2x2x2mm. Diffusion weighted images were acquired in 12 non collinear directions each 
at 5 b-values of 350, 650, 1000, 1300 and 1600 s/mm2, along with 4 b-0 images. 
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Part I: Global and regional volumetric analysis in normal 
pressure hydrocephalus: association with cognitive function and 
neuropsychiatric symptoms 
 
4.3. Methods 
4.3.1. Image analysis 
Total brain volume estimation 
Total brain volume estimation was conducted for the NPH group at pre-shunt only. This is 
because a shunt-induced artefact is visible at post-shunt. 
Before processing, all images were manually inspected and reviewed for artefact. Brain 
tissue volume, normalised for subject head size, was estimated with SIENAX (Smith et al., 
2002; Smith, De Stefano, Jenkinson, & Matthews, 2001), part of FSL (Smith et al., 2004). 
SIENAX starts by extracting brain and skull images from the single whole-head input data 
(Smith, 2002). The brain image is then affine-registered to MNI152 space (Jenkinson, 
Bannister, Brady, & Smith, 2002; Jenkinson & Smith, 2001) (using the skull image to determine 
the registration scaling); this is primarily in order to obtain the volumetric scaling factor to be 
used as a normalisation for head size. Next, tissue-type segmentation with partial volume 
estimation is carried out (Zhang, Brady, & Smith, 2001) in order to calculate total volume of 
brain tissue (including separate estimates of volumes of grey matter (GM), white matter (WM), 
peripheral grey matter and ventricular CSF).  
 
Subcortical segmentation 
An automated subcortical registration and segmentation tool in FSL (FSL FIRST; 
www.fmrib.ox.ac.uk/fsl) was used to extract subcortical volumes as described in (Patenaude, 
Smith, Kennedy, & Jenkinson, 2011). All automated segmentations were thoroughly 
individually reviewed for accuracy. 
SDGM structure and ventricular volumes were extracted for both groups. Volumes for 
the NPH group were extracted at two time-points: pre- and post-shunt, as they were below the 
level of the shunt artefact (therefore, segmentation was unaffected). FSL FIRST was used to 
segment the amygdala, caudate, hippocampus, nucleus accumbens, pallidum, putamen, and 
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thalamus from 3D T1-weighted images. Examples of subcortical segmentation are shown in 
Figure 4.1. SIENAX was used to obtain ventricular volumes normalised for head size, and 
volumetric scaling factors (as described in section 0) for normalizing SDGM structure volumes 
for head size. SDGM structure volumes were normalised for head size by multiplying by the 
volumetric scaling factors. As laterality effects were not hypothesised, normalised right and left 
volumes of the SDGM structures were combined to yield a single total volume for each 
structure.   
 
 
Figure 4.1: Representative FIRST segmentation of subcortical structures in a patient 
with normal pressure hydrocephalus (left) and a healthy control subject (right) 
 
4.3.2. Statistical analysis 
Demographic data 
Independent samples t-tests were conducted to test for group differences in age and ventricular 
volume. Pearson’s r correlations were conducted to investigate associations between 
demographic data and volumetric data; and with demographic data and neuropsychological test 
scores. Independent samples t-tests were conducted to investigate effects of sex on total brain, 
GM, and WM volume. 
 
Total brain volume 
One-way analyses of covariance (ANCOVAs) were conducted to test for group differences in 
total brain volume, GM, and WM volume while controlling for age and ventricular volume. 
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Pearson’s r correlations were conducted to investigate associations between 
neuropsychological test scores and total brain, GM, and WM volume in the NPH group. Partial 
correlations were conducted where appropriate. 
 
Subcortical deep grey matter structures 
ANCOVAs were conducted to test for group differences in SDGM structure volumes while 
controlling for age and ventricular volume. Paired samples t-tests were conducted to test for 
differences in SDGM volumes between pre- and post-shunt in the NPH group. Pearson’s r 
correlations were conducted to investigate associations between neuropsychological test scores 
and SDGM volumes in the NPH group. Partial correlations were conducted where appropriate. 
For ventricular volume, SDGM structures showing significant volumetric differences from pre- 
to post-shunt, and neuropsychological test scores showing significant differences from pre- to 
post-shunt percent change scores were calculated according to the following: ((follow-up value 
– baseline value)/ baseline value)*100. Subsequently, Pearson’s r correlations were conducted 
to investigate relationships between percent change neuropsychological test scores with percent 
volumetric changes and demographic data.  
 
Neuropsychological tests 
Paired samples t-tests were conducted to test for differences in neuropsychological test scores 
between pre- and post-shunt in the NPH group. 
 
4.4. Results 
4.4.1. Demographic information 
The final patient group consisted of fourteen patients (nine male and five female). Demographic 
information for the NPH group are summarised in Table 4.1. Four healthy controls were male 
and four were female. The NPH group was older than the control group: NPH group mean (SD) 
age in years = 76.43 (3.90), range = 70 – 84; control group mean (SD) age in years = 70.25 
(6.56), range = 64 – 80; and this difference was statistically significant (t (9.89) = 2.43, p = 
0.036).  
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4.4.2. Ventricular volumes 
Mean (SD) ventricular volume for the NPH group at pre-shunt was 160405.9 (15666.8) mm3 
and at post-shunt was 135820 (28012.3) mm3. Ventricular volume was reduced following shunt 
surgery for all patients (mean = -15.67%, range -1.97% to -48.94%). A paired samples t-test 
indicated that the mean ventricular volume for the NPH group at post-shunt was significantly 
smaller than at pre-shunt (t (13) = 4.39, p = 0.001). The mean (SD) ventricular volume for the 
control group was 71187 (17198.3) mm3. Independent samples t-tests indicated that the mean 
ventricular volume of the NPH group was significantly larger than that of the control group at 
both pre-shunt (t (20) = 12.41, p < 0.001) and post-shunt (t (20) = 5.89, p < 0.001). 
 
Table 4.1: Demographic information for the NPH group 
Demographic variables Mean SD 
Age 76.4 3.9 
IQ 110.8 10.4 
MMSE 24 3.3 
Years of education 11.1 2.2 
 
4.4.3. Correlation of demographic data with volumetric data  
NPH group 
Age was significantly negatively correlated with pre-operative WM volume (r = -0.60, p = 
0.024) and total brain volume (r = -0.61, p = 0.021; Figure 4.2), but was not significantly 
correlated with GM volume or ventricular volume. IQ and years of education were not 
significantly correlated with total brain, GM, or WM volume (all p > 0.05). Total brain, WM 
and GM volumes were not significantly different between males and females. Ventricular 
volume did not significantly correlate with pre-operative GM, WM, or total brain volume. 
IQ was significantly negatively correlated with volume of the pallidum at post-shunt (r 
= -0.62, p = 0.040). There were no significant correlations between age, years of education, or 
ventricular volume with SDGM structure volumes in the NPH group at pre-shunt or at post-
shunt (all p > 0.05). 
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Control group 
There were no significant correlations between age or ventricular volume with GM volume, 
WM volume, or total brain volume in the control group. Additionally, there was no significant 
correlation between age and ventricular volume. Age was not significantly correlated with 
volume of any of the SDGM structures. Ventricular volume was significantly negatively 
correlated with volume of the hippocampus (r = -0.82, p = 0.013), but was not significantly 
correlated with volume of any of the remaining SDGM structures. 
 
 
 
Figure 4.2: Scatterplots showing relationships between age and 
brain volume (ml) in NPH 
White matter volume (A.) and total brain volume (B.) extracted from pre-shunt 
scans. 
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4.4.4. Correlation of demographic data and ventricular volume with neuropsychological 
test scores in the NPH group 
IQ was significantly positively correlated with MMSE score at pre-shunt (r = 0.80, p = 0.003), 
and with semantic fluency at post-shunt (r = 0.60, p = 0.049). Age, years of education, and 
ventricular volume were not significantly correlated with scores in any of the 
neuropsychological tests at pre- or post-shunt. 
 
4.4.5. Baseline total brain volume, grey matter volume, and white matter volume 
Volumetric comparisons between patients with NPH at pre-shunt and controls  
There were no significant group differences in grey matter, white matter, or total brain volume 
after controlling for age and ventricular volume (Table 4.2). Similarly, there were no significant 
group differences in grey matter, white matter, or total brain volume when only controlling for 
age (all p > 0.05). 
 
Table 4.2: Results of ANCOVAs for group differences in grey matter, white matter, and 
total brain volume 
 NPH Mean (SD) 
volume 
Control Mean (SD) 
volume 
P value 
Grey matter 673247.5 (40433) 707765.6 (47196.2) 0.142 
White matter 640772.1 (33456.7) 667535.5 (40409.8) 0.264 
Total brain 1314019.5 (59379) 1375301.1 (71061.3) 0.094 
Note: Volumes are in mm3 
 
Correlation with cognitive test scores in the NPH group (pre-shunt) 
White matter volume was significantly positively correlated with GDS-15 score (r = 0.65, p = 
0.029). That is, greater white matter volume was associated with more severe depressive 
symptoms. Additionally, white matter volume was significantly negatively correlated with 
scores on the HVLT learning (r = -0.59, p = 0.035) and delayed (r = -0.60, p = 0.031) subtests. 
That is, greater white matter volume was associated with poorer performance on the two 
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subtests. Grey matter volume and total brain volume were not significantly correlated with 
scores in any of the cognitive tests. 
 Since age was significantly negatively correlated with white matter volume in the NPH 
group, partial correlations were conducted to investigate relationships between white matter 
volume with GDS-15, HVLT learning, and HVLT delayed scores after controlling for age. 
White matter volume and GDS-15 score were no longer significantly correlated (r = 0.58, p = 
0.080). There was a slight but non-significant negative relationship between white matter 
volume and HVLT learning score (r = -0.57, p = 0.054). The negative correlation between white 
matter volume and HVLT delayed score remained statistically significant (r = -0.69, p = 0.014). 
The nature of the relationship is shown in Figure 4.3. 
 
 
Figure 4.3: Scatterplot showing the relationship between white matter volume (ml) 
and score on Hopkins Verbal Learning Test - Delayed 
 
4.4.6. Subcortical volumetric comparisons between patients with NPH at pre-shunt and 
controls  
Results of ANCOVAs are shown in Table 4.3. Mean volume of the caudate was significantly 
reduced in the NPH group at pre-shunt compared to healthy controls after controlling for age 
and ventricular volume. 
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Table 4.3: Results of ANCOVAs for group differences in pre-shunt SDGM structure 
volumes 
SDGM structure NPH Mean (SD) 
volume 
Control Mean (SD) 
volume 
P value 
Thalamus 13141.5 (883.4) 17590.6 (1865.1) 0.147 
Caudate 6720.4 (485.1) 8627.6 (726.8) 0.045* 
Putamen 7150.3 (1771.8) 11658.7 (1269.2) 0.076 
Pallidum 2903 (639) 4139.9 (562.4) 0.073 
Hippocampus 5356.7 (1142.8) 9211.9 (1271.5) 0.491 
Amygdala 2631.4 (605.9) 3148.5 (638.9) 0.807 
Nucleus Accumbens 483.7 (100.9) 1010.6 (237.9) 0.720 
Note: Volumes are in mm3; * p < 0.05. 
 
4.4.7. Correlation between SDGM structure volumes and cognitive test scores at pre-
shunt 
Volume of the caudate was significantly positively correlated with MMSE score (r = 0.73, p = 
0.040), and volume of the nucleus accumbens was significantly positively correlated with 
HVLT immediate score (r = 0.70, p = 0.035). That is, greater caudate volume was associated 
with better performance on the MMSE, and greater nucleus accumbens volume was associated 
with better performance on HVLT immediate. There were no other significant correlations 
between SDGM structures and cognitive test scores at pre-shunt. 
 Since IQ and pre-operative MMSE score were significantly correlated, a partial 
correlation was conducted to investigate the relationship between caudate volume and MMSE 
after controlling for IQ. The relationship was no longer significant (r = 0.65, p = 0.160). 
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4.4.8. Subcortical volumetric comparisons between patients with NPH at post-shunt and 
controls  
Results of ANCOVAs are shown in Table 4.4. Mean volumes of the putamen, pallidum, 
hippocampus, and nucleus accumbens were significantly reduced in the NPH group at post-
shunt compared to healthy controls after controlling for age and ventricular volume. 
 
Table 4.4: Results of ANCOVAs for group differences in post-shunt SDGM structure 
volumes 
SDGM structure NPH Mean (SD) 
volume 
Control Mean (SD) 
volume 
P value 
Thalamus 14112.4 (1287.1) 17590.6 (1865.1) 0.092 
Caudate 6965.3 (822.6) 8627.6 (726.8) 0.165 
Putamen 8737.2 (1410.2) 11658.7 (1269.2) 0.039* 
Pallidum 3226.5 (646.5) 4139.9 (562.4) 0.045* 
Hippocampus 6302.9 (1051.6) 9211.9 (1271.5) 0.045* 
Amygdala 2889.4 (642.2) 3148.5 (638.9) 0.363 
Nucleus Accumbens 531 (182) 1010.6 (237.9) 0.028* 
Note: Volumes are in mm3; * p < 0.05. 
 
4.4.9. Correlation between SDGM structure volumes and cognitive test scores at post-
shunt 
Volume of the caudate was significantly positively correlated with semantic fluency (r = 0.67, 
p = 0.035), and significantly negatively correlated with AES-S (r = -0.73, p = 0.026). Volume 
of the nucleus accumbens was significantly positively correlated with MMSE score (r = 0.61, 
p = 0.028), HVLT immediate (r = 0.58, p = 0.039), HVLT learning (r = 0.68, p = 0.011), and 
HVLT delayed (r = 0.61, p = 0.027). For all significant positive correlations, greater volumes 
were associated with better performance on cognitive tests, while greater caudate volume was 
associated with less severe level of self-rated apathy. 
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 Since IQ and post-operative semantic fluency score were significantly correlated, a 
partial correlation was conducted to investigate the relationship between caudate volume and 
semantic fluency after controlling for IQ. The relationship was no longer significant (r = 0.53, 
p = 0.182). 
 
4.4.10. Pre- and post-shunt volumetric comparisons  
Paired samples t-tests indicated significant increase in volume of the thalamus, t (10) = -2.85, 
p = 0.017; and hippocampus, t (10) = -3.02, p = 0.013, following shunt surgery. The mean pre- 
and post-shunt volumes of the remaining SDGM structures were not significantly different. 
Pearson’s r correlations revealed no relationship between age, IQ, or years of education with 
percent change in volumes of the thalamus or hippocampus. Percent change in ventricular 
volume (from pre- to post-shunt) was significantly negatively correlated with percent change 
in volume of the thalamus (r = -0.88, p < 0.001), but did not correlate with percent change in 
volume of the hippocampus. 
 
4.4.11. Neuropsychological outcome 
Neuropsychological outcome in the NPH group following shunt is summarised in Table 4.5. 
Scores for all tests were in the direction of improvement following shunt surgery (apart from 
GDS-15 score which was unchanged). Paired samples t-tests indicated significant improvement 
in scores for semantic fluency, HVLT immediate, and HVLT learning. 
 
4.4.12. Correlation of percent change in cognitive test scores with SDGM structure and 
ventricular volumes  
There were no significant correlations between percent change in volumes of the thalamus and 
hippocampus, with percent change scores in semantic fluency, HVLT immediate, or HVLT 
learning. Further, percent change scores in semantic fluency, HVLT immediate, and HVLT 
learning were not significantly correlated with percent change in ventricular volume (all p > 
0.05). 
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Table 4.5: Neuropsychological outcome following shunt surgery 
Test N Pre-shunt 
Mean (SD) 
Post-shunt 
Mean (SD) 
t df P 
MMSE 12 23.92 (3.40) 24.58 (3.92) -0.70 11 0.497 
AES-S 10 18.60 (7.95) 15.60 (9.06) 1.15 9 0.278 
GDS-15 10 5.10 (2.51) 5.10 (3.93) 0.00 9 1.000 
Phonemic fluency 12 29.75 (14.20) 30.33 (16.96) -0.19 11 0.853 
Semantic fluency 11 10.00 (3.98) 13.45 (3.83) -2.40 10 0.038* 
HVLT immediate 12 3.83 (1.40) 4.58 (1.68) -3.00 11 0.012* 
HVLT learning 12 13.83 (4.86) 17.50 (6.07) -2.70 11 0.020* 
HVLT delayed 12 2.17 (2.76) 3.08 (4.17) -0.74 11 0.473 
Note: MMSE = Mini-Mental State Examination; AES-S = self-rated State Apathy Evaluation; GDS-15 = Geriatric 
Depression Scale short form; HVLT = Hopkins Verbal Learning Test; * p < 0.05. 
 
4.5. Summary 
Part I of the present study conducted a volumetric assessment in patients with NPH using 
automated segmentation techniques. Total brain volume and volumes of subcortical structures 
in NPH patients were compared to healthy controls; and associations between volumetric data 
and cognitive function/ outcome were investigated. 
 
4.5.1. Pre-operative total brain volume 
Total brain, GM, and WM volumes were extracted at pre-shunt in the NPH group. As would be 
expected, age was significantly negatively correlated with WM volume and total brain volume 
in the NPH group. However, ventricular volume was not significantly correlated with total 
brain, GM, or WM volume. The average total brain, GM, and WM volumes of the NPH group 
were smaller than those for the control group but the differences were not statistically 
significant. 
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One previous study (Serulle et al., 2014) compared GM, WM, and ventricular volumes 
in patients with NPH, patients with Alzheimer’s disease (AD), and healthy controls. They found 
a statistically significant reduction in GM volume in patients with AD compared to NPH 
patients and controls. Although the mean GM volume for the NPH group was smaller than the 
control group mean, the difference was not statistically significant. No significant differences 
in WM volume were observed across the three groups. Ventricular volume in the NPH group 
was significantly larger than in the two remaining groups. Therefore, the results of the present 
study support the findings by Serulle et al.  
These results might suggest that, despite the ventriculomegaly, total brain volume in 
patients with NPH is not markedly reduced, or that brain atrophy is absent or mild in NPH. 
However, as the sample sizes in these studies were small, a larger study is needed to verify this 
finding. Another explanation could be that the patients in the present study and in the previous 
study had relatively short disease durations but that brain atrophy could occur as the disease 
progresses. The relationship between disease duration and total brain volume in NPH would be 
an interesting topic for future research. Finally, brain atrophy may only occur in a subgroup of 
NPH patients, such as those with comorbid AD (Serulle et al., 2014).  
The present study also investigated whether total brain, GM, and WM volumes were 
associated with cognitive performance. After controlling for the effect of age, WM volume was 
significantly negatively correlated with HVLT delayed score, and there was a trend towards a 
significant negative correlation between WM volume and HVLT learning score. That is, 
reduced WM volume was associated with better performance on a measure of delayed recall. 
The reason for this relationship is unclear and warrants further investigation. However, GM and 
total brain volume did not significantly correlate with scores in any of the cognitive tests. 
 
4.5.2. Subcortical deep grey matter structure volumes 
Volumetric assessment of SDGM structures was conducted in patients with NPH at both pre- 
and post-shunt. At baseline, mean volume of the caudate nucleus was significantly reduced in 
NPH patients compared to healthy controls after controlling for age and ventricular volume. 
Correlations between subcortical volumes and neuropsychological test scores in the NPH 
patient group at pre-shunt revealed that greater caudate volume was associated with better 
performance on the MMSE, and greater nucleus accumbens volume was associated with better 
performance on the HVLT immediate subtest. However, after controlling for IQ, the 
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relationship between caudate volume and MMSE score was no longer significant. At post-
shunt, volumes of the putamen, pallidum, hippocampus and nucleus accumbens were 
significantly reduced in the NPH group compared to controls after controlling for age and 
ventricular volume. Additionally, at post-shunt, greater caudate volume was associated with 
better semantic fluency performance and less severe levels of apathy; and greater nucleus 
accumbens volume was associated with better performance on the MMSE as well as better 
performance on the immediate, learning and delayed subtests of the HVLT. After controlling 
for IQ, the relationship between caudate volume and semantic fluency was no longer 
significant. 
 Reduced caudate volume was previously noted by our laboratory in a group of NPH 
patients who had not yet undergone shunt surgery (DeVito et al., 2007). While the previous 
study segmented the caudate nuclei only, in the present study, volumes for a greater range of 
SDGM structures were extracted. Despite this, at pre-shunt, the caudate was the only SDGM 
structure showing a statistically significant volume reduction compared to controls. DeVito et 
al. (2007) further hypothesised that caudate volume loss may contribute to cognitive decline 
and apathy in NPH. In the present study, caudate volume was associated with apathy at post-
shunt. 
At post-shunt, while there was no significant difference in mean caudate volume 
compared to pre-shunt, mean caudate volume was no longer significantly reduced compared to 
controls. Instead, the putamen, pallidum, hippocampus, and nucleus accumbens showed 
significant volume reductions compared to controls. Further, volume of the nucleus accumbens 
was associated with performance on the MMSE at post-shunt, and with verbal learning and 
memory at pre- and post-shunt. The nucleus accumbens forms part of the ventral striatum and 
has been linked to learning and memory (Setlow, 1997), and dementia (de Jong et al., 2012). 
Thus, the associations between caudate and nucleus accumbens volume with scores on 
neuropsychological tests and apathy suggest that striatal volume reductions in NPH may be 
related to functional impairment of these areas. While volumes of the putamen and pallidum 
did not correlate with performance in cognitive tests, both of these regions have been shown to 
play a role in movement (DeLong et al., 1984; Heimer, Switzer, & Van Hoesen, 1982; 
Marchand et al., 2008; Mogenson, Jones, & Yim, 1980). Therefore, future studies should 
investigate whether gait dysfunction in NPH is related to volumes of the pallidum and putamen. 
Although there were significant group improvements in tests of semantic fluency, and 
verbal learning and memory following shunt surgery; as well as significant volume increases 
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in the thalamus, and hippocampus, percent change in these variables were not significantly 
correlated. Therefore, SDGM volumetric change following shunt surgery cannot account for 
the observed cognitive improvement in the present study. However, regional volumetric 
changes following shunt may be associated with other measures of cognitive or functional 
outcome. 
It is unclear why volumes of specific SDGM structures might increase following shunt 
surgery. While percent increase in volume of the thalamus was significantly correlated with 
percent reduction in ventricular volume, reduced ventricular volume was not significantly 
correlated with increased volume of the hippocampus. Therefore, ventricular reduction may not 
be the sole mechanism leading to SDGM volumetric changes. A previous study investigating 
whole brain volume change following diagnostic CSF removal found an increase in global brain 
volume which was particularly evident in periventricular, frontal, and temporal regions (Singer 
et al., 2012). The researchers hypothesised that increased brain volume may be due to increased 
cerebral blood volume, and that this in turn might lead to improved cerebral perfusion. 
However, further research is needed to investigate whether regional volumetric changes are 
associated with changes in rCBF. 
Overall, the results suggest there is reduction of volumes of subcortical structures both 
before and following shunt surgery in NPH that is not solely due to ventricular enlargement. 
Striatal volumes in particular appear to be associated with cognitive performance and apathy in 
NPH. These results suggest that at least some of the cognitive decline in patients with NPH may 
be due to subcortical dysfunction.  
 
4.5.3. Rationale for Part II 
There was a significant negative correlation between caudate volume and apathy at post-shunt 
(that is, a reduction in caudate volume was associated with increased apathy severity), but this 
relationship was not observed at pre-shunt. However, due to problems with caudate 
segmentation in particular (due to ventriculomegaly), caudate volumetric information was not 
available for five of the patients at pre-shunt, and three of the patients at post-shunt, 
considerably reducing the sample size for caudate volume analyses. Therefore, in order to 
further investigate the relationship between caudate volume and apathy in NPH patients (at pre- 
and post-shunt), Part II of the present study was conducted in which the caudate nuclei were 
segmented manually for the NPH group. Specifically, Part II aimed to investigate whether 
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caudate volume is related to apathy at pre-shunt (I.e. whether the reduced sample size explains 
the lack of a relationship at pre-shunt in Part I), as well as at post-shunt. 
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Part II: Volume of the caudate nucleus in NPH: association with 
apathy and cognition 
 
4.6. Introduction 
Part 1 of the present study reported an association between caudate volume and apathy at post-
shunt, but not at pre-shunt, in patients with NPH. Apathy was not significantly correlated with 
volume of any other subcortical deep grey matter (SDGM) structure at either pre- or post-shunt. 
However, at pre-shunt the caudate nuclei were not reliably extracted for five of the patients (and 
were therefore not included in the analysis) and this might explain the lack of relationship 
between caudate volume and apathy at pre-shunt. Previous research has suggested a link 
between caudate dysfunction and apathy in NPH (Kanemoto et al., 2015) and in other dementias 
(Bruen, McGeown, Shanks, & Venneri, 2008; Levy & Czernecki, 2006). Therefore, in order to 
further investigate the relationship between caudate volume and apathy, manual segmentation 
of the caudate was conducted from both pre- and post-shunt scans. 
 
4.7. Methods 
4.7.1. Image analysis 
Caudate segmentation was performed on T1-weighted images using ITK-SNAP version 3.4.0 
(www.itksnap.org; Yushkevich et al., 2006). The right and left caudate nuclei were traced 
manually on contiguous axial slices as described by Looi et al., (2008). Segmentation began 
with the most inferior slice where the caudate nucleus was visible, bounded by the frontal white 
matter anteriorly, the anterior commissure posteriorly, and the internal capsule laterally (Looi 
et al., 2008). Tracing proceeded superiorly from the head to the tail of the caudate until the tail 
of the caudate was no longer distinguishable from the wall of the lateral ventricle. Caudate 
segmentation was then checked in the coronal and sagittal views where any errors were 
corrected. Finally, a 3D view of the segmented caudate nucleus is compiled and this was 
checked for abnormalities (Figure 4.4). 
The volumetric scaling factors obtained using SIENAX in Part I of the present study 
(see section 0) were used to normalise the volumes for head size (volumes were normalised for 
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head size by multiplying by the volumetric scaling factors). As laterality effects were not 
hypothesised, normalised right and left volumes of the caudate were combined to yield a single 
total volume. Estimates of ventricular volume were also obtained using SIENAX (section 0). 
 
4.7.2. Statistical analysis 
Pearson’s r correlations were conducted to investigate associations between caudate volumes 
obtained via automated segmentation and via manual tracing. Independent samples t-tests were 
conducted to investigate differences in volumes in patients who were included in Part I and 
those who were excluded. Pearson’s r correlations were conducted to investigate associations 
between demographic data and neuropsychological test scores; demographic data and 
volumetric data; and between volumetric data and neuropsychological test scores. Partial 
correlations were conducted where appropriate. Independent samples t-tests were conducted to 
investigate effects of sex on caudate volume at pre- and post-shunt. A paired samples t-test was 
conducted to investigate differences in caudate volume at pre- and post-shunt. 
 
 
Figure 4.4: Segmented right caudate in (A) axial section, (B) sagittal section, and (C) 
coronal section in a representative NPH patient; (D) 3D rendering of caudate volume 
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4.8. Results 
4.8.1. Demographic information 
As detailed in section 4.4.1, one patient from the initial sample was excluded due to comorbid 
AD and one patient was excluded due to having a complicated post-operative course. Therefore, 
the final patient group for Part II of the present study was fourteen (nine male and five female). 
Demographic information is presented in Table 4.1. 
 
4.8.2. Comparison of volumes obtained via automated and manual segmentation 
Caudate volumes obtained via manual tracing and via automated segmentation (section 0) were 
significantly correlated at both pre- (r = 0.74, p = 0.035) and post-shunt (r = 0.76, p = 0.011). 
Mean (SD) volumes obtained by manual tracing and automated segmentation are shown in 
Table 4.6. Mean caudate volumes obtained via manual tracing were smaller than those obtained 
via automated segmentation. To examine whether this was due to the inclusion of additional 
patients in the manual tracing analysis, the patients were split into those who were included in 
the automated segmentation analyses in Part I of the present study, and those who had been 
excluded (due to failure of automated caudate segmentation). Manual tracing of the caudate 
was conducted for an additional six patients at pre-shunt, and an additional four patients at post-
shunt in comparison to automated segmentation in Part I. Independent samples t-tests indicated 
that the mean (manually segmented) caudate volumes for the patients who had been excluded 
from the automated segmentation were not significantly different from those for whom 
automated segmentation was successful at pre- (p > 0.05) or at post-shunt (p > 0.05) (see Table 
4.7). Therefore, the reduced volumes obtained via manual tracing are not due to the inclusion 
of additional participants. 
 
Table 4.6: Caudate volumes obtained via automated segmentation and manual tracing 
Method Pre-shunt caudate volume  
Mean (SD); N 
Post-shunt caudate volume  
Mean (SD); N 
Automated segmentation 6720.4 (485.1); 8 6965.3 (822.6); 10 
Manual tracing 6288.7 (1386.2); 14 5610 (901.5); 14 
Note: Volumes are in mm3; volumes shown have been normalised for head size. 
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Table 4.7: Caudate volumes obtained via manual tracing for patients included or 
excluded from automated segmentation 
Patient subgroup Pre-shunt caudate volume 
Mean (SD); N 
Post-shunt caudate volume 
Mean (SD); N 
Included in automated 
segmentation analysis 
6191.9 (1643.4); 8 5470.6 (1044.9); 10 
Excluded from automated 
segmentation analysis 
6417.7 (1086.1); 6 5958.5 (138.1); 4 
Note: Volumes are in mm3; volumes obtained via manual tracing method. 
 
4.8.3. Correlation between demographic data and neuropsychological test scores 
At pre-shunt, years of education was significantly positively correlated with semantic fluency 
(r = 0.68, p = 0.015). At post-shunt, years of education was significantly positively correlated 
with MMSE score (r = 0.53, p = 0.050). At pre-shunt, IQ was significantly positively correlated 
with MMSE score (r = 0.80, p = 0.002). At post-shunt, IQ was significantly positively 
correlated with semantic fluency (r = 0.60, p = 0.039) and HVLT learning (r = 0.61, p = 0.035). 
Age was not significantly correlated with scores in any of the neuropsychological tests at pre- 
or post-shunt (section 4.4.4).  
 
4.8.4. Pre- and post-operative volumetric results 
Caudate volume was not significantly correlated with ventricular volume, IQ or age at pre- or 
post-shunt (p > 0.05). Mean caudate volumes of males and females were not significantly 
different at pre- or post-shunt (p > 0.05). Years of education was significantly positively 
correlated with caudate volume at both pre- (r = 0.57, p = 0.035) and post-shunt (r = 0.60, p = 
0.023). There was no significant difference in caudate volume between pre- and post-shunt 
(means and standard deviations are shown in Table 4.6). 
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4.8.5. Correlation with neuropsychological test scores and neuropsychiatric symptoms 
Pre-shunt 
Caudate volume was significantly positively correlated with MMSE score (r = 0.63, p = 0.022), 
phonemic fluency (r = 0.64, p = 0.019), semantic fluency (r = 0.78, p = 0.003), and HVLT 
delayed (r = 0.59, p = 0.035) at pre-shunt. Since pre-operative MMSE score was significantly 
correlated with IQ, and caudate volume at pre-shunt was significantly correlated with years of 
education, a partial correlation was conducted to investigate the relationship between caudate 
volume and MMSE while adjusting for IQ and years of education. The correlation between 
caudate volume and MMSE was no longer significant (r = 0.50, p = 0.138). After adjusting for 
years of education, the relationships between caudate volume and phonemic and semantic 
fluency remained significant (p = 0.006 and p = 0.019, respectively; see Figure 4.5 and Figure 
4.6), while the relationship between caudate volume and HVLT delayed was no longer 
significant (p = 0.198). 
 
 
Figure 4.5: Scatterplot showing the relationship between caudate volume and 
phonemic fluency performance (pre-shunt) 
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Figure 4.6: Scatterplot showing the relationship between caudate volume and 
semantic fluency performance (pre-shunt) 
 
Post-shunt 
At post-shunt, caudate volume was significantly positively correlated with MMSE score (r = 
0.78, p = 0.001), meaning greater caudate volume was associated with better performance on 
the MMSE. Additionally, caudate volume was significantly negatively correlated with AES-S 
(r = -0.69, p = 0.009) and GDS-15 (r = -0.55, p = 0.042), meaning greater caudate volume was 
associated with less severe levels of apathy and depression. Following partial correlations 
adjusting for years of education, the relationship between caudate volume and AES-S score 
remained significant (r = -0.65, p = 0.023; Figure 4.7), however caudate volume was no longer 
significantly correlated with MMSE (p = 0.080) or GDS-15 (p = 0.165). 
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Figure 4.7: Scatterplot showing the relationship between caudate volume and apathy 
(post-shunt) 
 
4.8.6. Distribution of AES-S ratings at pre- and post-shunt 
Distributions of AES-S ratings at pre- and post-shunt are shown in Figure 4.8. As shown in the 
figure, the range of AES-S ratings at post-shunt is greater than at pre-shunt. 
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Figure 4.8: Box-plot diagram showing AES-S ratings in patients 
with NPH at pre- and post-shunt 
Pre-shunt – n = 11; median = 15; range = 10-32. Post-shunt – n = 13; median 
= 11; range = 7-36. 
 
4.9. Discussion 
In Part I of the present study, an association between apathy and caudate volume was found in 
patients with NPH at post-shunt but not at pre-shunt. However, the automated segmentation 
method used failed to accurately segment the caudate in a number of patients, particularly from 
pre-operative MRI scans, reducing the sample size considerably. Therefore, Part II of the 
present study was conducted to supplement the analyses related to the caudate. In Part II, the 
caudate was segmented via manual tracing in order to further investigate associations with 
apathy and cognition and, specifically, to investigate whether caudate volume is related to 
apathy at pre-shunt. 
 The results from Part II of the present study supported those from Part I in that there 
was a significant correlation between caudate volume and apathy at post-shunt, but not at pre-
shunt. The nature of the correlations indicated that, at post-shunt, greater caudate volume was 
associated with less severe levels of apathy. DeVito et al. (2007) found evidence for caudate 
atrophy in patients with NPH, and the researchers pointed out that the symptoms of NPH 
(including executive dysfunction and apathy) have been associated with dysfunction of the 
caudate. Additionally, 0 provided evidence for a relationship between bicaudate ratio (which 
was suggested to possibly relate to subcortical atrophy) with apathy. The results of the present 
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study provide support to the notion that caudate dysfunction occurs in NPH, and that this 
contributes to the behavioural symptomology. Kanemoto et al., (2015) recently found evidence 
for an association between improvement in apathy following shunt surgery with improved 
regional cerebral blood flow (rCBF) in the anterior cingulate cortices and the right caudate 
nucleus. Therefore, caudate volume reduction might relate to reduction in rCBF.  
 It is unclear why the association between apathy and caudate volume was specific to 
post-shunt. The sample size was reduced at pre-shunt in Part I of the study, however, pre- and 
post-shunt sample sizes were equal for Part II. Therefore, the lack of relationship at pre-shunt 
was not due to the reduced sample size in Part I. The distributions of AES-S ratings at pre- and 
post-shunt were plotted in Figure 4.8. As shown in the figure, the range of ratings was larger at 
post-shunt, perhaps indicating that the pre-operative range was not broad enough for a 
statistically significant relationship to be detected. Another explanation might be that some of 
the more cognitively impaired patients at pre-shunt lack insight into their apathetic symptoms, 
meaning their AES-S ratings were unreliable. However, the above findings should be verified 
in a larger sample size before investigating these issues further. 
 Caudate volume was further associated with performance in neuropsychological tests. 
While a number of the correlations in Parts I and II did not remain statistically significant after 
controlling for the effects of IQ and years of education, manually traced caudate volumes were 
significantly correlated with phonemic and semantic fluency at pre-shunt after controlling for 
years of education. Additionally, volume of the nucleus accumbens was significantly correlated 
with MMSE score at post-shunt, and with performance on tests of verbal learning and memory 
at pre- and post-shunt. Taken together, these results provide evidence for the importance of 
striatal volume loss in the cognitive and behavioural symptoms in NPH. 
 
4.9.1. Structural MR imaging of NPH 
Caudate volumes obtained via automated segmentation were significantly correlated with those 
obtained via manual tracing at both pre- and post-shunt suggesting that automated segmentation 
was reasonably accurate for at least a subgroup of patients. However, a number of patients had 
to be excluded from the analyses in Part I of the present study due to inaccurate segmentation 
of the caudate (or of multiple subcortical structures). Therefore, in cases of more extreme 
ventriculomegaly, the automated segmentation method was unreliable. Of course, there are 
trade-offs for each method. While automated segmentation is less time consuming compared to 
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manual tracing and reduces observer bias, this method was not always reliable in the NPH 
patients due to ventriculomegaly. Manual tracing is more accurate, however, it is time-
consuming to trace in three planes, and there are recognised difficulties with tracing the tail of 
the caudate due to its small volume (Looi et al., 2008). 
 
4.9.2. Limitations 
There are a number of limitations to the present study. The sample sizes were small meaning 
that results should be interpreted with caution. Additionally, the small sample sizes combined 
with the fact that not all patients completed all neuropsychological tests meant that regression 
analyses could not be used. A third limitation concerns the use of self-rated scales. Future 
research should aim to verify these findings using informant- or clinician-rated scales, in 
addition to self-rated scales. Finally, the present study did not include a measure of disease 
duration which may relate to the magnitude of brain structural changes in patients with NPH.  
 
4.10. Conclusions 
Chapter 4 found evidence for volume reductions in a range of subcortical structures in patients 
with NPH. Striatal volume loss in particular appears to play a role in the cognitive and 
behavioural symptomology in NPH. 
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Chapter 5  
Investigating the efficacy of a novel rewarding learning task as an 
objective measure of motivation and apathy in patients with 
normal pressure hydrocephalus 
 
5.1. Introduction 
Apathy is a common symptom in patients with dementia, including patients with Alzheimer’s 
disease (Landes et al., 2001), Parkinson’s disease (Leentjens et al., 2008), frontotemporal 
dementia (Chow et al., 2009), and vascular dementia (Fuh, Wang, & Cummings, 2005). The 
prevalence of apathy in patients with NPH has also been shown to be high (44% - 86%; see 
section 3.3.2, Kanemoto et al., 2016; Kito et al., 2009). Apathy is most commonly measured 
using rating scales (see section 1.4.4). These can be self-rated (by the patient), informant-rated 
(by a family member or caregiver), or clinician-rated; or a combination of these. However, 
rating scales may be problematic for use with patients who have dementia. For example, self-
rated apathy scales may be unreliable if patients lose insight into their apathetic symptoms (i.e. 
as a result of cognitive decline; Aalten, Van Valen, Clare, Kenny, & Verhey, 2005; Starkstein, 
Jorge, Mizrahi, & Robinson, 2006a), while a disadvantage of informant-rated scales is that a 
caregiver may be unreliable or unavailable (Sockeel et al., 2006). Additional complications are 
associated with testing-retesting paradigms. For example, when investigating the effect of a 
treatment using informant-rated scales there is a risk of bias towards a positive treatment effect 
due to informants’ expectations or a placebo effect (Kanemoto et al., 2016; Kaufer, Cummings, 
& Christine, 1996). Therefore, there is a need to develop an objective measure of apathy, or 
motivation, for use with dementia patients (including patients with NPH). 
 Chapter 3 investigated change in apathy following shunt surgery using the State Apathy 
Evaluation scale (Blackwell et al., 2008) which is a modified version of the self-rated Apathy 
Evaluation Scale (AES-S; Marin et al., 1991) in patients with NPH. While there was a 
significant relationship between improvement in AES-S score and improvement in Mini-
Mental State Examination score, AES-S score did not significantly improve (reduce) following 
shunt surgery (mean time between shunt and reassessment was 4.17 months). Chapter 4 also 
did not find evidence for significant improvement in apathy following shunt surgery. Similarly, 
Kito et al. (2009) investigated change in neuropsychiatric symptoms in 10 iNPH patients using 
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the Neuropsychiatric Inventory (NPI; Cummings et al., 1994) but did not find a significant 
improvement in apathy following shunt. However, Kanemoto et al. (2016), investigating the 
effect of lumboperitoneal shunt surgery on neuropsychiatric symptoms in 22 patients with 
iNPH using the NPI, observed a significant improvement in apathy at 3 months post-shunt. 
 The conflicting results to date are likely due to a combination of small sample sizes and 
the use of different rating scales. While the patients in Chapters 3 and 4 may not have shown 
significant group improvements in apathy due to the low average baseline scores (median scores 
were 17.5 and 18.6, respectively; cut off for apathetic symptoms = 19, using 0 to 54 scoring 
range), Kanemoto et al. (2016) point out that the self-rated AES may be unreliable due to 
patients’ loss of insight into their symptoms. However, the informant-rated NPI may be biased 
towards a positive effect of shunt treatment (Kanemoto et al., 2016; Kaufer et al., 1996). As the 
problems associated with apathy scales are largely due to subjectivity, there is a need to develop 
an objective measure of apathy or motivation. This would be especially useful for assessing 
apathy in patients who have dementia and for evaluating effects of treatments. 
 
The challenge for developing an objective measure of motivation for use with dementia patients 
is that it should be simple enough for patients with cognitive decline to understand and 
complete. The present study investigated whether a reward learning paradigm, the simple 
Salience Attribution Test (sSAT), could be used as an objective measure of motivation. Apathy 
is associated with dysfunction of the dopaminergic reward system and linked to reward learning 
ability and motivation (Mitchell, Herrmann, & Lanctôt, 2011). The sSAT is a simplified version 
of the Salience Attribution Test originally devised by Roiser et al. (2009) which has provided 
useful information about motivation in healthy individuals and in patients with schizophrenia. 
The task was simplified for use in patients with dementia, and the present study assessed how 
well it measured motivation in healthy volunteers. 
 First, the original Salience Attribution Test from Roiser et al. (2009) is described in 
section 5.1.1, and the simplified version of the task (the sSAT) is then presented briefly. The 
sSAT is then described in detail in section 5.2.2. 
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5.1.1. The Salience Attribution Test (Roiser et al. 2009) 
The Salience Attribution Test taps stimulus-reinforcement association learning by measuring 
response times to stimuli of differing reward contingencies. Stimulus-reinforcement 
associations are associations between environmental stimuli and outcomes (e.g. reward/ 
punishment/ no outcome). Learning of stimulus-reinforcement associations can be investigated 
using conditioning experiments in which a neutral stimulus is repeatedly paired with a reward. 
Over time, the association between the previously neutral stimulus with a reward is learned and 
begins to affect behaviour (Schultz, Dayan, & Montague, 1997). Learning of stimulus-
reinforcement associations is modulated by dopaminergic pathways in the brain which code 
reward prediction errors (Murray, Corlett, et al., 2008; Schultz et al., 1997), and reward 
information is processed primarily in frontal regions of the brain as well as in the basal ganglia. 
The previously neutral stimulus is called the conditioned stimulus because its association with 
a reward triggers a conditioned response (e.g. salivating/ approach). 
 The Salience Attribution Test is a computerised reward learning task in which 
participants must respond (press a button) as quickly as possible to the onset of a target (a black 
square in the centre of the screen; see Figure 5.1). Pictures appear on the screen just before the 
onset of the target, and they signal the likelihood that a participant will win a monetary reward 
on a given trial. The pictures vary on two dimensions: colour (blue or red); and shape (animal 
or household object). Therefore, there are four types of pictures: blue animals; red animals; blue 
household objects; red household objects. In the task, one dimension of the picture is task-
relevant (e.g. colour) while the other is task-irrelevant (e.g. shape). The task-relevant dimension 
gives information about the likelihood of a reward. That is, a reward is more likely to follow 
one level of the task-relevant domain (colour, in this example) than the other. For example, blue 
pictures (regardless of shape) are reinforced on 87.5% of trials, while red pictures are reinforced 
on only 12.5% of trials. If shape is the task-irrelevant domain, it means that both types of shape 
are equally likely to precede a reward (50%). The reward contingency of a stimulus is the 
likelihood that it will be followed by a reward. Participants are not told about the reward 
contingencies of the different stimuli (pictures) but learn these over the course of the task. 
 The pictures that precede the target are the (previously neutral) conditioned stimuli 
which indicate the probability of a reward. Stimuli with high reward contingencies have been 
shown to be associated with faster response times relative to stimuli that do not predict a reward 
(Cools et al., 2005; Murray, Corlett, et al., 2008; O’Doherty et al., 2004). This effect has been 
termed reinforcement-related speeding, and is attributed to increased motivation in 
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anticipation of a (predicted) reward (Murray, Corlett, et al., 2008). As described by Roiser et 
al. (2009) this effect reflects adaptive motivational salience (or the correct assignment of 
salience to stimuli) where the learned association between a previously neutral stimulus and a 
reward can affect behaviour.  
 
 
Figure 5.1: The Salience Attribution Test (from Roiser et al. 2009) 
The conditioned stimuli are either coloured blue or red. Participants respond to 
the target (black square) which is preceded by conditioned stimuli of varying 
reward contingencies. Following a response, feedback is presented on the screen.   
 
Roiser et al. (2009) measured adaptive motivational salience in two ways: implicit 
motivational salience - behavioural adaptive motivational salience defined as the speeding of 
responses to high-probability rewarding stimuli relative to low-probability rewarding stimuli; 
and explicit motivational salience – subjective learning of the reward contingencies of stimuli, 
defined as the increase in probability rating for high-probability rewarding stimuli relative to 
low-probability rewarding stimuli. The participants in their study showed a reinforcement-
related speeding effect, and they also rated high-probability rewarding stimuli as more likely to 
be followed by a reward than low-probability rewarding stimuli. Therefore, the task was 
successful in tapping both implicit and explicit motivational salience. Attenuated adaptive 
motivational salience, on the other hand, may be associated with a motivational deficit such as 
apathy (Roiser et al., 2009). Indeed, Roiser et al. found that medicated patients with 
schizophrenia showed a reduction in implicit motivational salience compared to controls, and 
this was related to a measure of anhedonia. 
Using functional magnetic resonance imaging, Roiser, Stephan, den Ouden, Friston, and 
Joyce (2010) found that the presentation of high- versus low-probability rewarding cues elicited 
hemodynamic responses in regions of the brain associated with the ‘affective’ cortico-striatal-
thalamic loop including the ventral tegmental area, the medial dorsal thalamus, and the ventral 
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striatum, regions which respond to the rewarding associations of stimuli. The researchers 
hypothesised that dopaminergic activity mediates learning of stimulus-reward associations. 
 It should be noted that the Salience Attribution Test can also provide a measure of 
aberrant motivational salience, or the incorrect assignment of salience to task-irrelevant stimuli, 
a process which may underlie the positive symptoms in schizophrenia (such as delusions). 
However, for the purposes of the present study, the sSAT was simplified to measure adaptive 
motivational salience, only, as it is linked to goal-directed behaviour or motivation. This meant 
that the conditioned stimuli in the sSAT varied on only one dimension (colour) instead of two 
(colour and shape).  
 
Like the Salience Attribution Test, the sSAT features a target (a black box) to which participants 
must respond quickly in order to win money, and which is preceded by pictures (two circles 
appearing at the top and bottom of the screen) which signify the probability that a reward will 
follow (see Figure 5.2). The circles vary in colour (blue, yellow, or red) in a task-relevant 
fashion, that is, the colour of the cue signals the probability that money will be awarded in a 
given trial. One level of the cue (e.g. blue) is reinforced in 80% of trials (high availability); 
another level (e.g. yellow) is reinforced in 50% of trials (medium availability); and the last level 
(e.g. red) is reinforced in only 20% of trials (low availability).  
 As with in Roiser et al. (2009) this task allows us to calculate two measures of adaptive 
motivational salience; these are explicit (or subjective) salience, and implicit (or behavioural) 
salience. Explicit motivational salience is measured using a visual analogue scale (VAS) in 
which participants estimate the reinforcement contingencies of each of the three coloured cues. 
Implicit motivational salience is measured using participants’ response times. It is expected that 
control participants would show both implicit and explicit adaptive motivational salience using 
this task, while patients with NPH would show attenuated adaptive implicit motivational 
salience compared to healthy controls, reflecting their apathetic symptoms. However, the 
present study investigated whether the sSAT is sensitive to implicit and explicit adaptive 
motivational salience in healthy controls. 
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Figure 5.2: Screenshots from the simple Salience Attribution Test 
The pictures (blue circles) appear on the screen before the onset of the target 
(black square). Participants respond to the target and on-screen feedback is 
given. 
 
 Since patients with NPH are typically elderly, the sSAT was piloted in both younger 
and older healthy adults to investigate whether there are age-related differences in performance. 
Normal aging is associated with structural atrophy as well as reductions in dopaminergic 
neurotransmission which may affect stimulus-reward learning (Mell et al., 2005, 2009). There 
were two research objectives in the present study: (1) to investigate whether the sSAT is 
sensitive to explicit and implicit adaptive motivational salience in healthy participants and 
whether, therefore, it could be an appropriate task for measuring motivation in patients with 
NPH; and (2) whether there were age-related differences in performance. The hypothesises 
were that: (1) participants would rate high-probability reward cues as more rewarding than 
medium- or low-probability reward cues; (2) participants would respond faster to the high-
probability reward cues relative to medium- or low-probability reward cues; and (3) older adults 
would show reduced adaptive implicit motivational salience compared to younger adults. 
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5.2. Methods 
5.2.1. Participants 
Two groups of healthy volunteers were assessed using the sSAT: younger adults (aged 21 to 
35, n = 25); and older adults (aged 50 to 90, n = 19). Participants were recruited via 
advertisement within Cambridge. This study received ethical approval from the University of 
Cambridge Psychology Research Ethics Committee. 
 
5.2.2. The simple Salience Attribution Test (sSAT) 
The sSAT was presented using MATLAB on a Paceblade. Participants began with a tutorial 
which featured instructions for the task, and built-in practice sessions allowing participants to 
familiarise themselves with the task and also providing a baseline measure of response time 
(RT). 
 The first practice session consisted of two blocks of 20 trials. During this session, a 
fixation cross appeared in the centre of the screen. After a short interval (0.5 – 1.5 seconds, 
variable), the probe appeared and participants were instructed to try to respond as quickly as 
possible, by pressing the right shift key, before it disappeared. The mean RT from the first block 
was used as the mean probe duration in the second block. The standard deviation of the quickest 
half of the trials (SDF) in the first block was used to set the maximum and minimum probe 
durations in the second block (mean from first block ± 2 × SDF). The RT and standard deviation 
from the second trial were used to calculate the mean, maximum and minimum probe durations 
for the main game in the same way. Participants received the following feedback during the 
practice session: “Good” if a response is made before the box disappears; “Try to respond 
faster” if a response is made after the box disappears; and “Too early” if a response was made 
before the onset of the box. However, no monetary rewards were given during the practice 
session.  
 Participants then completed a second practice session followed by the main game which 
consisted of two blocks of 60 trials. For the second practice session, participants were instructed 
to respond to the probe, as in the first practice session. However, in this session cues (pink 
circles) preceded the probe. Instructions for this part of the task informed the participants that 
the cue has a specific reward contingency, giving a reward on only a certain percentage of trials, 
but they were not told what the reward contingency was. The second practice session consisted 
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of 4 trials and participants were rewarded in 3 of these. Followed the second practice session, 
participants were asked to indicate the percentage of trials in which the pink circle gave a reward 
using a visual analogue scale (75% being the correct response). At this point, the experimenter 
could discuss with the participant how often a reward was given in the second practice session 
so that participants were clear on how to estimate the reward contingency of a cue. 
 For the following two blocks of trials in the main game blue, yellow or red cues 
appeared, signalling the onset of the probe. The reward contingencies for the different coloured 
cues were 20%, 50% and 80%. The colours associated with each of the reward contingencies 
were counterbalanced between participants. The order in which the coloured cues appeared was 
fully randomised to eliminate order effects. At the beginning of each trial, a fixation cross 
appeared in the centre of the screen. After 1000ms one of the three coloured cues appeared at 
the top and bottom of the screen and remained until the end of the trial. After a variable interval 
(500-1500ms) the probe appeared in the centre of the screen replacing the fixation cross and 
participants attempted to respond by pressing the right shift key.  
 Participants received feedback and a monetary reward dependant on cue type. If no 
reward was available for a given trial the following appeared: “Sorry no money available”. If a 
reward was available (reinforced trial), participants could win between 5 and 100 pence 
depending on speed of response. If a response was made after the probe had disappeared, or not 
at all, during a reinforced trial, the message “Missed: 5 pence” appeared. If a response was 
made too soon (less than 100ms after onset of probe) then the message “Too early: 5 pence” 
appeared. If participants responded slower than their mean RT, but before the probe 
disappeared, “Good: 10 pence” was displayed. For responses up to 1.5 SDFs faster than a 
participants’ mean RT, the message “Quick: X pence” appeared, and for responses over 1.5 
SDFs faster than their mean RT, “Very quick: X pence” appeared. The amount of reward given 
was calculated as follows: X = 10 + 90 × (mean RT – trial RT)/(3 × SDF), up to 100 pence per 
trial. The amount of money awarded per trial was added to the participants’ running total for 
the block and displayed below the feedback. 
 After each block of trials a 10mm VAS scale was displayed in which participants 
indicated how often they thought each level of the cue was followed by a monetary reward (the 
estimated reinforcement probabilities of each cue). The three scales ranged from 0-100%. 
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5.2.3. Statistical analysis 
A two-way repeated measures analysis of variance (ANOVA) was used to analyse the effect of 
cue reward probability on response times for blocks 1 and 2. The two within-group factors were 
cue reward probability (High; Medium; Low), and block (1; 2). A repeated measures ANOVA 
was used to analyse VAS ratings to three levels of cue reward probability for blocks 1 and 2. 
The two within-group factors were cue reward probability (High; Medium; Low), and block (1; 
2). 
 
5.3. Results 
One younger adult participant and one older adult participant were excluded from analyses 
because their RTs were more than three standard deviations away from the mean. Mean (SD) 
age in years was 25.60 (4.18) for the younger adult group, and 66.10 (7.89) for the older adult 
group.  
 
5.3.1. Younger adults 
Younger adults’ (n = 24) mean response times and VAS ratings for the three reward-probability 
cues in blocks 1 and 2 are shown in Table 5.1. 
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Table 5.1: Younger adults' mean (SD) response times (ms) and VAS ratings for high, 
medium, and low reward probability cues in blocks 1 and 2 
Cue Reward Probability  Block RT (ms) 
mean (SD) 
VAS rating  
mean (SD) 
High 1 290.66 (39.28) 64.17 (17.49) 
 2 292.32 (33.82) 63.75 (15.48) 
Medium 1 289.94 (38.20) 42.92 (17.75) 
 2 287.40 (40.80) 39.79 (12.89) 
Low 1 292.40 (41.40) 18.75 (15.27) 
 2 289.93 (46.16) 16.04 (13.75) 
 
Implicit motivation 
There was no significant main effect of reward probability on RT, F(2, 46) = .21, p = .81, ηp2 = 
.009, thus younger adults did not demonstrate adaptive implicit salience. There was no 
significant main effect of block, F(1, 23) = .07, p = .79, ηp2 = .003, and there was no significant 
interaction between reward probability and block, F(2, 46) = .29, p = .75, ηp2 = .01. 
 
Explicit motivation 
There was a significant main effect of probability, F(2, 46) = 83.75, p < .001, ηp2 = .79, with 
participants rating high, medium, and low probability-reinforcement cues significantly 
differently. Pairwise comparisons using the Bonferroni correction revealed that mean VAS 
rating of the high-probability reward cue was significantly higher than mean VAS rating of the 
medium-probability reward cue (p < .001) and of the low-probability reward cue (p < .001). 
Additionally, mean VAS rating of the medium-probability reward cue was significantly higher 
than mean VAS rating of the low-probability reward cue (p < .001). Therefore, younger 
participants were roughly estimating the correct reward contingencies of the three cues, thus 
demonstrating adaptive explicit salience. There was no main effect of block, F(1, 23) = 1.58, p 
= .22, ηp2 = .06, and no interaction was observed between cue reward probability and block F(2, 
46) = .22, p = .80, ηp2 = .01. 
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5.3.2. Older adults 
Older adults’ (n = 19) mean response times and VAS ratings for the three reward-probability 
cues in blocks 1 and 2 are shown in Table 5.2. 
 
Table 5.2: Older adults' mean (SD) response times (ms) and VAS ratings for high, 
medium, and low probability reward cues in blocks 1 and 2 
Cue Reward Probability Block RT (ms) 
mean (SD) 
VAS rating  
mean (SD) 
High 1 312.73 (42.53) 55.00 (20.86) 
 2 296.97 (42.83) 56.67 (14.95) 
Medium 1 320.09 (46.04) 42.22 (13.53) 
 2 285.02 (37.76) 35.83 (14.37) 
Low 1 303.82 (38.73) 23.61 (16.16) 
 2 301.82 (54.43) 23.61 (14.43) 
 
Implicit motivation 
There was no significant main effect of reward probability on RT, F(2, 34) = .11, p = .90, ηp2 = 
.006, thus older adults did not to demonstrate adaptive implicit salience. There was a significant 
main effect of block, F(1, 17) = 6.62, p = .02, ηp2 = .28 with participants responding faster in 
Block 2 than in Block 1 perhaps demonstrating a practice effect.  
 There was a significant interaction between reward probability and block, F(2, 34) = 
4.18, p = .02, ηp2 = .197. Further analysis of the interaction revealed that in block 1 participants 
responded slower to the medium-probability reward cue compared to high- and low-probability 
reward cues, while in block 2 participants responded faster to the medium-probability reward 
cue compared to high- and low-probability reward cues. Paired samples t-tests were conducted 
to compare response times to each reward probability cue in blocks 1 and 2. There was a 
significant difference in response times to the medium-probability reward cue in block 1 (M = 
320.09, SD = 46.04) and block 2 (M = 285.02, SD = 37.76); t(17) = 3.99, p = .001. There were 
no other significant differences. Therefore, differences in response times to the medium-
probability reward cue could account for the main effect of block on response times.  
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Explicit motivation 
There was a significant main effect of probability, F(2, 34) = 27.53, p < .001, ηp2 = .62, with 
participants rating high, medium, and low probability-reinforcement cues significantly 
differently. Pairwise comparisons using the Bonferroni correction revealed that mean VAS 
rating of the high-probability reward cue was significantly higher than mean VAS rating of the 
medium-probability reward cue (p = .003) and of the low-probability reward cue (p < .001). 
Additionally, mean VAS rating of the medium-probability reward cue was significantly higher 
than mean VAS rating of the low-probability reward cue (p = .001). This reflects the 
observation that participants were roughly estimating the correct reward contingencies of the 
three cues, thus demonstrating adaptive explicit salience. There was no main effect of block, 
F(1, 17) = .50, p = .49, ηp2 = .03, and no interaction was observed between cue reward 
probability and block F(2, 34) = 1.36, p = .27, ηp2 = .07. 
 
5.4. Discussion 
The aim of the present study was to evaluate the suitability of a reward learning task, a 
simplified version of the Salience Attribution Test (Roiser et al., 2009), to act as an objective 
measure of motivation for assessing apathy in patients with normal pressure hydrocephalus. 
The present study piloted the task in younger and older healthy adult participants to investigate 
whether participants would show adaptive explicit and implicit motivational salience similar to 
that found using the Salience Attribution Test (Roiser et al., 2009), and whether there are age-
related differences in performance. The hypotheses were that: (1) participants would rate high-
probability reward cues as more rewarding than medium- or low-probability reward cues; (2) 
participants would respond faster to the high-probability reward cues relative to medium- or 
low-probability reward cues; and (3) older adults would show reduced adaptive implicit 
motivational salience compared to younger adults. The first hypothesis was supported as both 
younger and older adults rated high-probability reward cues as more rewarding than medium- 
and low-probability reward cues, and thus they demonstrated adaptive explicit salience. 
However, the second hypothesis was not supported as neither group responded faster to the 
high-probability reward cues relative to medium- or low-probability reward cues. 
Consequently, the third hypothesis was not supported as neither group demonstrated adaptive 
implicit motivational salience. As the healthy participants in the present study did not 
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demonstrate adaptive implicit motivational salience, the sSAT would be unsuitable for use as 
an objective measure of motivation in NPH. 
 The sSAT was simplified from the original Salience Attribution Test which may be the 
reason that the reinforcement-related speeding effect (which has previously been reported in 
healthy participants; Cools et al., 2005; Murray, Clark, et al., 2008) was not found in the present 
study. The task was simplified (1) to measure adaptive motivational salience only, and not 
aberrant motivational salience; and (2) so that the task would be appropriate for patients with 
NPH who are typically elderly. However, as a result, the task was likely too easy for the healthy 
participants, meaning that a ceiling effect was observed whereby participants responded equally 
quickly to all stimuli regardless of their reward contingencies. 
 
5.4.1. Alternative measures 
A possible alternative task which could be used as an objective measure of motivation in 
patients with dementia could be The Progressive Ratio Task from the recently developed 
EMOTICOM test battery (Bland et al., 2016). The task comprises a simple ‘odd one out’ 
paradigm and participants are rewarded during successful trials. However, the reward gets 
progressively smaller over the course of the task. Participants are told that they can discontinue 
the task at any point, but that if they do so they will have to sit facing the screen for the 
remainder of the session. From this, a ‘motivational breakpoint’ can be calculated which is the 
maximum effort expended in order to receive a reward. This task is a good candidate for 
objectively measuring motivation in patients with NPH as the task is simple enough that it 
would be appropriate for older participants, and comparable normative data is already available 
for healthy adult participants (Bland et al., 2016). 
 Alternatively, wearable technologies may provide useful information for quantifying 
apathy or motivation in patients with dementia, such as those which measure patients’ activity 
levels (Goldfine et al., 2016), or even wearable recording technologies for caregivers for 
capturing behavioural symptoms (Matthews et al., 2015). 
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5.5. Conclusions 
The present study investigated whether a novel reward learning task, the sSAT: a simplified 
version of the Salience Attribution Test, was sensitive to adaptive implicit and explicit 
motivational salience in younger and older healthy adults and whether, therefore, it could be 
used as an objective measure of motivation in patients with NPH. Both groups demonstrated 
subjective understanding of the reward contingencies for each cue (explicit motivational 
salience), however no corresponding behavioural changes were observed in either group. That 
is, participants did not respond faster to the target when it was preceded by a more rewarding 
cue and, thus, did not demonstrate adaptive implicit motivational salience. The sSAT is 
therefore unsuitable as an objective measure of motivation for patients with NPH. 
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Chapter 6  
General discussion 
 
6.1. Summary of the thesis 
This thesis aimed to expand on the neuropsychological and the neuropsychiatric research 
relating to normal pressure hydrocephalus, with specific emphasis on investigating the effect 
of shunt surgery on neuropsychological performance in patients, and investigating the 
significance of the symptom of apathy. Three studies that investigated cognitive function and 
apathy in patients with normal pressure hydrocephalus were reported, and a further feasibility 
study of a novel reward learning task to determine whether it might be useful as an objective 
measure of motivation and apathy for patients with dementia was reported. 
 Study 1 (Chapter 2, ‘The effect of shunt surgery on neuropsychological performance in 
normal pressure hydrocephalus: A systematic review and meta-analysis’) used meta-analytic 
techniques to investigate neuropsychological outcome following treatment for NPH. 
Specifically, Study 1 examined whether specific aspects of neuropsychological functioning are 
more likely than other aspects to show improvement following shunting and whether, therefore, 
a consistent pattern of neuropsychological change emerges. Study 2 (Chapter 3, ‘Apathy, 
ventriculomegaly and neurocognitive improvement following shunt surgery in normal pressure 
hydrocephalus’) investigated the significance of the symptom of apathy for cognitive outcome 
in NPH, prevalence of apathy in patients with NPH, and whether a simple measure of 
ventricular enlargement was related to level of apathy. Study 3 (Chapter 4, ‘Brain structural 
correlates of cognitive dysfunction and neuropsychiatric symptoms in normal pressure 
hydrocephalus) used structural imaging analysis techniques to investigate whole brain and 
subcortical volumetric changes in NPH and associations with cognitive dysfunction and apathy. 
Study 4 (Chapter 5, ‘Investigation into the efficacy of a novel rewarding learning task as an 
objective measure of motivation and apathy in patients with normal pressure hydrocephalus’) 
examined performance in a novel reward learning task (the simple Salience Attribution Test; 
sSAT) by younger and older healthy adults in order to investigate the task’s utility as an 
objective measure of apathy or motivation for use with patients with dementia. 
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6.2. Main contributions of this research 
The main findings of this thesis were as follows: 
Study 1, Chapter 2: 
(i) Meta-analyses were conducted on average difference scores (from pre-to post-
shunt) for seven neuropsychological tests spanning global cognition, learning and 
memory, executive function, and psychomotor speed. Statistically significant 
estimated average difference scores were observed for all seven tests in the direction 
of improved performance following shunt surgery. However, detailed examination 
of the results suggested that the evidence for improvement in two of the tests (two 
tests of executive function) was not robust. Therefore, while there was good 
evidence for improvements in tests of global cognition, learning and memory, and 
psychomotor speed following shunt surgery, the evidence for improved 
performance in tests of executive function was less clear. 
(ii) Meta-regressions revealed no significant effect of age, sex, or time between shunt 
and reassessment on outcome in a measure of global cognitive functioning. 
 
Study 2, Chapter 3:  
(i) The frequency of apathetic symptoms (as measured using the self-rated Cambridge 
State Apathy Evaluation scale; AES-S) was 44% at pre-shunt and 14% at post-
shunt. The frequency of depressive symptoms (measured using the short form of 
the Geriatric Depression Scale; GDS-15) was 52% at pre-shunt and 25% at post-
shunt. 
(ii) Frequency of apathetic and depressive symptoms did not change significantly from 
pre- to post-shunt. 
(iii) AES-S and GDS-15 ratings were significantly correlated at both pre- and post-
shunt. AES-S and GDS-15 scores were also correlated with neuropsychological test 
scores. 
(iv) The bicaudate ratio (a measure of ventricular enlargement) was significantly 
positively correlated with self-rated levels of apathy and depression at pre-shunt. 
That is, greater degree of ventriculomegaly was associated with greater levels of 
self-rated apathy and depression. 
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(v) There were significant post-operative group improvements in performance in tests 
of phonemic fluency, semantic fluency, and delayed recall. 
(vi) There was a non-significant trend for a reduction in mean apathy rating at post-
shunt compared to pre-shunt. 
(vii) Following shunt treatment, a reduction in apathy severity was significantly 
correlated with improved performance in a measure of global cognitive function. 
 
Study 3, Chapter 4: 
Part I: 
(i) Total brain volume, total grey matter (GM) volume, and total white matter (WM) 
volume were not significantly different between patients with NPH (pre-shunt) and 
controls. 
(ii) WM volume was significantly negatively correlated with performance on a measure 
of delayed verbal recall, after controlling for age, in patients with NPH at pre-shunt. 
That is, reduced WM volume was associated with better performance on the task. 
(iii) At pre-shunt, mean volume of the caudate was significantly reduced in the NPH 
group compared to healthy controls after controlling for age and ventricular volume. 
(iv) At pre-shunt, volume of the nucleus accumbens was significantly positively 
correlated with performance on a measure of immediate verbal recall in the NPH 
group. That is, greater nucleus accumbens volume was associated with better 
performance on the task. 
(v) At post-shunt, mean volumes of the putamen, pallidum, hippocampus, and nucleus 
accumbens were significantly reduced in the NPH group compared to healthy 
controls after controlling for age and ventricular volume. 
(vi) At post-shunt, volume of the caudate was significantly negatively correlated with 
AES-S rating. That is, greater caudate volume was associated with less severe level 
of self-rated apathy. Additionally, volume of the nucleus accumbens was 
significantly positively correlated with performance on tasks of global cognitive 
function and verbal learning and memory. That is, greater nucleus accumbens 
volume was associated with better performance on the tasks. 
(vii) Volumes of the thalamus and the hippocampus were significantly larger at post-
shunt compared to pre-shunt. Percent change in ventricular volume was significantly 
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correlated with percent change in volume of the thalamus, but not with percent 
change in volume of the hippocampus. 
(viii) There were significant post-operative group improvements in performance in tests 
of semantic fluency, immediate and total verbal recall. 
(ix) Percent change in volumes of the thalamus and hippocampus were not significantly 
correlated with percent change in semantic fluency, immediate and total verbal 
recall scores. 
 
Part II: 
(i) Caudate volumes obtained via manual tracing and via automated segmentation were 
in good agreement. 
(ii) There was no significant difference in caudate volume between pre- and post-shunt. 
(iii) At pre-shunt, caudate volume was significantly positively correlated with 
performance on tasks of phonemic and semantic fluency, after controlling for years 
of education. That is, greater caudate volume was associated with better 
performance on the tasks. 
(iv) At post-shunt, caudate volume was significantly negatively correlated with AES-S 
rating, after controlling for years of education. That is, greater caudate volume was 
associated with less severe levels of apathy. 
 
Study 4, Chapter 5:  
(i) Both older and younger healthy adults demonstrated adaptive explicit salience. That 
is, they correctly estimated the relative reward contingencies of the three stimuli in 
the sSAT task. However, neither group demonstrated adaptive implicit motivational 
salience during the task (their behaviour did not change to reflect learning of the 
reward contingencies of the stimuli). The sSAT task is, therefore, deemed to be 
unsuitable as an objective measure of motivation or apathy in NPH. 
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6.3. Interpretation and integration of findings 
6.3.1. Neuropsychological outcome following treatment for NPH 
The first aim of this thesis was to investigate the effect of shunt surgery on neuropsychological 
performance in patients with NPH. A number of studies have found evidence for impaired 
neuropsychological functioning in patients. In particular, patients show impairments in 
memory, executive function, psychomotor speed, and visuospatial abilities (DeVito et al., 2005; 
Duinkerke et al., 2004; Gleichgerrcht et al., 2009; Iddon et al., 1999; Katzen et al., 2011; Mataró 
et al., 2003; Saito et al., 2011; Solana et al., 2012b). However, the pattern of neuropsychological 
change following treatment for NPH has not been established.  
 In order to investigate neuropsychological outcome following treatment for NPH, 
Chapter 2 conducted meta-analyses of outcome for the most frequently used 
neuropsychological tests in studies of NPH. The tests spanned global cognitive function, 
learning and memory, executive function, and psychomotor speed. A significant problem facing 
investigations into the neuropsychology of NPH to date concerns the small sample sizes 
contained in many studies. Chapter 2 pooled results from 23 studies and 1059 patients to gain 
a clearer picture of neuropsychological outcome. Results indicated statistically significant 
estimated average difference scores for all tests in the direction of improvement following shunt 
surgery. However, despite the significance levels, the results for two of the studies (two 
measures of executive function) did not appear to be robust. 
 The results suggested that, on average, shunt surgery leads to improvements in 
neuropsychological functioning. This is in agreement with a number of studies which find 
improvements on neuropsychological tests following shunting (Chaudhry et al., 2007; 
Duinkerke et al., 2004; Gleichgerrcht et al., 2009; Hellström et al., 2008; Katzen et al., 2011; 
Raftopoulos et al., 1994; Solana et al., 2012b; Stambrook et al., 1988; Thomas et al., 2005). 
Regarding the pattern of post-shunt improvement, there was good evidence for improvements 
on tests of global cognitive functioning, learning and memory, and psychomotor speed, while 
the results concerning outcome on tests of executive function were less clear. One of the three 
tests of executive function included in the meta-analyses showed good evidence for 
improvement following shunt surgery. However, the evidence for improvement in performance 
on the remaining two tests was not considered to be robust. Therefore, the results might suggest 
that, on average, performance on tasks of executive function is less likely to improve following 
shunt surgery.  
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 Some studies have found that performance on tests of executive function does not 
improve following shunt (Iddon et al., 1999; Thomas et al., 2005) or is less likely to improve 
compared to other cognitive domains (Solana et al., 2012b). Additionally, there is large 
variability in results relating to outcome in tests of executive function following shunt (see 
section 2.4). If executive dysfunction is less likely to improve following shunt compared to 
impairments in other domains, it might reflect irreversible impairment to fronto-subcortical 
connectivity resulting from NPH (Iddon et al., 2004). Accordingly, executive dysfunction may 
only improve in a subgroup of patients with NPH (such as those who have mild executive 
dysfunction at baseline, as opposed to those with more severe executive dysfunction which 
might indicate greater disease severity/ longer disease duration and thus greater structural 
damage to the brain). This could explain why some studies find good evidence for improvement 
in tests of executive functions (e.g. Gleichgerrcht et al., 2009; Saito et al., 2011). However, it 
should be noted that the three tests of executive function included in the meta-analyses do not 
adequately tap higher-level executive functions such as planning or decision making. Therefore, 
there is a need to assess high-level executive functions in patients with NPH before and after 
shunt surgery in order to investigate this finding further. 
 
Establishing an expected pattern of neuropsychological change following shunt surgery is 
important for a number of reasons. Firstly, it is useful for providing patients with realistic 
information regarding the likely benefits of treatment. Secondly, it could inform further 
treatment or care options. For example, residual cognitive deficits (such as executive 
dysfunction) following shunt surgery can have significant implications for patients’ quality of 
life, and could impact on their ability to complete daily tasks meaning that patients might 
require assistance from a carer. Alternatively, targeted treatment of residual cognitive deficits 
could be an option for some patients, e.g. via non-pharmacological treatment methods such as 
targeted cognitive training (Sahakian et al., 2015); or via pharmacological treatments such as 
cognitive enhancing drugs (Keenan et al., 2005). Thirdly, an established pattern of 
neuropsychological change could aid in diagnosis of NPH, as well as quantifying outcome 
following shunt treatment. 
 
Does NPH represent a reversible form of dementia? 
Whether or not NPH represents a reversible dementia is debated. The results of Chapter 2 
provide support to the notion that neuropsychological performance is improved following shunt 
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surgery in patients with NPH. However, the results do not provide information about the extent 
of cognitive recovery. Very few studies of long-term cognitive outcome have been conducted 
and therefore it is not known whether patients ever return to “normal”. Although current 
evidence suggests this is unlikely (Hellström et al., 2008, 2012b). Nevertheless, for many 
patients, there is considerable improvement in the cognitive symptoms following shunt 
treatment which can have a substantial impact on patients’ quality of life. 
 
6.3.2. The symptom of apathy in NPH 
The second aim of the thesis was to investigate the significance of the symptom of apathy for 
cognitive function and outcome since this symptom is under-researched in NPH. Chapter 3 
reported evidence that levels of apathy and depression were related to neuropsychological 
functioning at both pre- and post-shunt. However, when investigating whether change in apathy 
or depression was related to cognitive improvement, improved global cognitive functioning was 
associated with change in apathy levels but not with change in depression severity. Therefore, 
apathy may be a significant obstacle for cognition and functional outcome. 
 
How common is apathy in NPH? 
In Chapter 3, the prevalence of apathy was investigated by examining the frequency of patients 
scoring within the apathetic range of the AES-S. Based on this criteria, apathy was present in 
44% of patients at pre-shunt, and in 14% at post-shunt. In comparison, prevalence of depression 
was 52% at pre-shunt, and 25% at post-shunt. Only two studies have previously investigated 
prevalence of apathy in NPH (Kanemoto et al., 2016; Kito et al., 2009) and they found higher 
rates of apathy (70-86% at pre-shunt). The same studies reported lower rates of depression (14-
36% at pre-shunt). 
 This discrepancy is likely due to the different assessment measures used. Both 
Kanemoto et al. (2016) and Kito et al. (2009) used the Neuropsychiatric Inventory (NPI) to 
assess apathy and depression (see section 0 for a description). The NPI relies on informant 
reporting whereas AES-S and GDS-15 are both rated by the patients themselves.  
A criticism of the use of self-rated scales in studies of NPH is that the patients may have 
impaired insight into their symptoms meaning that their ratings are unreliable. Insight or self-
evaluation has been shown to be associated with functioning of the frontal regions (Hornberger 
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et al., 2014; van der Meer, Costafreda, Aleman, & David, 2010). Hornberger et al. (2014) 
conducted a voxel-based morphometry analysis in patients with neurodegenerative conditions 
and found that atrophy of ventromedial and frontopolar prefrontal cortical regions was 
associated with loss of insight. Further, loss of insight was most severe in patients with 
behavioural variant frontotemporal dementia (which is characterised by degeneration of the 
frontal and temporal lobes) compared to patients with language subtypes of frontotemporal 
dementia and patients with Alzheimer’s disease (AD). Although there is evidence for 
impairments in frontal functioning in patients with NPH (Iddon et al., 1999; Sasaki et al., 2007), 
this appears to be mediated by a primary dysfunction of fronto-subcortical mechanisms (Iddon 
et al., 1999; Momjian et al., 2004; Shprecher, Schwalb, & Kurlan, 2008; Waldemar et al., 1993) 
and there is limited evidence for cortical atrophy in NPH (Serulle et al., 2014). Nevertheless, a 
recent study investigated cortical thickness in patients with iNPH who were either cerebrospinal 
fluid tap test (CSF-TT) responders or non-responders (Kang, Yoon, Lee, & Lee, 2013). Kang 
et al. (2013) found that CSF-TT non-responders showed increased cortical thinning in most 
areas of the brain compared with CSF-TT responders but particularly in the left superior frontal 
gyrus (an area which has been associated with self-awareness; Goldberg, Harel, & Malach, 
2006). However, there were no significant differences in cortical thickness between CSF-TT 
non-responders and patients with AD, which the researchers suggested might indicate the 
presence of comorbid AD pathology in this group. Therefore, impaired insight may not be as 
prominent in NPH as it is in other neurodegenerative conditions. However, an early study of 23 
patients with hydrocephalic dementia (most of whom had a known or tentative cause of 
hydrocephalus; age range: 36-70) reported that impaired insight was a prominent symptom 
(Gustafson & Hagberg, 1978) and so there is a need to investigate whether this is a problem for 
the use of self-rated scales in patients with NPH. 
Although there is a need to investigate this issue further, in the CSF disorders clinic at 
Addenbrooke’s care is taken to ensure that the information obtained from self-rated scales is as 
accurate as possible. The following measures are in place: patients are advised that they may 
complete the scales privately if they wish; the statements contained within the rating scales can 
be read aloud by the research psychologist if needed; patients are encouraged to consider their 
responses to the statements (e.g. by thinking of examples of how they do or don’t meet a 
behaviour); and finally, the scoring of the AES allows the research psychologist to check 
whether patients have not read the questions (that is, each statement is scored out of four 
indicating least to most severity of apathy, apart from two for which the scoring is reversed). 
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On the other hand, the nature of the scoring on the NPI may make it biased towards a 
false positive result and could explain the higher prevalence reported by Kanemoto et al. (2016) 
and Kito et al. (2009). However, it should be noted that the sample size in Chapter 3 was small 
and, in addition, a number of patients did not complete the AES-S at pre-shunt, possibly 
affecting the results. 
 
Does shunt surgery lead to a reduction in apathy? 
Chapters 3 and 4 provided information about the effect of shunt surgery on apathetic symptoms. 
While mean group apathy rating was reduced following shunt surgery in both Chapters, neither 
showed a statistically significant reduction in apathy severity. However, it should be noted that 
there was an overlap of five patients in Chapters 3 and 4. Additionally, the difference in 
prevalence of apathetic symptoms between pre- and post-shunt was examined in Chapter 3. 
While prevalence was reduced following shunt surgery, the difference was not statistically 
significant. 
 Kanemoto et al. (2016) previously reported a significant reduction in apathy severity 
but not in prevalence, at three months post-shunt. In contrast, Kito et al. (2009) assessed change 
in apathy severity only, and did not find a statistically significant reduction in apathy severity 
at three months post-shunt. Kito et al. suggested that the patients in their study may have been 
at an early disease stage meaning levels of apathy at baseline were mild. Additionally, the mean 
baseline apathy ratings in Chapters 3 and 4 were below the cut-off for apathetic symptoms and 
so this could explain the lack of improvement of apathy severity in these studies. 
As yet, the effect of shunt surgery on apathetic symptoms in NPH has not been 
elucidated. Larger studies with better assessment measures are required in order to examine this 
issue further. 
 
Is apathy distinct from depression in NPH? 
AES-S and GDS-15 ratings were significantly correlated at both pre- and post-shunt in Chapter 
3. Additionally, both were related to scores in cognitive tests and bicaudate ratio. Therefore, 
the symptoms of apathy and depression likely overlap. However, improvement in global 
cognitive function was associated with a reduction in apathy but not depression, suggesting that 
the two are differentially related to cognitive outcome. 
121 
 
 However, few studies have investigated both apathy and depression together in patients 
with NPH. Depression is more commonly assessed in patients (without also including a measure 
of apathy), so the co-occurrence and significance of each has not been determined. Additionally, 
if a measure of apathy is not included, apathetic symptoms may be misdiagnosed as depression. 
In Chapter 3, the proportions of patients scoring only in the depressive range of the GDS-15 
and not in the apathetic range of the AES-S, and vice versa, was small (although this was not 
compared to the general population). However, the self-rated nature of both scales means that 
patients themselves may have falsely attributed apathetic symptoms to depression (or 
depressive symptoms to apathy). Therefore, in order to investigate this further, objective 
assessment measures are needed. 
 A better understanding of this issue is of primary importance as it could have 
implications for treatment options. For example, apathy could be a target for treatment using 
cognitive enhancing drugs (Keenan et al., 2005). 
 
How to measure apathy 
The problems outlined above in relation to measurement of apathy generally relate to (1) the 
differences in assessment measures being used across studies, and (2) the subjective nature of 
the tests. In order to more accurately investigate the significance of the symptom of apathy in 
NPH (including prevalence and outcome) more reliable assessment measures are needed. Of 
greatest help would be an objective measure of motivation which would be easy to use for 
patients with dementia, and could be used in conjunction with apathy rating scales. 
Additionally, when measuring apathy using rating scales, where possible it is important to 
include both self- and informant-ratings in order to obtain a more cohesive picture of the 
symptomology. Finally, assessments of neuropsychiatric/ behavioural symptoms in patients 
with NPH should include measures of both apathy and depression.  
 
6.3.3. Structural correlates of cognitive dysfunction and apathy 
Chapter 3 examined relationships between bicaudate ratio (BCR; a measure of ventricular 
enlargement and possibly related to subcortical atrophy) and apathy and depression; and BCR 
and global cognitive function in patients with NPH at pre-shunt. BCR was significantly 
correlated with levels of apathy and depression. That is, greater pre-operative ventriculomegaly 
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was associated with more severe levels of apathy and depression. BCR was not significantly 
correlated with global cognitive function. Since evidence for caudate atrophy in patients with 
NPH has previously been found (DeVito et al., 2007), a structural MR imaging study was 
conducted in Chapter 4 to investigate structural correlates of cognitive dysfunction and apathy 
in NPH with a particular focus on subcortical volumetric assessment. Both automated 
segmentation and manual tracing methods were used. 
 The results from Chapter 4 suggested that striatal volume loss in particular was 
associated with cognitive dysfunction and neuropsychiatric symptoms in patients with NPH. 
Further, caudate volume was significantly correlated with levels of apathy at post-shunt, with 
larger caudate volumes being associated with less severe levels of apathy. The results, therefore, 
provide support to the notion that the cognitive and behavioural symptoms in NPH result from 
subcortical pathology. 
 
6.4. Summary of the limitations of the investigations 
There are a number of limitations to the current work and these are discussed below. 
 
6.4.1. Classification of significant improvement following shunt 
There is no consensus as to how to classify significant improvement in cognition following 
shunt surgery in patients with NPH. In Chapters 3 and 4, improvement was based on assessment 
of differences in group means from pre- to post-shunt. However, other studies have used 
different criteria for improvement. For example, Chang et al. (2006) examined improvement on 
the individual patient level. Significant improvement in each task was defined as at least 25% 
improvement in score, or reduction in time taken to complete the task (where appropriate). An 
individual was classified as ‘improved’ if they showed at least 25% improvement on more than 
50% of the tasks. By analysing changes on the group level, only, some important patterns in the 
data may have been missed. However, due to the small sample sizes in this thesis, this kind of 
analysis is likely inappropriate. 
 This also has implications for interpretation of the meta-analysis results where 
difference scores in neuropsychological tests from pre- to post-shunt were also examined on 
the group level.  
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6.4.2. Practice effects 
Practice effects is an important issue for consideration when investigating outcome following 
shunt surgery. This thesis did not analyse neuropsychological performance in a control group 
in order to investigate the influence of practice effects on follow-up scores. However, parallel 
versions of neuropsychological tests were used in order to mitigate practice effects. 
Additionally, a number of studies have provided evidence that practice effects are minimal in 
investigations of cognitive outcome following shunt surgery (Katzen et al., 2011; Saito et al., 
2011; Solana et al., 2010). Nevertheless, it is important that future studies include a control 
group to undergo repeated testing in order to investigate the influence of practice. 
 
6.4.3. Heterogeneity of groups 
Heterogeneity of patients is a significant problem for NPH research. Patients often have 
comorbid disorders such as Alzheimer’s disease, or cerebrovascular risk factors. Although it is 
desirable to conduct investigations on ‘pure’ NPH, excluding patients on the basis of comorbid 
disorders is problematic for a number of reasons. Firstly, small sample sizes is a pervasive 
problem in NPH research and excluding further patients reduces the statistical power in studies. 
Secondly, excluding participants based on comorbidities means that results may not be 
generalizable to all patients with NPH.  
Additionally, it has been recommended that patients with idiopathic NPH (iNPH) and 
patients with secondary NPH (sNPH) be separated in studies of cognitive outcome following 
shunt (Larsson et al., 1991; Thomas et al., 2005) as the two have been shown to respond 
differently to shunt surgery. Specifically, patients with sNPH are more likely to respond 
positively to shunt surgery than those with iNPH (Larsson et al., 1991; Thomas et al., 2005). In 
Chapters 3 and 4, patients with iNPH and sNPH were not separated and so this could have 
affected the results. 
 
6.4.4. Assessment methods 
As discussed previously, apathy and depression were measured using self-rated measures in 
Chapters 3 and 4 which may be problematic. The development of objective measures of 
neuropsychiatric or behavioural changes in NPH would be of high clinical value. 
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6.5. Directions for future work 
6.5.1. Post-shunt neuropsychological functioning 
Future studies should investigate the extent of cognitive recovery that occurs in patients with 
NPH following shunt surgery. If significant cognitive impairments remain, they may be a target 
for treatment. For example, future studies could investigate the efficacy of cognitive training 
paradigms for reducing residual cognitive impairment in NPH. Cognitive rehabilitation has 
shown to produce measurable benefits in functioning in patients with dementia (Clare et al., 
2010) and brain injury (Rohling, Faust, Beverly, & Demakis, 2009), thus it could be a viable 
option for patients with NPH. Alternatively, the efficacy of pharmacological treatment with 
cognitive enhancing drugs could be investigated further. One case study has demonstrated that 
the cognitive enhancer methylphenidate may be a promising treatment for alleviating cognitive 
dysfunction and apathy in patients with NPH (Keenan et al., 2005). 
 Additionally, it is important for future studies to investigate whether executive function 
improves following shunt surgery. Specifically, higher-level executive functions such as 
decision making or planning should be assessed in patients with NPH before and following 
shunt surgery to better quantify changes in executive function. 
 
6.5.2. Apathy 
Future studies should aim to determine the optimal method for assessing apathy in patients with 
NPH (and other dementias). Initially, future studies should aim to determine whether the 
different assessment scales produce different results regarding prevalence and outcome of 
apathy. Secondly, insight into apathy should be investigated in patients with NPH in order to 
investigate whether self-ratings are reliable. Thirdly, the development of an objective measure 
of apathy for use in patients with dementia should be a priority. Finally, future studies should 
aim to elucidate the effects of apathy on cognition and vice versa. 
 
6.5.3. Structural imaging in NPH 
Future studies should investigate whether subcortical volume loss is related to impaired 
regional cerebral blood flow in subcortical regions, and whether volume increase is related to 
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improved blood flow. Longitudinal volumetric assessment is also of value to investigate 
whether brain atrophy continues after shunt surgery as well as the clinical implication of this. 
  
6.6. Achievement of the aims of this thesis 
This thesis aimed to expand on the neuropsychological and neuropsychiatric research in NPH. 
More specifically, this thesis aimed to investigate (i) the effect of shunt surgery on 
neuropsychological performance in patients with NPH; (ii) the significance of the symptom of 
apathy in NPH; (iii) structural correlates of cognitive dysfunction and apathy in NPH; and (iv) 
the efficacy of current apathy assessment measures. 
 The results of this thesis provided evidence that there is a beneficial effect of shunt 
surgery on neuropsychological performance in patients with NPH. Although a number of 
studies found that patients improved on neuropsychological tests following shunt, a consistent 
pattern of improvement had failed to emerge. A meta-analysis was conducted to pool the 
available data in order to provide a clearer picture of post-shunt cognitive change. From the 
results, it appears that, on average, patients improve on tests of learning and memory, global 
cognitive function, and psychomotor speed. However, there is a need to further investigate the 
effect of shunt surgery on executive function. 
 In evaluating the significance of the symptom of apathy, Chapter 3 found evidence that 
apathy in NPH is related to cognitive function and outcome, as well as degree of 
ventriculomegaly at baseline. Importantly, reduction in apathetic symptoms following shunt in 
Chapter 3 was associated with improved performance on a measure of global cognitive 
functioning. This might suggest that the symptom of apathy may be a barrier to functional 
recovery in patient with NPH which could have implication for treatment options. The most 
important conclusion from these investigations is that apathy should be objectively measured 
in patients with NPH in addition to depression. 
 The results of the structural imaging project provided evidence for the role of subcortical 
pathology in the cognitive and behavioural symptomology in NPH. Specifically, the impaired 
functioning of the caudate appears to underlie the symptom of apathy in NPH. This might 
suggest that cognitive dysfunction and apathy in NPH have shared neural underpinnings. 
 Finally, this thesis provided an evaluation of a possible objective measure of apathy, 
something which would be of great clinical utility, particularly for assessing apathy in patients 
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with dementia or cognitive decline. Although the task described here was ultimately deemed to 
be unsuitable for this purpose, some alternative measures were proposed. 
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APPENDIX A. The Cambridge State Apathy Evaluation scale 
(self-rated) 
Indicate how much you agree with each statement right now. INSTRUCTIONS: For each statement 
below, circle one number to indicate how true you think each statement is for you in the past couple of 
weeks. Is the statement (0) not at all true, (1) slightly true, (2) somewhat true, or (3) very true? Please 
provide one rating for every statement, even if you are not confident of your answer. 
NOTE: This questionnaire is asking how you FEEL. So, for example, if you FEEL like getting things 
done but struggle to because of other factors, you should answer the question based on what you feel 
like doing, not what you actually do. 
 Not at all Slightly Somewhat Very 
I feel interested in things 0 1 2 3 
I feel like getting things done (rather than putting them 
off) 
0 1 2 3 
Getting things started on my own is important to me 0 1 2 3 
I am interested in having new experiences 0 1 2 3 
I am interested in learning new things 0 1 2 3 
I don’t feel like putting any effort into anything 0 1 2 3 
I feel like approaching tasks whole-heartedly 0 1 2 3 
I feel it is important to see a job through to its end 0 1 2 3 
I feel like spending time pursuing my interests/ hobbies 0 1 2 3 
I feel that I need someone to tell me what to do (otherwise 
I’d do nothing) 
0 1 2 3 
I am less concerned about my problems than I ought to be 0 1 2 3 
I would like to meet new people 0 1 2 3 
I feel like spending time with friends 0 1 2 3 
I would be excited if good things were to happen 0 1 2 3 
I think I have an accurate understanding of my problems 0 1 2 3 
I feel like doing a good job and achieving something 0 1 2 3 
I feel full of initiative 0 1 2 3 
I feel motivated 0 1 2 3 
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APPENDIX B. Meta-analyses results when assuming alternative 
correlations between average pre- and post-operative scores 
 
Results of meta-analyses of the average difference between pre-operative and post-operative 
neuropsychological test scores when assuming alternative correlations (between the average 
pre-operative and post-operative scores) of 0.4 and 0.8 are presented in Table B-1 and Table B-
2, respectively. 
 
 
Table B-1: Results of meta-analyses when assuming an alternative correlation of 0.4 
Note: MMSE, Mini-mental state examination; RAVLT, Rey Auditory Verbal Learning Test; TMT, trail making 
test. 
 
 
 
 
 
 
 
 
Test 
n of 
Studies 
Estimated 
average 
difference  
95% CI  p 
Cochran’s Q  
(d.f.; p) 
I2 
Estimated 
between-
study 
variance 
MMSE 19 2.17 points 1.42, 2.92 < 0.001 
75.20  
(18; < 0.001) 
76.1% 1.77 
RAVLT total 7 5.55 words 3.76, 7.33 < 0.001 
12.29 
(6; 0.06) 
51.2% 2.44 
RAVLT 
delayed 
7 1.42 words 0.57, 2.27 0.001 
40.55 
(6; < 0.001) 
85.2% 0.97 
Backwards 
digit span 
6 0.34 digits 0.04, 0.65 0.03 
30.10 
(5; < 0.001) 
83.4% 0.10 
Phonemic 
verbal 
fluency 
8 2.41 words 0.76, 4.07 0.004 
7.57 
(7; 0.37) 
7.6% 0.45 
TMT-B 9 -41.54 sec -80.73, -2.36 0.04 
27.92 
(8; < 0.001) 
71.3% 2.2e+03 
TMT-A 13 -26.03 sec -35.64, -16.42 < 0.001 
14.42 
(12; 0.28) 
16.8% 48.71 
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Table B-2: Results of meta-analyses when assuming an alternative correlation of 0.8 
Note: MMSE, Mini-mental state examination; RAVLT, Rey Auditory Verbal Learning Test; TMT, trail making 
test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Test 
n of 
Studies 
Estimated 
average 
difference  
95% CI  p 
Cochran’s Q  
(d.f.; p) 
I2 
Estimated 
between-
study 
variance 
MMSE 19 2.22 points 1.47, 2.97 < 0.001 
158.56 
(18; < 0.001) 
88.6% 2.23 
RAVLT total 7 5.84 words 4.04, 7.64 < 0.001 
17.56 
(6; 0.007) 
65.8% 3.05 
RAVLT 
delayed 
7 1.44 words 0.51, 2.37 0.002 
97.45 
(6; < 0.001) 
93.8% 1.33 
Backwards 
digit span 
6 0.37 digits 0.04, 0.70 0.03 
62.42 
(5; < 0.001) 
92.0% 0.15 
Phonemic 
verbal 
fluency 
8 3.24 words 1.09, 5.40 0.003 
18.87 
(7; 0.009) 
62.9% 5.52 
TMT-B 9 -46.41 sec -87.44, -5.37 0.03 
54.86 
(8; < 0.001) 
85.4% 2.9e+03 
TMT-A 13 -25.47 sec -35.89, -15.05 < 0.001 
29.04 
(12; 0.004) 
58.7% 163.02 
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APPENDIX C. The Geriatric Depression Scale (short form) 
 
Instructions: Circle the answer that best describes how you felt over the past week. 
 
1. Are you basically satisfied with your life? yes no 
2. Have you dropped many of your activities and interests? yes no 
3. Do you feel that your life is empty? yes no 
4. Do you often get bored? yes no 
5. Are you in good spirits most of the time? yes no 
6. Are you afraid that something bad is going to happen to you? yes no 
7. Do you feel happy most of the time? yes no 
8. Do you often feel helpless? yes no 
9. Do you prefer to stay at home, rather than going out and doing 
things? 
yes no 
10. Do you feel that you have more problems with memory than 
most? 
yes no 
11. Do you think it is wonderful to be alive now? yes no 
12. Do you feel worthless the way you are now? yes no 
13. Do you feel full of energy? yes no 
14. Do you feel that your situation is hopeless? yes no 
15. Do you think that most people are better off than you are? yes no 
          
Total Score ____________ 
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